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Enolates constitute one of the most commonly utilized intermediates in synthetic 
organic chemistry. However, the regioselective generation of enolates remains a 
challenge, especially for non-symmetric ketones possessing identical degrees of 
substitution at the α-positions. Our research has shown that regioselective enolate 
generation can be achieved by the activation of enones and enals with either 1) 
nucleophilic phosphine catalysis or 2) transition metal catalysis to generate enolates 
regioselectively. These enolates can be subsequently trapped with electrophiles.  
Using nucleophilic phosphine catalysis we have developed the first method for 
the α-arylation of enones, enals, and nitroalkenes using bismuth(V) reagents. This 
phosphine-catalyzed arylation methodology is mild in that a strong base is not required. 
Additionally, the products of this reaction are easily elaborated to complex molecules. 
 vii
This method has been strategically applied in a concise formal and enantioselective total 
synthesis of the blockbuster antidepressant (-)-paroxetine (PAXIL®). 
 In transition metal catalysis, we have used enantioselective Cu-catalyzed 
conjugate addition of Grignard reagents to enones to provide magnesium enolates, which 
can be arylated using bismuth(V) reagents to furnish products of vicinal 
difunctionalization of enones. These products are obtained in modest to good yields with 
complete control of both relative and absolute stereochemistry. Another method for 
regioselective enolate generation is the Rh-catalyzed hydrogenation of enones and enals. 
Using this method we have developed a reaction that involves addition of metallo-
aldehyde enolates to ketone acceptors to afford aldol products. This is the first catalytic 
direct addition of transition metal enolates to ketones. 
  
 viii
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Chapter 1: Historical Overview of Nucleophilic Catalysis via Conjugate 
Addition of Phosphines to Enones and Enoates  
1.1 Introduction 
Organocatalytic transformations have emerged as powerful methods for carbon–
carbon bond formations. 1  Transformations based on nucleophilic activators form a 
distinct sub class of organocatalytic reactions.2 Between 1960 and 1990 phosphines were 
not used extensively as nucleophiles. However, in the last decade reports on nucleophilic 
catalysis employing phosphine nucleophiles have increased dramatically. Conjugate 
addition of phosphine nucleophiles to activated alkenes provides intermediates that can 
be trapped by electrophiles resulting in new C-C bond formation. Tertiary phosphines 
and amines have pyramidal geometry, whereas phosphines are configurationally stable at 
above room temperature, tertiary amines undergo inversion at room temperature. This 
means phosphines retain chirality at phosphorus at room temperature which can 
potentially be exploited in asymmetric synthesis. In this account we present an overview 
of phosphine mediated reactions based on conjugate addition of p-nucleophiles to vinylic 
carbonyl and vinylic nitrile compounds.  
1.2 Rauhut-Currier Reaction 
In 1963 Rauhut and Currier reported a phosphine-catalyzed dimerization of alkyl 
acrylates.3 Later, in 1965 McClure,4 Baizer and Anderson5 independently reported a 
phosphine-catalyzed dimerization of acrylonitrile. This transformation is believed to 
proceed via reversible phosphine conjugate addition to an activated alkene to give a 
zwitterionic enolate I, which undergoes conjugate addition with a second activated alkene. 
 1

























Scheme 1.1 Mechanism for Rauhut-Currier reaction 
In 1969 Morita and Kobayashi reported a reaction between activated alkenes and 
fumaric/maleic esters catalyzed by tricyclohexylphosphine to provide product 1.3 
(Scheme 1.2).6  The first cross coupling reaction between acrylonitrile and acrylate was 
reported by McClure in 1970 (Scheme 1.3). 7  The cross coupling product 1.6 was 
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Scheme 1.3 First Cross Rauhut-Currier reaction 
Three decades passed with very few reports of phosphine-catalyzed Rauhut-
Currier reaction. During this period several groups reported tertiary amine-catalyzed 
variants of the Rauhut-Currier reaction.8 In 2000, Jenner reported a phosphine-catalyzed 
dimerization of β-substituted acrylonitrile and acrylate under both ambient and high 
pressure. 9  The lack of selectivity in Rauhut-Currier reactions involving different 
activated alkenes remained a major limitation. Krische and Roush have concurrently 
addressed this problem through an intramolecular process, in which the activated alkene 
partners are tethered (Scheme 1.4). 10 Aromatic-aliphatic mixed bis(enone) 1.9 gives the 
cycloisomerization products 1.10 and  1.11 as a 1:1 mixture of isomers, whereas the  
homologous substrate 1.12  affords the cyclohexenes 1.13 and 1.14 in a 7:1 ratio, 
respectively. These data suggests that the kinetic phosphine adducts are trapped 
efficiently via cyclization to cyclopentene, but for cyclohexene formation, a slow 
cyclization rate enables a pre-equilibrium of tributylphosphine adducts. Unsymmetric 
 3
electronically biased bis(enones) undergo chemoselective cycloisomerization initiated  by 
addition of the more electrophilic alkene onto the less electrophilic alkene as shown in 
substrates 1.15, 1.21, 1.24 and 1.27. For substrates lacking significant electronic 
difference, steric factors direct chemoselectivity as demonstrated in substrate 1.18. It was 
observed by both groups that tertiary amine nucleophiles such as DABCO, DBU, Et2NH, 
and DMAP, which are common catalysts for Morita-Baylis Hillman reaction, were less 
effective in catalyzing intramolecular Rauhut-Currier reaction than the trialkylphosphine 
nucleophiles. This low reactivity is attributed to the fact that trialkylphosphines are more 
nucleophilic than the corresponding tertiary amines. Triarylphosphines are not viable 
catalysts for this transformation. In 2004 Krische and Luis reported that vinyl sulfones 
serve as effective Michael acceptors in phosphine-catalyzed intramolecular Rauhut-
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Scheme 1.5 Enone-sulfone cycloisomerization 
Recently Roush and Thalji reported a tandem Rauhut-Currier/aldol reaction that 
results in unprecedented chemoselectivity in the aldol step (Scheme 1.6).12 Experimental 
data indicate that the phosphonium moiety of the phosphine-enone Michael adduct 1.40 
controls the chemoselectivity. The phosphonium unit interacts with the adjacent carbonyl 
as seen in intermediate 1.40, enhancing the acidity of the β-phosphonium-substituted 
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1.2.1 Application of Rauhut–Currier Reaction in Total Synthesis 
In 2003 Krische and Agapiou showed that thioenoates participate in highly 
chemoselective phosphine-catalyzed cross Michael cycloisomerization with appendant 
aryl ketone and enoate partners to afford cyclopentene and cyclohexene products 
(Scheme 1.7).13 This methodology was subsequently applied in a concise total synthesis 















1.42 1.43 1.44  
Scheme 1.7 Enone-thioenoate cycloisomerization and total synthesis of (±)-ricciocarpin 
A 
Roush and co-workers reported a transannular phosphine mediated Rauhut-
Currier cyclization, also known as a vinylogous-Morita-Baylis-Hillman reaction, of the 
Diels-Alder adduct 1.45 en route to total synthesis of (-)-spinosyn A (Scheme 1.8).14 The 
product of the transannular reaction 1.46 was elaborated to the desired natural product (-






















































Scheme 1.8 Transannular Rauhut-Currier reaction and total synthesis of (-)-spinosyn A 
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1.3 Morita-Baylis–Hillman Reactions 
The phosphonium enolate intermediates generated via phosphine conjugate 
addition to activated alkenes can be captured by other electrophiles such as aldehydes. In 
1968 Morita and co-workers reported the first reaction between acrylates and 
acrylonitrile with aldehydes in the presence of tricyclohexylphosphine to afford 2-(1-
hydroxy-alkyl)acrylonitriles or -acrylates (Scheme 1.9). 15  Subsequent to this seminal 
result, in 1972 Baylis and Hillman reported a similar transformation using the tertiary 
amines such as DABCO, pyrrocoline, and quinuclidine.16 This Morita-Baylis-Hillman 
reaction is an atom economical transformation for coupling activated alkenes, which 
include acrylic esters, acrylonitrile, vinyl ketones, phenyl vinyl sulfones, phenyl vinyl 
sulfonate esters, vinyl phosphonates and acrolein with a variety of electrophiles such as 
aliphatic, aromatic, and α-β-substituted aldehydes. The phosphine-catalyzed MBH 
reaction involving β-substituted activated alkenes requires more forcing conditions due to 








EWG = CN, CO2Me
R = Me, Et,  n-Pr, i-Pr, Ph, p-Cl-C6H4, P-Me-C6H4  
Scheme 1.9 Discovery of Morita-Baylis-Hillam reaction 
Low conversion rate, substrate dependent chemical yields, and the susceptibility 
of the phosphine catalyst to undergo air-oxidation is a significant limitation of the 
Morita-Baylis-Hillman reaction when applied to complex synthetic problems. Based on 
 9
kinetic studies by Kaye and Bode the rate determining step is the trapping of the transient 
zwitterionic enolate by the aldehyde. 17  Due to these limitations the MBH reaction 
remained under developed for over a decade despite its synthetic potential. In the 1980s 
there was significant research activity in this area devoted to tertiary amine-catalyzed 
variants of MBH reaction.2 Tertiary amines are cheaper and less toxic than 
trialkylphosphine catalysts, however phosphines give better yields in a shorter reaction 
time.  
Kawanisi and co-workers improved the efficiency of the phosphine-catalyzed 
MBH reaction by introducing a lewis acid-base complex, tributylphosphine and 
triethylaluminum in dichloromethane.18  Later in 2002 Taylor and co-workers applied 
these conditions to the synthesis of epi-epoxydon. 19  Leahy and Rafel observed 
unexpected rate acceleration in both amine and phosphine catalyzed MBH reactions upon 
lowering the reaction temperature to 0 °C (Scheme 1.10).20 Typically MBH reactions 
take between 4-7 days to reach completion, but at 0 °C, the similar transformations were 
done in less than 12 hours. The authors rationalized this surprising observation by 
considering the transient enolate intermediates A and B, which are both in equilibrium 
with the starting material and react at different rates with the aldehyde. It was speculated 
that the relative concentration of A and B is different at 0 °C compared to at elevated 
temperature and thus the accelerated rate in MBH reaction reflects this difference. 
Evidence consistent with this proposal is that there was no rate enhancement in MBH 
reaction of acrylonitrile and benzaldehyde, since acrylonitrile is not predisposed to form 
intermediates like A.21  
 10
Fu and Netherton in 2001 addressed the air-sensitivity problem associated with 
trialkylphosphines by employing the air and moisture stable phosphonium salts as 
catalyst precursors and sodium phenoxide base (Scheme 1.11). 22  These conditions 
addressed both reaction efficiency and air sensitivity of the phosphine catalyst, the MBH 



















R = Me, Et, i-Pr, Bu, Ph
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Scheme 1.11 MBH reaction using phosphonium salts 
The Morita-Baylis-Hillman reaction rate can be accelerated by using Lewis base-
Brønsted acid co-catalysts.23 According to mechanistic studies performed by Liu and Shi 
the Brønsted acid in the co-catalyzed systems stabilizes the phosphonium enolate 
intermediates via hydrogen-bonding with the enolate anion, thus driving the reaction 
 11
forward (Scheme 1.12).23c The co-catalyzed mechanism was investigated using 31P NMR 





















Scheme 1.12 A plausible mechanism for phosphine- Brønsted acid co-catalyzed MBH 
reaction 
1.3.1 Intramolecular Morita-Baylis-Hillman Reaction 
The first phosphine-catalyzed intramolecular variant of the Morita-Baylis-
Hillman reaction was reported by Frater in 1992.24 This reaction afforded cyclization 
products in low yields (17-23%). Murphy investigated this reaction further and reported 
cyclization of enones onto aldehydes to form both five and six- membered rings (Scheme 
1.13).25  Tributylphosphine catalyst gave good chemical yields for six-membered ring 





















1.57 1.58 1.59 1.60
 
Scheme 1.13 Intramolecular Morita-Baylis-Hillman reaction 
Keck and Welch observed that thioenoates cyclize efficiently onto aldehydes in 
the presence of trimethylphosphine to give both five-membered and six-membered ring 
products (Scheme 1.14). 26  The enoate cyclization onto the aldehyde was sluggish 
providing the MBH adduct 1.63 in low 33% yield. They found that enolizable aldehydes 
were more prone to side reactions, such as dimerization, and cylizations are more 

























Scheme 1.14 Keck’s intramolecular Morita-Baylis-Hillman reaction 
In 2004 Koo and co-workers reported a triphenylphosphine mediated 
intramolecular MBH reaction (Scheme 1.15).27 A dramatic solvent effect was observed in 
this reaction, when polar solvents like t-BuOH and MeCN provided excellent yields of 
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desired cyclic products while less polar solvents gave lower yields. Recently Toy and co-
workers performed similar experiments using both E and Z enones with an appendant 
aldehyde (Scheme 1.16).28  The substrates possessing (Z)-alkene stereochemistry 1.71 
gave a higher yield of the desired cyclic product than did the corresponding E isomer 





































1.69 1.70 1.71 
Scheme 1.16 Effect of alkene geometry on MBH reaction 
1.3.2 Asymmetric Morita-Baylis-Hillman Reaction 
In 1992 Franter and co-workers reported the first asymmetric intramolecular 
MBH reaction using p-chiral phosphine (-)-CAMP 1.73 to catalyze cyclization of an 
enoate onto a ketone to afford cyclopenten-ol ester 1.74 in 14% ee (Scheme 1.17).23,  29
Subsequent to this seminal result Soai in 1998 reported the first asymmetric 
 14
intermolecular MBH reaction utilizing chiral phosphine catalysts such as BINAP to 
catalyze the coupling of pyrimidine carboxaldehydes and methyl acrylate in low (9-44%) 
ee (Scheme 1.18).30 They observed that the use of (S)-Tol-BINAP improved the chemical 
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Scheme 1.18. The first phosphine-catalyzed asymmetric intermolecular MBH reaction 
Zhang and co-workers prepared and applied D-manitol derived chiral 
phospholanes 1.81-1.84 to the asymmetric MBH reaction (Scheme 1.19). 31  These 
phosphine catalysts gave the MBH adduct 1.80 in low enantioselectivity. Rate 
enhancement was observed in the case of hydroxyl phospholane 1.81. Ikegani reported in 
2000, that phenol and BINOL (10 mol%) are effective bronsted acid co-catalysts when 
used with tributylphosphine (20 mol%) in the coupling of cyclic enones with aliphatic 
aldehyde to afford MBH adducts in almost quantitative yields.23a The  reaction of 2-
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cyclopentenone with hydrocinnamaldehyde in the presence of (R)-BINOL and 
tributylphosphine gave the desired MBH adduct in low ee (<10 ee) however, a calcium 
Lewis acid co-catalyst [Ca+2-(R)-BINOL] (16 mol%) with tributylphosphine (10 mol%) 
gave the MBH adduct in 62% yield and 56% ee. Schaus and co-workers have developed 
a highly enantioselective MBH reaction using partially saturated BINOL derivatives 
substituted at the 3/3′ position as co-catalysts with triethylphosphine in the coupling of 2-
cyclohexenone 85 and a variety of aldehydes (Scheme 1.20). 32 This reaction provides 
MBH adducts in good yields and excellent enantioseletivities (67-96% ee). Aliphatic 


























83% yield, 17% ee
1.81 1.82 R = CH3 29% yield 19% ee
1.83 R = Bn 18% yield, 2% ee
1.84
56% yield, 18% ee  
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Scheme 1.20 MBH reaction catalyzed by BINOL derivative 
Carretero and co-workers have shown that readily available 
ferrocenyldialkylphosphines are viable catalysts for MBH reaction between acrylates and 
aldehydes to provide MBH adducts in excellent yield (62-98%). 33  The asymmetric 
variant of this reaction was attempted using a set of planar chiral 
ferrocenyldialkylphosphines and the best enantioselectivities were obtained using 
Mandyphos as catalyst (up to 65% ee). 
1.3.3 Aza-Morita-Baylis-Hillman-Reaction 
A phosphine-catalyzed modification of the Morita-Baylis-Hillman reaction was 
first reported by Kahn and Bertenshaw in 1989 in which acrylates and aldehydes are 
coupled in presence of a sulphonamide or carbamate using triphenylphosphine to give 2-
methylidene-3-amino esters (Scheme 1.21).34 The α-aminoalkyl acrylates obtained in this 














R1 = Me, MeO
R2 = Ph, n-Pr
R3 = Ts, Boc, Cbz
50-98 %1.92 1.93 1.94 1.95
 
Scheme 1.21 Phosphine-catalyzed aza-Baylis-Hillman reaction 
After the intial report by Kahn, Shi and co-workers have done extensive studies in 
aza-MBH reaction, where aldehydes have been replaced by the highly reactive N-
arylidene-tosylamides, to give α-alkylidene-β-amino carbonyl compounds (Scheme 
1.22).35 2-Cyclopentenone 1.54 and methyl vinyl ketone 1.100 participate in aza-MBH 
reaction in the presence of phosphine catalysts and a diverse range of activated imines 
derived from both electron rich and electron deficient aromatic aldehydes to give 
coupling products 1.97 and 1.101 in good yield. Phosphine catalysts are better catalysts 
than tertiary amines in this reaction. When a similar reaction was performed using 2-
cyclohexenone 1.85, a mixture of products was isolated: the MBH product 1.98 and two 
diastereomers of bicyclic products derived from the aldol reaction followed by 
intramolecular Michael addition of sulfonamide 1.99. Recently Toy and co-workers have 
been able to perform aza-MBH reactions using polystyrene-supported triphenylphosphine 
as a catalyst for coupling methyl vinyl ketone and phenyl acrylate with various tosyl 




















































Scheme 1.22 Shi’s aza-Morita-Baylis-Hillman reaction. 
Subsequently, Shi and Zhao utilized N-arylidenediphenylphosphinamides 1.102 
as electrophiles in aza-MBH reactions of a variety of acrylates, and acrylonitriles with 
methyl vinyl ketone using Ph2PMe, PPh3, and DABCO as catalysts (Scheme 1.23).37 The 
reaction of N-arylidenediphenylphosphinamides 1.102 with methyl acrylates requires 
Ph2PMe as a catalyst for optimal yields and for acylonitrile DABCO is the catalyst of 
choice. The authors report that the N-arylidenediphenylphosphinamides can  be generated 
in situ by performing a one pot, three-component aza-MBH reaction of arylaldehydes, 
diphenylphosphinamide and methyl vinyl ketone in the presence of a Lewis acid TiCl4 
















Ar = p-EtC6H4, p-MeoC6H4, p-FC6H4, p-ClC6H4,
Ar = p-BrC6H4, p-NO2C6H4, C6H5-CH=CH






Scheme 1.23 Enones and acrylates with N-arylidenediphenylphosphinamides in aza-
MBH reaction 
Shi and co-workers have studied a more challenging variant of the aza-Morita-
Baylis-Hillman reaction, involving β-substituted activated alkenes and N-tosyl imines 
(Scheme 1.24). 38  In this reaction β-substituted aldehydes, enones, enoates, and 
thioenoates are coupled with a variety of N-tosyl imines 1.96 in THF at ambient 
temperature in the presence of a tertiary phosphine Lewis base such as PPh2Me or 
PPhMe2 to give the corresponding aza-MBH adducts in good yields as a mixture of E- 












R = H, Ph, Me, OMe, OPh, SPh
Ar = m-NO2C6H4, p-MeC6H4, p-FC6H4, p-ClC6H4,
p-BrC6H4, p-NO2C6H4, m-F-C6H4






Scheme 1.24 MBH reaction of β-substituted activated alkenes and electrophiles 
1.3.4 Asymmetric aza-Morita-Baylis-Hillman Reaction 
Following the successful discovery of the aza-Morita-Baylis-Hillman reaction of 
activated alkenes with N-tosyl imines in the presence of triphenylphosphine catalysts, Shi 
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and co-workers turned their attention to the asymmetric variant of this reaction using 
chiral triarylphosphine catalysts. They designed the 2′-diphenylphosphanyl-
[1,1′]binaphthalenyl-2-ol catalyst, which catalyzes the asymmetric aza-MBH reaction of 
a diverse number of N-tosyl imines with methyl vinyl ketone or phenyl acrylate to give 
aza-MBH adducts in good yield with good enantioselectivity  (76-94% ee (Scheme 
1.25).39 The reaction involving acrylates and acrolein was sluggish and thus required 
elevated temperatures of 40 °C in CH2Cl2 to give aza-MBH product in 52-77% ee. The 
authors believe that the chiral catalyst is bifunctional with the phosphine acting as a 
Lewis base and the phenolic OH acting as a Brønsted acid via hydrogen bonding. 31P 
NMR spectroscopic data support an intramolecular hydrogen bonding between the 
phenolic OH and the carbonyl oxygen which in turn stabilizes the in situ generated 
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Scheme 1.25 Asymmetric aza-MBH reaction 
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1.4 Phosphine-Catalyzed/Mediated α-Allylation of Enones 
A variant of the Rauhut-Currier reaction that involves trapping of the transient 
enolates generated via phosphine conjugate addition to the enone with non-classical 
electrophiles such as π-allyls was reported by Krische and co-workers in 2003.40 The 
authors utilized allylic carbonate as a latent electrophile, which is activated by a low 
valent palladium to form a palladium-π-allyl, at the same time an appendant enone is 
activated by tributylphosphine to generate a phosphium enolate intermediate 1.109 
(Scheme 1.26). The two intermediates react to give a cyclic organophosphonium, which 
undergoes β-elimination to give the enone cycloallylation products 1.110-1.114. This 
cycloallylation reaction provides five cyclic products 1.110-1.112 in good to excellent 
yields. The six-membered cycloallyation products 1.113-1.114 were obtained in slightly 
diminished yields. The authors observed that whereas enoates are not viable 
pronucleophiles, thioenoates 1.112 work well. This transformation is remarkable in that it 
merges both organic and transition metal catalysis by uniting nucleophilic features of the 






















1.110 1.111 1.112 1.113 1.114
92% 83% 73% 64% 66%  
Scheme 1.26 Cycloallylation of enones using both phosphine and palladium catalysts 
In 2005 Krafft and Haxell reported the first entirely organomediated 
intramolecular variant of Krische’s cycloallylation reaction, where they utilized allylic 
chlorides as electrophillic partners (Scheme 1.27). 41 This transformation is a two step 
one-pot procedure for cycloallylation of enones that involves, conversion of the enone-
allylic acohol substrate 1.115 to an allylic chloride 1.116 using thionyl chloride followed 
by addition of tributylphosphine catalyst to afford 5- and 6-membered ring 
cycloallylation products 1.117-1.121 in good yields. Both mono- and disubstituted 
alkenes are formed using this method with very good selectivity in the absence of 
transition metal catalysts, however exogenous stoichiometric base is required to facilitate 
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Scheme 1.27 Phosphine mediated cycloallylation of enones 
1.5 Phosphine-Catalyzed/Mediated α-Alkylation of Enones 
The classical Morita-Baylis-Hillman reaction (MBH) is an organocatalytic 
transformation that encompasses coupling of activated alkenes and sp2 hybridized carbon 
electrophiles such as aldehydes, α-keto esters, 1,2-diketones, aldimines, enoates, enones 
and vinyl sulfones. Krafft and co-workers in 2005 reported the first organomediated 
variant of the intramolecular MBH reaction involving alkyl halides as electrophiles, to 
give the product of cycloalkylation (Scheme 1.28).42 In this reaction cycloalkylation of 
enones is achieved in the presence of a stoichiometric amount of tributylphosphine in t-
BuOH at ambient temperature followed by addition of aqueous base under phase transfer 
conditions, to afford both 5- and 6-membered ring products for example 1.123-1.126. 
Remarkably, control experiments showed that tributylphosphine does not react with the 
alkyl halide to form the phosphonium salt. 
 Having developed this synthetic method Krafft and co-worker turned their 
attention to rendering it catalytic in phosphine, this was achieved by lowering the PBu3 
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catalyst loading to 20 mol% with minimal changes in reaction conditions.43 Phosphine-
catalyzed cycloalkylation of enones proceeds well to form both 5- and 6-membered 
cycloalkylation products in excellent yields. The authors observed that PBu3 is the 
optimal catalyst for 5-membered ring formation and PMe3 is the catalyst of choice for 6-
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Scheme 1.28 Phosphine-mediated cycloalkylation of enones 
Recently Krafft and Wright reported the first phosphine mediated MBH reaction 
that utilizes epoxides as electrophiles (Scheme 1.29).44 This unprecedented reaction that 
involves the use of epoxides in MBH reaction follows the usual mechanism where 
conjugate addition of PMe3 to the enone gives rise to a Zwitterionic enolate that adds to 
the epoxide. Subsequent alkoxide induced elimination of the phosphine gives the cyclic 
homoaldol adducts 1.128-1.135. For good selectivity between endo and exo cyclization 















1.128 R1 = Me, 67%
1.129 R1 = Ph, 66%
PMe3 (100 mol%)
t-BuOH, 25 °C










1.130 R1 = Me, 43%
1.131 R1 = Ph, 92%
1.132 R1 = Me, 60%
1.133 R1 = Ph, 50%
1.134 R1 = Me, 76%






Scheme 1.29 Phosphine Mediated MBH reaction involving epoxide electrophiles 
1.6 Phosphine Catalyzed Allylic Substution of MBH Acetates 
In 2003 Krische and co-workers reported the first phosphine catalyzed reaction 
for allylic amination of MBH acetates. 45  The MBH acetates undergo regioselective 
allylic substitution in the presence of PPh3 and 4,5-dichlorophthalimide or phthalimide 
through a tandem SN2′- SN2′ substitution mechanism to give products of N-allylation 
(Scheme 1.30). By performing a survey of leaving group and pronucleophile 
combinations the authors observed a dramatic dependence on the Δ pKa between the 
conjugate acid of the leaving group and the pronucleophile vis-à-vis the generation of an 
electrophile-nucleophile ion pair. If the leaving group is not basic enough, deprotonation 
of the pronucleophile does not occur. Optimal yields were achieved using acetate as a 
leaving group and 4,5-dichlorophthalimide as a pronucleophile. The allylic amination 
products 1.138, 1.140, 1.142 and 1.144 were obtained in 73-95% (Scheme 1.31). Use of 
phthalimide as pronucleophile gave the allylic amination products 1.137, 1.139 and 1.143 
in low yields (18-20%). However, the reaction using methyl vinyl ketone derived MBH 
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acetate, which is a better electrophile was less sensitive to the nature of pronucleophile 
and provided an excellent yield (92%) of the phthalimide derived amination product 
1.141. All the products were obtained as single regioisomers presumably due to the 
generation of the electrophile-nucleophile ion pair that enhances regio-retention by 
suppressing direct addition of the nucleophile to the less substituted MBH acetate.  



























































1.137, X = H, 8%
1.138, X = Cl, 90%
1.139, X = H, 15%
1.140, X = Cl, 73%
1.141, X = H, 92%
1.142, X = Cl, 95%
1.143, X = H, 20%
1.144, X = Cl, 86%
R1 =  CH3, OCH3
R2 = Ar, n-Pr
 
Scheme 1.31 Phosphine-catalyzed allylic amination of MBH acetates 
The phosphine-catalyzed allylic substitution of MBH acetates was extended to 
carbon nucleophiles by Krische and Cho in 2005. 46  In the presence of 2-
trimethylsilyloxy furan and a substoichiometric amounts of triphenylphosphine (20 
mol%) MBH acetates 1.145 undergo regiospecific allylic substitution to afford the 
products of C-allylation 1.146-1.149 in good to excellent yields, along with good regio 
and diastereoselectivies (Scheme 1.32). The observed high diastereoselectivity in this 
reaction can be rationalized by invoking a closed transition state arising from an endo-
selective Diels-Alder cycloaddition of the siloxyfuran ate complex with the enone 
resulting from conjugate addition of the phosphine to the MBH acetate followed by 
Grob-type fragmentation (Scheme 1.33). The observed high level of diastereoselectivity 
in the products 1.146-1.149 indicates that the intermediate phosphine adducts forms as a 
single enone geometrical isomer. The authors were able to control the absolute 
stereochemistry of this transformation by using a chiral auxiliary approach, where a (-)-8-
 28
phenylmenthol ester was used in place of a methyl ester which provided excellent yield 






















1.146a, 88%, >95:5 d.r.
1.146b, 9%
1.147a, 63, 15%, >95:5 d.r.
1.147b, 7%
1.148a, 62%, >95:5 d.r.
1.148b, not observed
1.149a,  83%, 3.5:1 d.r
1.149b, not observed
R1 =  CH3, OCH3
R2 = Ar, Cyclo-Pr, alkenyl
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1.7 Other phosphine-Catalyzed Reactions Involving Activated Alkenes  
Evans and co-workers in 1978 reported a method for phosphonisilylation of α,β-
unsaturated carbonyl compounds in the presence of triphenylphosphine and silylating 
agents.47 Inanaga et al have employed this transformation to generate phosphonium silyl 
ketene acetals from allylic acrylates. The ketene acetal undergo Ireland-type [3,3] 
rearrangement and subsequent deprotonation by a base to provide the product 1.151 

























Scheme 1.34 Phosphine-catalyzed [3,3] rearrangement of allylic acrylates 
 
Toste et al in 2003 reported a phosphine-catalyzed method for the hydration and 
hydroalkylation of enones, enoates and nitriles.49 In this reaction addition of water and 
alcohols to acyclic enones, enoates, and nitriles in the presence of trimethylphosphine 
proceeds to provide hydration and hydroalkylation products 1.153-1.158 in good to 
excellent yields 56-95% (Scheme 1.35). Attempts to hydrate and hydroalkylate cyclic 
enones gave competitive dimerization products. It was also observed that whereas water, 
primary, secondary and aryl alcohols added to methyl vinyl ketone, tert-butyl alcohol did 
not. Based on these experiments, deuterium labeling, and 31P NMR experiments the 
authors proposed a catalytic mechanism (Scheme 1.36). Conjugate addition of the 
phosphine to the methyl vinyl ketone forms the phosphonium enolate A, which 
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deprotonates an alcohol molecule forming an alkoxide phosphonium ion pair B. The 
alkoxide ion pair undergoes conjugate addition to another enone molecule resulting in 
enolate ion pair C. Subsequent protonation of the enolate in C gives the desired 
hydroalkylation product.  
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1.153, R = H, 77%
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1.8 Summary and Outlook 
In the phosphine-catalyzed cross Rauhut-Currier reaction the selectivity problem 
has been addressed via an intramolecular process. However, there are no enantioselective 
variants of this reaction reported in the chemical literature. The phosphine-catalyzed 
Morita-Baylis-Hillman reaction has been extensively studied in the last two decades. 
Asymmetric variants have been developed, however there are no highly enantioselective 
phosphine catalyzed intramolecular MBH reactions. For the asymmetric intermolecular 
MBH reaction high selectivity is only achieved using Lewis acidic co-catalysts such as 
BINOL derivatives. There is potential for design of phosphine catalysts that would confer 
high levels of asymmetry in both inter and intramolecular MBH reaction.   
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ENONES AND ENALS AS LATENT ENOLATES IN CATALYTIC C-
C BOND FORMING PROCESSES: TOTAL SYNTHESIS OF (-)-
PAROXETINE (PAXIL®) 
 
Chapter 2: Catalytic α-Arylation of Enones, Enals, Nitroalkenes and the 




The Krische research group has an ongoing program predicated on the utilization 
of enones and enals as latent enolates. Enolate chemistry forms the cornerstone of 
numerous classical transformations in organic synthesis, including the aldol and Michael 
reactions.1,2  Seminal studies by Stork demonstrate that  tandem enone reduction-enolate 
alkylation is an effective method for regiospecific generation and trapping of the 
thermodynamically less stable enolate isomer 2.2 in the decalin system relating to steroid 
synthesis (Scheme 2.1).3 The use of chemically robust enones as latent enolates is a 
promising alternative to the preformation of the more labile enols and enolates. 
Subsequent to Stork’s report, catalytic methods for the activation of enones, which are 
suited for reaction with a variety of electrophiles have been developed. These methods 
are grouped in three categories: nucleophilic activation via conjugate reduction, 
nucleophilic activation via conjugate addition of carbon nucleophiles, i.e. 
carbometallative methods and nucleophilic activation via reversible conjugate addition of 
N- or P-nucleophiles i.e. nucleophilic organocatalysis. This chapter is devoted to work 
that encompass nucleophilic catalysis via conjugate addition of phosphine nucleophiles to 














Scheme 2.1 Regiospecific enolate generation via enone reduction 
 Nucleophilic catalysis represents an important sub-class of organocatalytic 
transformations.4 We have developed a family of catalytic transformations in the area of 
phosphine catalysis, taking advantage of the unique reactivity of enolates generated via 
phosphine conjugate addition to α,β-unsaturated carbonyl compounds.5 The phosphonium 
enolates obtained via phosphine conjugate addition to α,β-unsaturated carbonyl 
compounds have been trapped with classical electrophiles such as aldehydes, ketones and 
activated alkenes. Non-classical electrophiles like arenes are potential coupling partners 
for phosphonium enolates, though transition metal catalyzed enolate arylations are known, 
this would be the first account of an organocatalytic enolate arylation. 
2.1.1 Transition Metal-Catalyzed Enolate Arylation  
 Enolate nucleophiles rarely react with aromatic or vinylic halides, even though 
numerous natural products, therapeutic agents, and synthetic intermediates posses an 
aromatic unit at the α-position of a carbonyl group. In 1973, Semmelhack and co-workers 
reported the first intramolecular nickel-catalyzed arylation of preformed ketone 
enolates. 6 a Subsequently, Millard and Rathke discovered an intermolecular variant 
involving nickel-catalyzed arylation and vinylation of preformed lithium enolates.6b In 
1979, Fauvarque and Jutand reported a nickel and palladium-catalyzed arylation of the 
Reformatsky enolates.6c Palladium-catalyzed coupling of  preformed tin enolates and enol 
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silanes were reported following Fauvarque’s initial report.7 These reactions are limited in 
substrate scope since they involve mainly acetates or methyl ketones. Ketone substrates 
possessing β-hydrogens gave product of β-ketone arylation. Another drawback to these 
methods is the requisite preformation of the enolate nucleophiles. 
 A plausible catalytic mechanism for the palladium catalyzed addition of enolates 
to aryl halides is shown in Scheme 2.2. It is believed that the reaction proceeds via 
oxidative addition of LnPd0 to the aryl halide to afford the organometallic intermediate A. 
Transmetallation of the enolate nucleophile to Pd-complex A generates the 
organometallic intermediates B or C. Finally, reductive elimination from the 

































Scheme 2.2 A plausible mechanism for Pd-catalyzed ketone arylation 
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 In 1997, Buchwald, Hartwig and Miura reported concurrently the first palladium- 
catalyzed reaction for direct coupling of ketones with arylbromides (Scheme 2.3).8 This 
method requires a combination of Pd2(dba)3 and a phosphine ligand along with a 
stoichiometric amount of a strong base. The products of α-arylation of ketones are 
obtained in good to excellent yields; additionally this method is compatible with a wide 
variety of functional groups including ethers, nitriles, imines, amides and acetals.    
O










R = Alkyl, Aryl
R' = Alkyl, Aryl  
Scheme 2.3 Palladium-catalyzed direct α-arylation of ketones. 
 Buchwald and co-workers in 1998, reported the first catalytic asymmetric α-
arylation of ketones using homochiral BINAP as a ligand for palladium to afford 
products with all-carbon quaternary centers.9a High chemical yields and enantioselectivity 
were achieved by using increased Pd catalyst loading (10-20 mol%). This is a major 
limitation to the synthetic utility of this reaction. This reaction was later improved by 
using only 2 mol% Pd catalyst loading and MOP-type ligands in the presence of NaOt-Bu 
at room temperature to afford aryl ketones in excellent yields.9b In 2001, Hartwig and Lee 
used optically active heterocyclic carbene ligands for an intramolecular palladium 
catalyzed amide arylation to afford α,α-disubstituted oxindole in modest 
enantioselectivity.9c Later Buchwald reported a highly enantioselective (83-98% ee) 
Ni(0)-catalyzed α-arylation of α-substituted γ−butyrolactones using chiral BINAP 
ligands with aryl chlorides and bromides.9d  
 41
2.1.2 Enolate Arylation Using Triarylbismuth(V) Reagents 
 Seminal studies by Barton and co-workers involving oxidation of quinine to 
quininone resulted in α-arylated quininone product, this experiment revealed that 
bismuth(V) reagents10 such as Ph3BiCO3 can be utilized as arylating agents.11 Following 
this result a variety of enolizable substrates have been arylated using a diverse range of 
triarylbismuth(V) reagents (Scheme 2.4 eq 1).12 Selective monoarylation is difficult to 
achieve in the case of 1,3–dicarbonyl compounds. Phenols can be C-arylated in the 
presence of triarylbismuth(V) reagents under both basic and neutral conditions (Scheme 
2.4, eq 2).13 Non-enolizable substrates could be arylated by first performing the enolates 
followed by treatment with triarylbismuth(V) reagents to provide products of α-arylation 
of carbonyl compounds (Scheme 2.4, eq 3 & 4).14 Enolates trapped as enol silane can be 



































2.10a 2.10b  
Scheme 2.4 Arylation of carbonyl compounds and phenols using bismuth(V) reagents 
2.1.2.1 Mechanism for C-Arylation of Enolates Using Bismuth(V) Reagents 
 An intermediate containing a covalent Bi-O was invoked to explain the oxidation 
of alcohols by bismuth(V) reagents. A similar covalent Bi-O containing intermediate was 
proposed for C-arylation of phenols and enolates.12b-c The existence of the covalent Bi-O 
bond was corroborated by isolation and characterization of the (aryloxy)bismuth 
intermediate 2.12 from the reaction of the preformed anion  of 3,5-ditbutylphenol 2.11 
with tetramethylguanidine (TMG) and triphenylbismuth dichloride (Scheme 2.5).13a 
Careful thermal decomposition of intermediate 2.12 provided the C-phenylated phenol 
2.13 in 82% yield. The second step of the arylation is a reductive elimination which is 
believed to proceed through a concerted mechanism, in which the π-electrons of the enol 



































2.14 2.15 2.16  
Scheme 2.6 Proposed mechanism reductive elimination step 
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2.2 Catalytic α-Arylation of Enones and Enals Using Triarylbismuth(V) 
Reagents 
 Transition metal-catalyzed enolate arylation6-9 by way of ketone, ester, and amide 
pronucleophiles has received much attention however, general catalytic methods for 
arylation of enones have not been described. 16  We have developed a method for 
regiospecific α-arylation of enones and enals under conditions of nucleophilic catalysis.17 
Cyclic enones and enals can be arylated upon exposure to 1 equivalent of Ar3BiCl2 and 
Hünig’s base in the presence of a catalytic amount of tributylphosphine to afford α−aryl 
enones and α−aryl enals in good to excellent yields. 
 A catalytic mechanism for this transformation is envisioned based on the 
mechanistic studies by Barton and co-workers for arylation of alkali enolates (Scheme 
2.7).13a Conjugate addition of tributylphosphine to the enone generates phosphonium 
enolate A, which then adds to triarylbismuth(V) dichloride  reagent to provide 
intermediate B. Reductive elimination followed by β-elimination of tributylphosphine 
affords the α-aryl enone. The feasibility of this phosphine-catalyzed enone α−arylation 
using triarybismuth(V) reagents requires the compatibility of the Lewis basic 
tributylphosphine and the Lewis acidic bismuth(V) reagent. Bismuth(V) reagents are 
good oxidants, however we believe that oxidation of the bulky tributylphosphine should 























Scheme 2.7 Proposed catalytic mechanism for α−arylation of enones and enals 
2.2.1 Optimization 
 To test the feasibility of this phosphine-catalyzed α−arylation of enones, 2-
cyclohexenone 2.17a (100 mol%)  was exposed to Ph3BiCl2 (100 mol%) in the presence 
of tributylphosphine (100 mol%) and Hünig’s base (100 mol%) at room temperature in 
CH2Cl2 (1M) solvent. Gratifyingly, the product of α-arylation 2.17b was obtained in 87% 
isolated yield as a single regioisomer as determined by 1H NMR analysis (Table 2.1, 
entry 1). Upon decreasing the catalyst loading to 20 mol%, α-arylation product was 
obtained in 85% yield, however the reaction time increased to 42 hours (Table 2.1, entry 
2). With the knowledge that t-BuOH as a solvent enhances the rate in the Morita-Baylis-
Hillman reaction, it was speculated that t-BuOH might be a good solvent for this reaction, 
however attempts to run the reaction in this solvent gave a modest 67% yield of the 
desired product (Table 2.1, entry 4). This low yield could be attributed to the poor 
solubility of triphenylbismuth dichloride in t-BuOH. Finally, using a mixed solvent 
system of CH2Cl2 and t-BuOH (9:1) gave the α-arylation product 2.17b in 93% yield 
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with a significant decrease in reaction time (Table 2.1, entry 5). These conditions served 
as the standard condition for this transformation. 
























































2.2.2 Substrate Scope 
To probe the substrate scope of this transformation, a variety of triarylbismuth(V) 
dichlorides were prepared by treating ArMgBr with BiCl3 followed by oxidation of the 
resulting triarylbismuth(III) compounds with chlorine gas or sulfuryl chloride (SO2Cl2).18 
Under our standard conditions, the catalytic α-arylation of 2-cyclohexenone 2.17 (Table 
2.2) and 2-cyclopentenone 2.18 (Table 2.3) were performed. The formation of α-
arylation products 2.17b-2.17e and 2.18b-2.18e demonstrates that transfer of aryl groups 
from para-substituted triarylbismuth dichlorides proceeds readily and in good yields 
(Tables 2.2 and 2.3). The ability to transfer bromo-substituted arenes illustrates the 
functional group tolerance of this methodology compared to nickel or palladium-
catalyzed enolate arylation methods. The formation of α-arylation products 2.17f-2.17h 
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and 2.18f-2.18h shows that meta-substituted aryl groups transfer efficiently, even in the 
case of the electron rich methoxy-substituted systems. Unfortunately, para-
methoxyarenes gave trace amount of product. This could be attributed to the strong π-
donating effect of the methoxy moiety, which reduces the Lewis acidity of the 
triarylbismuth dichoride. Transfer of disubstituted arenes is achieved effectively as 
demonstrated by the formation of α-arylation products 2.17i and 2.18i.  
Table 2.2. Phosphine-catalyzed α-arylation of 2-cyclohexenone using Ar3BiCl2 reagents 
PBu3 (20 mol%)
Ar3BiCl2 (100 mol%)
2.17a, 93% 2.17b, 44% 2.17c, 66%
O O
O O O









































To further explore the substrate scope of this transformation, we screened a 
variety of acyclic enones. Experiments revealed that α,β-unsaturated pronucleophiles 
need substitution at the β-position to attenuate competitive anionic polymerization. 
Attempts to α-arylate acylic enones gave trace amount of the desired product, leading to 
the speculation that reactive pronucleophiles must achieve an s-trans conformation. For 
example cyclic enones such as 2-cyclohexenone and 2-cyclopentenone which are reactive 
pronucleophiles are locked in the s-trans conformation. To test our hypothesis, we 
examined the α-arylation of β-substituted enals such as crotonaldehyde which exist 
predominantly in the s-trans-conformation. Gratifyingly, crotonaldehyde 2.19 
participates in the α-arylation to provide α-arylated enals 2.19a-2.19d in modest to good 
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yields (Table 2.4) under standard conditions though two equivalents of crotonaldehyde 
must be employed. The stereochemical assignment was based on 1H NMR of previously 
reported material for 2.19a,53 the diagnostic vinylic proton was observed at 6.7 ppm as 
reported in literature for the E-isomer. 







2.19a, 61% 2.19b, 49%
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2.3 Catalytic α-Arylation of Nitroalkenes Using Triarylbismuth(V) 
Reagents 
 
 The α,β-unsaturated nitroalkenes are useful and versatile synthetic intermediates 
in organic chemistry. 19  The electron deficient nature of nitroalkenes facilitates their 
application in the Diels-Alder reaction as dienophiles 20 and in conjugate addition 
chemistry as Michael acceptors.21 In addition to these applications, the nitro group can be 
easily converted to a variety of functional groups including aldehydes, ketones, oximes, 
nitrones, hydroxylamines, and amines.19b-c, 22  Historically, nitroalkenes are known for 
their biological activity as insectides, 23  fungicides, 24  antibacterials, 25  and antitumor 
agents.26 Inspired by the versatility and the biological importance of nitroalkenes, we 
focused our attention to the arylation of nitroalkenes in an effort to extend the scope of 
our phosphine-catalyzed regiospecific α-arylation methodology.17 
2.3.1 Optimization 
To assess the feasibility of utilizing nitroalkenes, as pronucleophiles, β-
nitrostyrene 2.20a (100 mol%) was exposed to Ph3BiCl2 (110 mol%) and Hünig’s base 
(100 mol%) in the presence of tributylphosphine (20 mol%) at room temperature in THF. 
Gratifyingly, the α-arylation product 2.20b was obtained in 50% isolated yield as a single 
alkene isomer, as determined by 1H NMR analysis, where the vinylic proton is observed 
at 8.23 ppm for the E-isomer and literature reports 8.25ppm.59a and melting point 72-73 
°C, Lit.59b is 74 °C (Table 2.5, Entry 1). Under otherwise identical conditions, but 
doubling the loading of Ph3BiCl2 led to an increase in yield of 2.20b to 56% (Table 2.5, 
Entry 2). Upon changing the solvent to EtOAc, 2.20b was obtained in 14%, isolated yield 
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(Table 2.5, Entry 3). This is attributed to the poor solubility of Ph3BiCl2 in EtOAc. 
Performing the reaction at 50 °C improved the solubility of Ph3BiCl2, resulting in a 67% 
yield of 2.20b with a significant shortening of the reaction time. (Table 2.5, Entry 4). 
Efforts to further optimize this reaction by varying concentration and reaction 
temperature did not result in any improvement in chemical yield (Table 2.5, Entries 5-7). 
These reaction conditions represent our standard conditions for α-arylation of 
nitroalkenes (Table 2.5, entry 4). 































EtOAc (1M) 50 2 652005
1 THF (0.5M) 25 36 50110
Time (h)
6 EtOAc (0.2M) 200 50 12 65




2.3.2 Substrate Scope 
Under our standard conditions, the catalytic α-arylation of aromatic nitroalkenes 
was explored using diverse triarylbismuth(V) dichlorides. β-Nitrostyrene 2.20a 
undergoes α-arylation readily to provide products 2.20b-2.20e in good yield (Table 2.6). 
As demonstrated by the formation of α-arylation products 2.20c-2.20e para, meta and 
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disubstituted triarylbismuth(V) dichlorides transfer aryl groups efficiently, even when the 
α,β-unsaturated pronucleophile bears an electron rich methoxy- and methyl substituents. 
The α-arylation of p-methoxy-β-nitrostyrene 2.21a proceeds efficiently to provide 
products 2.21b-2.21d in good yields and as single alkene isomer (Table 2.6). As shown 
by product 2.22b o-bromo-β-nitrostyrene 2.22a undergoes α-arylation effectively. 
Notable is the transfer of the bromo substituted aryl group as illustrated by formation of 
2.21b, which would be problematic under the conditions of palladium catalysis.  
Table 2.6 Phosphine catalyzed α-arylation of aromatic nitroalkenes using 
triarylbismuth(V) reagents. 
 
. To further probe the scope of this transformation we synthesized heteroaromatic 




































corresponding aldehydes and nitromethane. Arylation of these heteroaromatic 
nitroalkenes 2.23a-2.25a proceed effectively to provide products of α-arylation 2.23b-
2.25c in good yields as a single alkene isomer as determined by 1H NMR analysis (Table 
2.7).  







































2.23b-2.25c2.23a, Ar = 2-Pyrolyl
2.24a, Ar = 3-Furyl
2.25a, Ar = 3-Indolyl
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2.4 Application of the Phosphine-Catalyzed Enone α-Arylation in 
Formal and Enantioselective Total Synthesis of Paroxetine (PAXIL®)  
 
In the previous sections we described the development of a catalytic method for 
the regiospecific α-arylation of enones, enals, and nitroalkenes wherein transiently 
generated (β-phosphino)enolates or oxaphospholenes are captured by arylbismuth(V) 
reagents. The scope of this process complements the corresponding palladium catalyzed 
enolate arylations, as strongly basic reagents are not required for enolate generation and 
the use of enones as enolate precursors enables regiospecific enolate generation.8,9 Here, 
the synthetic utility of the phosphine-catalyzed enone α-arylation is highlighted through 
its strategic use in a concise formal and enantioselective total syntheses of the 
blockbuster antidepressant (-)-paroxetine (PAXIL).  
Paroxetine, a GlaxoSmithKline product marketed as Paxil/Seroxat, is an 
enantiomerically enriched trans-3,4-disubsituted piperidine used for the treatment of 
depression, obsessive compulsive disorder, and panic disorder.27 As one of the leading 
prescription drugs worldwide, paroxetine has received considerable attention from 
synthetic chemists, evoking a surprisingly diverse array of strategies for its asymmetric 
synthesis. To date, approaches to the asymmetric synthesis of paroxetine encompass the 
physical resolution of racemates, 28  enzyme catalyzed asymmetric transformations, 29 
chiral auxiliary based approaches, 30  asymmetric deprotonation using chiral bases, 31 
catalytic enantioselective transformations,32 as well as the use of naturally occurring 
chiral starting materials.33 
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 Due to the large number of reported prior synthesis of PAXIL, we will discuss the 
GlaxoSmithKline synthesis29c,e (Scheme 2.8) and the shortest enantioselective synthesis 
reported by Jacobsen group.32 The GlaxoSmithKline synthesis is 13 linear steps featuring 
an enzymatic resolution of the prochiral diester 2.26 to provide intermediate 2.27. This 
intermediate has been elaborated to amino alcohol 2.28 in 6 steps and 2.28 was converted 









































[S, S]-A (5 mol%)
t-BuOH (1.2 equiv) 
































Paroxetine hydrochloride  
Scheme 2.9 Jacobsen’s synthesis 
The shortest enantioselective synthesis was reported by Jacobsen and co-workers 
in 2003.32 This synthesis employs an enantioselective Michael addition of a nitrile to an 
aryl substituted α,β-unsaturated imide 2.29 in the presence of the catalyst Salen-Al 
complex [S,S]-A to provide intermediate 2.30 in excellent yields and excellent 
enantioselectivity after recrystalization (Scheme 2.9). The intermediate 2.30 was 
transformed to the amino alcohol 2.31 in 4 steps, and 2.31 was converted to paroxetine 
hydrochloride in 3 steps. This is an expeditious way for asymmetric synthesis of PAXIL 
(8 steps), however it involves an epimerization step which makes it less attractive.  
Our objective is to show case the synthetic application of our enone arylation 
methodology. Another goal is to improve on the exist methods for asymmetric synthesis 
of PAXIL. We hope to cut the number of steps in the GlaxoSmithKline syntheis by half, 
thus providing the shortest enantioseletive synthesis. 
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2.4.1 Retrosynthetic Analysis 
Retrosynthetically, paroxetine is envisioned to derive from N-benzylaminoalcohol 
2.28, which could be obtained from α-arylated dihydropyridinone 2.33a via 1,4 reduction 
followed by Wittig olefination, hydrolysis and carbonyl reduction. The α-arylated 
dihydropyridinone 2.33a would arise from dihydropyridinone 2.32 via phosphine-


















2.28 2.33a 2.32  
 
Scheme 2.10 Retrosynthetic analysis of (-)-paroxetine  
2.4.2 Formal Synthesis of (±)-Paroxetine (PAXIL®) 
The forward synthesis begins with dihydropyridinone 2.32 which is prepared 
from commercially available N-benzyl glycine ester in 3 steps.34 With dihydropyridinone 
2.32 in hand, its ability to participate in the phosphine catalyzed α-arylation was 
examined (Scheme 2.11). Upon exposure to (p-F-Ph)3BiCl2 (100 mol%), catalytic 
tributylphosphine (20 mol%), and Hünig’s base (100 mol%) at room temperature in 
CH2Cl2–t-BuOH (9:1) solvent, aryl transfer proceeds readily to give α-arylated 















79%2.32 2.33a  
Scheme 2.11 Catalytic α-arylation of dihydropyridinone 2.32 
Elaboration of α-aryldihydropyridinone 2.33a to N-benzylamino alcohol 2.28, a 
common intermediate in synthesis of paroxetine, is achieved in 4 manipulations. L-
Selectride reduction35 of 2.33a occurs in 87% yield to provide the N-benzylamino ketone 
2.34a. Wittig olefination of N-benzylamino ketone 2.34a affords enol ether 2.35 in 65% 
yield with single olefin geometry as determined by 1H NMR. Acid hydrolysis of 2.35 
followed by NaBH4 reduction of the resulting aldehyde provides the N-benzylamino 
alcohol 2.28 in 63% yield as a single stereoisomer. N-benzylamino alcohol 2.28 exhibits 
spectral properties identical in all aspects as previously reported material, which has been 
converted to paroxetine in 2 steps.28i,29e,31b,c,33 Thus, the synthesis of 2.28 represents a 























Conditions: (a) L-Selectride, THF, -78 °C, 87% (b) Ph3PCH2OMe Cl, NaHMDS,THF, 0 °C, 65%




Scheme 2.12 Conversion of α-aryl dihydropyridinone 2.33a to (±)-paroxetine  
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2.4.3 Enantioselective Total Synthesis of (-)-Paroxetine (PAXIL®) 
Having completed a formal racemic synthesis of paroxetine, efforts were focused 
on an enantioselective total synthesis. Here, a potentially effective strategy involves 
asymmetric protonation36,37 of enol silanes 2.36a or 2.36b, which are derived in a single 
manipulation from enones 2.33a and 2.33b by way of conjugate reduction with trapping 
of the resulting enolate in situ using trimethylsilyl chloride or tert-butyldimethylsilyl 
chloride, respectively.35 However, enol silane 2.36a did not react upon exposure to 
Yamamoto’s BINOL-SnCl4 reagent,36a-c perhaps due to the presence of the Lewis basic 
N-benzyl amine. Treatment of the carbamoyl-protected enol silane 2.36b to the BINOL-
SnCl4 reagent gave the desired α-arylketone 2.34b in 80% yield, but with very low levels 
of optical enrichment (10% ee). Yanagisawa’s recently reported silver fluoride catalyzed 
asymmetric protonation gave a more promising result, providing the α-arylketone 2.34b 








2.36a, (R1 = Bn, R2 = TBS)
2.36b, (R1 = CO2Me, R2 = TMS)




2.34a, (R1 = Bn)
2.34b, (R1 = CO2Me)
b c
Conditions: (a) MeOCOCl, CH2Cl2, 25 °C, 86%. (b) Li(s-Bu)3BH, THF, -78 °C, then R3SiCl, 74%
(TBSCl) and 86% (TMSCl). (c) AgF (cat.), (R)-BINAP (cat.), CH2Cl2:MeOH (20:1), 90%, 39% ee 
(refers to the conversion  of 2.36b to 2.34b).  
Scheme 2.13 Attempted asymmetric protonation of enol silanes 2.36a and 2.36b 
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The difficulties encountered in preparing optically enriched aminoketones 2.34a 
or 2.34b led us to consider alternative synthetic routes. Accordingly, oxazaborolidine-
catalyzed asymmetric 1,2-reduction of enones 2.33a and 2.33b was explored.38 The N-
benzyl protected enone 2.33a gave the corresponding allylic alcohol 2.37 in 35% yield 
and 70% ee (Scheme 2.14). It was speculated that the presence of the Lewis basic N-
benzyl amine of 2.33a was incompatible with the Lewis acidic oxazaborolidine catalyst, 













2.33a 2.37  
Scheme 2.14 Oxazaborolidine reduction of 2.33a 
Gratifyingly, oxazaborolidine-catalyzed asymmetric 1,2-reduction of the 
corresponding N-carbamoyl protected enone 2.33b provides allylic alcohol 2.38 in 95% 
yield and 96% enantiomeric excess (Scheme 2.15). Allylic alcohol 2.38 was converted to 
the diphenyl phosphate 2.39 and was subjected to conditions for anti-selective copper-
mediated SN2′ allylic substitution39 using (i-PrO)Me2SiCH2MgCl as a hydroxymethyl 
anion equivalent.40 The resulting homoallylic silane 2.40 was obtained in 96% yield, and 
was subjected to Tamao oxidation to provide the homoallylic alcohol 2.41 in 70% yield. 
As revealed by chiral stationary phase HPLC analysis, compound 2.41 is obtained in 92% 
enantiomeric excess. The high fidelity of chirality transfer supports the anti-SN2' 
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mechanism for allylic substitution and the slight decrease in enantiomeric excess is 
























Conditions: (a) (S)-Me-CBS (cat), BH3·SMe2, CH2Cl2, -20 °C, 95%, 96% ee. (b) (PhO)2P(O)Cl, 
DMAP (cat.), Pyr, CH2Cl2, 25 °C, 89%. (c) (i-PrO)Me2SiCH2Cl, Mg, 25 °C, then CuCN, THF,
-30 to 0 °C, 96%. (d) KF, H2O2, DMF, 25 °C, 70%, 92% ee.  
Scheme 2.15 Conversion of enone 2.33b to homoallylic alcohol 2.41  
Stereoselective substrate-directed catalytic homogeneous hydrogenation of the 
homoallylic alcohol 2.41 was accomplished using Crabtree’s conditions41,42 to provide 
the corresponding saturated alcohol 2.42 in 69% yield as a single diastereomer as 
determined by 1H NMR analysis (Scheme 2.16). The alcohol was converted to the 
phenolic ether 2.43 in 76% yield through its reaction with sesamol under Mitsunobu 
conditions. 43  Finally, deprotection of methyl carbamate was achieved under basic 
conditions,44 and the amine was isolated as its HCl salt to provide (-)-paroxetine as 
hydrochloride salt in 92% yield. (-)-Paroxetine hydrochloride obtained in this manner 












Conditions: (a) [Ir(COD)(PCy3)Pyr]PF6, CH2Cl2, 25 °C, 69%. (b) DIAD, PPh3, sesamol, 














Scheme 2.16 Enantioselective total synthesis of (-)-paroxetine  
2.3.5 Attempted Concise Route to (-)-Paroxetine 
A more concise approach to (-)-paroxetine is potentially achieved via direct anti-
selective copper-mediated SN2′ allylic substitution using a sesamol-based phenoxymethyl 
anion. Stimulated by this prospect, the tributylstannylmethyl ether was prepared from 
sesamol and tributyl(iodomethyl)stannane. 45  Allylic substitution using the 
phenoxymethyl anion derived cuprate with allylic phosphate 2.33c gave the desired 
phenolic ether in 27% yield. This low yield is attributed to the instability of the 
intermediate α-alkoxy organolithium reagent and the resulting organocuprate with 
respect to α-elimination, as evident by the recovery of sesamol. Hence, this strategy was 






c 2.44, R = H









Conditions: (a) BnOCOCl, CH2Cl2, 25 °C, 89%. (b) NaBH4, CeCl3·7H2O, CH3OH, 25 °C, 76%.
c) (PhO)2P(O)Cl, DMAP (cat.), Pyr, CH2Cl2, 25 °C, 86%. (d) Ar-OCH2SnBu3, BuLi, THF, -78 °C, 
then CuBr·SMe2, THF, -78 to -10 °C, 27%.
d
 
Scheme 2.17 Attempted concise approach to (-)-paroxetine 
2.5 Summary and Concluding Remarks 
 Cylic enones, β−substituted enals, and aromatic nitroalkenes undergo 
regiospecific α-arylation under the conditions of nucleophilic catalysis using 
triarylbismuth(V) dichlorides. This transformation is a regiochemical complement to 
Heck arylation. The preservation of the alkene moiety in the product facilitates further 
functionalization of the arylated products. The drawbacks to this method include the 
transfer of only one aryl group from the triarylbismuth(V) reagent, inability to transfer 
ortho-substituted arenes, and diminished yields on transferring electron rich aryl groups. 
This method has been strategically applied in a concise formal and enantioselective total 
synthesis of the antidepressant (-)-paroxetine (PAXIL). Future studies will focus on the 
invention of related reagents for efficient aryl, heroaryl, and alkyl transfer under the 





2.6 Experimental Section 
General 
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Anhydrous solvents were transferred by an oven-dried syringe. Flasks were oven-dried 
and cooled under a stream of argon. Tetrahydrofuran (THF) was distilled from 
sodium/benzophenone ketyl. Dichloromethane was distilled from calcium hydride. 
Methanol (MeOH) was distilled from magnesium turnings and iodine. Ethyl acetate was 
distilled from magnesium sulfate. Tributylphosphine was distilled at reduced pressure 
and stored under inert atmosphere. Other solvents and chemical reagents obtained from 
commercial sources were used without further purification, unless otherwise noted.  
Triarylbismuth dichloride reagents were prepared according to literature procedure.18 All 
known products exhibited spectral properties consistent with literature reports 2.17a,46 
2.17b, 47  2.17h, 48  2.18a, 49  2.18b, 50  2.18c, 51  2.18d, 52  2.19a, 53  2.19b, 54  and nitroalkenes 
2.21a-2.25a were prepared according to reported literature procedures 2.21a-2.22a,55 
2.23a,56 2.24a,57 and 2.25a.58The arylation product 2.20b exhibited spectral properties 
consistent with previously reported data. 59 Dihydropyridinone 2.32 was prepared from N-
benzyl glycine ethyl ester according to literature procedures.34 The E/Z product ratios 
were determined by proton nuclear magnetic resonance (1H NMR).  Analytical thin-layer 
chromatography (TLC) was carried out using 0.2-mm commercial silica gel plates (DC-
Fertigplatten Krieselgel 60 F254). Preparative column chromatography employing silica 
gel was performed according to the method of Still.60 Melting points were determined on 
a Thomas-Hoover melting point apparatus in open capillaries and are uncorrected. 
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Infrared spectra were recorded on a Perkin-Elmer 1420 spectrometer. High-resolution 
mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as m/e (relative 
intensity). Accurate masses are reported for the molecular ion (M+1) or a suitable 
fragment ion. 
Proton nuclear magnetic resonance (1H NMR) spectra were recorded with a 
Varian Gemini (300 MHz) spectrometer and a Mercury (400 MHz) spectrometer. 
Chemical Shifts are reported in delta (δ) units, parts per million (ppm) downfield from 
trimethylsilane. Coupling constants are reported in Hertz (Hz). Carbon-13 nuclear 
magnetic resonance (13C NMR) spectra were recorded with a Varian Gemini 300 (75.5 
MHz) spectrometer and a Mercury 400 (100 MHz) spectrometer. Chemical shifts are 
reported in delta (δ) units, parts per million (ppm) relative to the center of the triplet at 
77.00 ppm for deuteriochloroform. 13C NMR spectra were routinely run with broadbrand 
decoupling. 
Representative Procedure for α-Arylation of Enones 2.17-2.18 and Enal 2.19  
  To a reaction vessel charged with triphenylbismuth dichloride (261 mg, 0.52 
mmol, 100 mol%) and 2-cyclohexen-1-one 2.17 (50µL, 0.52 mmol, 100 mol%) was 
added CH2Cl2-t-BuOH (9:1 ratio, 0.52 mL, 1M), followed by diisopropylethylamine 
(90µL,  0.52 mmol, 100 mol%) and tributylphosphine (25µL, 0.10 mmol, 20 mol%). The 
reaction mixture was allowed to stir at room temperature until complete consumption of 
triphenylbismuth dichloride was observed by TLC (2-12 hours), at which point the 
reaction mixture was evaporated onto SiO2. Purification by silica gel chromatography 
hexane/ethyl acetate 9:1 gave 2.17a (0.083g, 93%) as a white solid.  
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Representative Procedure for α-Arylation of Nitroalkenes 2.20a-2.25a 
To a clean dry 13 X 100 test tube charged with β-nitrostyrene 2.20a (50mg, 0.33 
mmol, 100 mol%) and Ar3BiCl2 (0.35g, 0.67 mmol, 200 mol%) was added EtOAc (0.7 
mL, 0.5M), followed by tributylphosphine (17μL, 0.067 mmol, 20 mol%) and 
diisopropylethylamine (60 μL, 0.33 mmol, 100 mol%). The reaction vessel was place into 
a preheated oil bath (50 °C) and the reaction was allowed to stir at this temperature until 
complete consumption of the starting material was observed by TLC analysis (3h). The 
reaction vessel was removed from the heating oil bath and allowed to cool to room 
temperature, at which point a solution of 50% aqueous Na2CO3 (2 mL) was added and 
allowed to stir for 10 min, this step enables conversion of excess Ph3BiCl2 to the more 
polar and insoluble Ph3BiCO3 which can easily isolated. The resulting mixture was 
filtered through celite, washed three times with Et2O (5 mL), the filtrate was extracted 
with Et2O (3 X 5 mL), the organic extracts were combined, dried over MgSO4, filtered 
and evaporated onto silica gel. Purification via column chromatography (SiO2, 19:1 to 3:2 
hexane/ethyl acetate) gives the α-arylation product 2.20b (51 mg, 0.22 mmol) in 67% 














  To 100 mL flask charged with tris-(4-fluorophenyl)bismuth dichloride (12.3 g, 
21.75 mmol, 110 mol%) and 2.32 (3.7 g, 19.77 mmol, 100 mol%) was added CH2Cl2-t-
BuOH (9:1), (36 mL, 0.5M), followed by tributylphosphine (0.5 mL, 1.99 mmol, 10 
mol%) and diisopropylethylamine (3.4 mL,  19.78 mmol, 100 mol%). The reaction 
mixture was allowed to stir at room temperature until complete consumption of starting 
material was observed by TLC (3 h), at which point the reaction mixture was evaporated 
onto silica gel. Purification by column chromatography (SiO2, 9:1 to 3:2 hexane/ethyl 
acetate) gives the title compound 2.33a (4.39 g, 15.60 mmol) in 79% yield as an off white 
solid. Mp 66.5-68.5 °C. 1H NMR (400 MHz, CDCl3): δ 7.35 (m, 6H), 7.03 (m, 4H), 3.70 
(s, 2H), 3.43 (d, J = 3.42 Hz, 2H), 3.33 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 194.1, 
162.5 (d, J = 247.5 Hz), 145.2, 137.4, 136.3, 130.8, 130.2 (d, J = 8.5 Hz), 129.1, 128.5, 
127.6, 114.9 (d, J = 21.5 Hz), 61.8, 61.7, 52.6. IR (film): 3063, 3029, 2918, 2803, 2750, 
1683, 1601, 1509, 1349, 1223, 1160, 823, 699 cm-1. HRMS: Calcd for C18H17NOF [M+1] 









4-(4-Fluorophenyl)-3-oxo-3,6-dihydro-2H-pyridine-1-carboxylic acid methyl ester 
enone 2.33b 
 Methylchloroformate (2 mL, 24.91 mmol, 200 mol%), was added dropwise to a 
solution containing 2.33a (3.5 g, 12.45 mmol, 100 mol%) in CH2Cl2 (20 mL) at room 
temperature. The reaction mixture was stirred at this temperature for 18h, at which point 
the reaction mixture was evaporated onto silica gel and purified via column 
chromatography (SiO2, 4:1 to 1:1 hexane/ethyl acetate) to give the title compound 2.33b 
(2.64 g, 10.55 mmol) in 86% yield as a white solid. Mp 110-111 °C. 1H NMR (400 MHz, 
CDCl3): δ 7.32 (dd, J = 8.6, 5.5 Hz, 2H), 7.05 (t, J = 8.6 Hz, 3H), 4.45 (d, J = 2.1 Hz, 
2H), 4.29 (s, 2H), 3.77 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 191.2, 162.1 (d, J = 
247.5 Hz), 155.3, 143.4, 137.2, 130.1 (d, J = 3.1 Hz), 130.2 (d, J = 7.7 Hz), 115.1 (d, J = 
21.5 Hz), 53.0, 51.9, 43.6. IR (film): 3053, 2981, 2863, 1723, 1673, 1606, 1463, 1403, 











4-(4-Fluorophenyl)-3-oxo-3,6-dihydro-2H-pyridine-1-carboxylic acid benzyl ester  
2.33c 
 Benzylchloroformate (1.21 g, 7.12 mmol, 200 mol%) and 2.33a (1 g, 3.56 mmol, 
100 mol%) were reacted according to the procedure described for 2.33b. The crude 
product was purified via column chromatography (SiO2, 4:1 to 1:1 hexane/ethyl acetate) 
to give compound 2.33c (1.03 g, 3.16 mmol) in 89% yield as a white solid. Mp 80-81 °C. 
1H NMR (400 MHz, CDCl3): δ 7.37 (m, 5H), 7.31 (dd, J = 8.9, 5.5 Hz, 2H), 7.04 (t, J = 
8.9 Hz, 2H), 5.19 (s, 2H), 4.47 (d, J = 3.8 Hz, 2H), 4.32 (s, 2H). 13C NMR (100 MHz, 
CDCl3): δ 191.1, 162.7 (d, J = 247.5 Hz), 154.7, 143.3, 137.2, 135.8, 130.3 (d, J = 7.7 
Hz), 128.5, 128.2 (d, J = 6.9 Hz), 115.1 (d, J = 21.5 Hz), 67.8, 51.9, 43.6. IR (film): 3033, 
2956, 2829, 1688, 1601, 1509, 1430, 1350, 1231, 1160, 1100, 814 cm-1. HRMS: Calcd 






  To a solution containing 2.33a (0.71 g, 2.53 mmol, 100 mol%) in dry THF (15 
mL) at -78 °C was added L-Selectride (1M in THF 2.6 mL, 2.53 mmol, 100 mol%) 
dropwise. The mixture was stirred at -78 °C for 1h, at which point aqueous NH4Cl (10% 
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solution, 20 mL) was added. The reaction mixture was transferred to a separatory funnel 
and was extracted with CH2Cl2 (3 x 15 mL). The combined organics were dried (MgSO4), 
filtered and evaporated in vacuo to afford an oily residue. Purification by column 
chromatography (SiO2, 9:1 to 3:2 hexane/ethyl acetate) gives compound 2.34a (0.609 g, 
2.15 mmol) in 87% yield as pale yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.33 (m, 5H), 
7.11 (m, 2H), 7.03 (m, 2H), 3.64 (s, 2H), 3.53 (t, J = 10.0 Hz, 1H), 3.36 (dd, J = 14.1, 
1.8 Hz, 1H), 3.06 (dm, J = 9.2 Hz, 1H), 2.93 (d, J = 13.8 Hz, 1H), 2.58 (m, 1H), 2.21 ( m, 
2H). 13C NMR (100 MHz, CDCl3): δ 205.2, 162.2 (d, J = 246.2 Hz), 136.9, 133.65, 130.2 
(d, J = 8.4 Hz), 129.0, 128.4, 127.4, 115.3 (d, J = 11.5 Hz), 64.4, 62.5, 54.3, 51.9, 32.7. 
IR (film): 3062, 3029, 2949, 2801, 1722, 1604, 1511, 1454, 1224, 1098, 833, 740, 700 







4-(4-Fluorophenyl)-3-oxo-piperidine-1-carboxylic acid methyl ester 2.34b 
A mixture of silver fluoride (2 mg, 16 μmol, 10 mol%) and (R)-BINAP (5.8 mg, 9 
μmol, 6 mol%) was dissolved in methanol (0.2 mL) and stirred at room temperature for 
10 min in the dark. At which point CH2Cl2 (2 mL) was added and the solution was stirred 
for another 10 min. The solution was cooled to -78 °C and 2.36b (50 mg, 0.15 mmol, 100 
mol%) in dichloromethane (2 mL) was added dropwise. The mixture was warmed to -30 
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°C and stirred at this temperature for 72h, at which point the mixture was evaporated to 
dryness. Purification via column chromatography (SiO2, 4:1 to 1:1 hexane/ethyl acetate) 
gives the title compound 2.34b (35 mg, 0.014 mmol) in 90% yield as colorless oil. Chiral 
HPLC (Daicel Chiralpak OJ-H column, 85:15 hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  
t major = 67.0 min, t minor = 97.7 min ee = 39%). 1H NMR (500 MHz, DMSO-d6 @ 100 °C): 
δ 7.19 (dd, J = 8.6, 5.5 Hz, 2H), 7.10 (t, J = 11.1 Hz, 2H), 4.14 (A part of AB pattern, d, 
J = 17.4 Hz, 1H), 4.05 (B part of AB pattern, d, J = 17.4 Hz, 1H), 3.85 (m, 2H), 3.63 (s, 
3H), 3.56 (m, 2H), 2.21 (m, 2H). 13C NMR (125 MHz DMSO-d6 @ 100 °C): δ 203.9, 
160.7 (d, J = 243.1 Hz), 154.7, 133.3 (d, J = 3.5 Hz), 129.2 (d, J = 8.1 Hz), 114.2 (d, J = 
1.3 Hz), 53.2, 51.9, 41.7, 29.1. IR (film): 2956, 1700, 1602, 1511, 1449, 14404, 1223, 







1-Benzyl-4-(4-fluorophenyl)-3-methoxymethylene piperidine 2.35 
 To a vigorously stirred suspension of methoxymethyltriphenylphosphonium 
chloride61 (0.5 g, 1.76 mmol, 100 mol%) in dry THF (18 mL) was added a solution of 
NaHMDS (2M in THF 3.5 mL, 7.06 mmol, 400 mol%) dropwise. The resulting red 
solution was stirred at this temperature for 2h, at which point 2.34a (0.5g, 1.76 mmol, 
100 mol%) in THF (3 mL) was added dropwise over 10 min. The reaction mixture was 
stirred at room temperature for 20h, at which point aqueous NH4Cl (1M, 30 mL) was 
 72
added. The resulting mixture was extracted with diethyl ether (3 x 15 mL) and the 
combined organics were combined, dried (MgSO4), filtered and evaporated in vacuo to 
give a yellow oil. Purification of the residue via column chromatography (SiO2, 9:1 to 4:1 
hexane/ethyl acetate) gives the title compound 2.35 (0.35g, 11.29 mmol) in 65% yield as 
yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.34 (m, 5H), 7.19 (m, 2H), 6.99 (t, J = 8.9 Hz, 
2H), 5.14 (s, 1H), 3.83 (d, J = 12.3 Hz, 1H), 3.70 (A part of AB pattern, J = 13.0 Hz, 1H), 
3.50 (B part of AB pattern, J = 13.0 Hz, 1H), 3.42 (s, 3H), 3.16 (d, J = 10.3 Hz, 1H), 
2.90 (d, J = 11.6 Hz, 1H), 2.60 (d, J = 12.3 Hz, 1H), 2.21 (td, J = 11.3, 2.7, 1H), 1.98 (m, 
1H), 1.78 (m, 1H). 13C NMR (75 MHz, CDCl3): δ 161.4 (d, J = 244.4 Hz), 143.2, 137.9, 
137.7, 129.8 (d, J = 7.6 Hz), 129.4, 128.1, 126.9, 117.5, 114.9 (d, J = 21.1 Hz), 63.0, 
59.4, 52.8, 51.6, 43.9, 32.7. IR (film): 3029, 2933, 2846, 2798, 1677, 1603, 1509, 1222, 







[1-Benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol 2.28   
A solution of the enol ether 2.35 (50 mg, 0.16 mmol, 100 mol%) in  THF (3 mL), 
was treated with 0.1M aqueous H2SO4 (2.4 mL, 0.24 mmol, 150 mol%). The solution was 
allowed to reflux for a 12h period, at which point the heating bath was removed and the 
reaction was allowed to reach room temperature. Saturated aqueous NaHCO3 (10 mL) 
was added, and the resulting mixture was extracted with diethyl ether (3 x 5 mL). The 
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combined organics extracts were dried (MgSO4), filtered and evaporated in vacuo to 
provide the crude aldehyde (34 mg, 0.11 mmol) in 72 % yield as a yellow oil. 1H NMR 
(300 MHz, CDCl3): δ 9.45 (d, J = 1.8 Hz, 1H), 7.34 (m, 5H), 7.28 (m, 2H), 7.02 (t, J = 
8.5 Hz, 2H), 3.62 (s, 2H), 3.18 (dm, J = 11.4 Hz, 1H), 2.99 (dm, J = 11.4 Hz, 1H), 2.90 
(dm, J = 18.4 Hz, 1H), 2.77 (dd, J = 9.0, 7.0 Hz, 1H), 2.12 (t, J = 11.1 Hz, 2H), 1.89 (m, 
2H). 13C NMR (75 MHz, CDCl3): δ 203.0, 161.6 (d, J = 244.7 Hz), 138.6, 137.8, 129.1, 
128.8 (d, J = 7.9 Hz), 128.3, 127.2, 115.5 (d, J = 21.4 Hz), 63.1, 54.4, 53.5, 53.0, 43.1, 
34.1. IR (film): 2938, 2806, 1721, 1603, 1510, 1465, 1224, 1160, 833, 699 cm-1. HRMS: 
Calcd for C19H21NOF [M+1] 298.1607, found 298.1601. The crude aldehyde was 
dissolved in ethanol (2 mL) and treated with NaBH4 (6 mg, 0.16 mmol, 100 mol%): The 
reaction mixture was stirred at room temperature for 1h. The reaction mixture was treated 
with 2N aqueous sodium hydroxide (10 mL) and extracted with CH2Cl2 (3 x 5 mL), and 
combined organic extracts were dried (MgSO4), filtered and evaporated in vacuo to give 
an oily residue. Purification of the residue via column chromatography (SiO2, 9:1 to 3:2 
hexane/ethyl acetate) gives the title compound 2.28 (30 mg, 0.10 mmol) in 63% yield 
over two steps as colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.34 (m, 5H), 7.17 (m, 
2H), 6.98 (t, J = 8.6 Hz, 2H), 3.60 (A part of AB pattern, J = 13.2 Hz, 1H), 3.56 (B part 
of AB pattern, J = 13.2 Hz, 1H), 3.37 (dd, J = 11.3, 3.0 Hz, 1H), 3.21 (m, 2H), 2.98 (d, J 
= 11.0 Hz, 1H), 2.33 (m, 1H), 1.98 (m, 3H), 1.79 (m, 3H). IR (film): 3427, 2934, 2848, 
2799, 1604, 1510, 1222, 1130, 836, 739, 700cm-1. HRMS: Calcd for C19H23NOF [M+1] 







tetrahydropyridine  2.36a  
To a solution containing 2.33a (0.1 g, 0.35 mmol, 100 mol%) in dry THF (2 mL) 
at -78 °C was added  L-Selectride (1M in THF 0.36 mL,  0.35 mmol, 100 mol%) 
dropwise. The mixture was stirred at this temperature for 1h, upon which TBSCl (59 mg, 
0.39 mmol, 110 mol%) in THF (1 mL) was added dropwise. The reaction mixture was 
allowed to stir at this temperature for an additional 1h and then left to warm to room 
temperature. Evaporation of the reaction mixture in vacuo affords an oily residue that was 
purified by column chromatography (SiO2, 9:1 hexane/ethyl acetate) to give 2.36a (0.104 
g, 2.62 mmol) in 74% yield as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.34 (m, 
7H), 6.95 (t, J = 8.7 Hz, 2H), 3.63 (s, 2H), 2.99 (s, 2H), 2.63 (t, J = 5.6 Hz, 2H), 2.43 (m, 
2H), 0.74 (s, 9H), -0.19 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 161.1 (d, J = 243.5 Hz), 
140.8, 130.1 (d, J = 7.6 Hz), 129.3, 128.3, 114.6 (d, J = 21.1 Hz), 62.2, 56.3, 50.1, 29.2, 
25.5, 17.9, -4.2. IR (film): 2928, 2856, 1669, 1601, 1509, 1471, 1222, 837, 780 cm-1. 










acid methyl ester 2.36b 
Aryl enone 2.33b (0.2 g, 0.80 mmol, 100 mol%), L-selectride (1M in THF 0.8 mL, 
0.80 mmol, 100 mol%) and chlorotrimethylsilane (0.12 mL, 0.88 mmol, 110 mol%) were 
reacted according to the procedure described for 2.36a. The crude product was purified 
via Kugelrohr distillation to give 2.36b (0.23 g, 0.71 mmol) in 86% yield as colorless oil. 
1H NMR (300 MHz, CDCl3): δ 7.32 (dd, J = 8.2 Hz, 2H), 6.98 (t, J = 8.7 Hz, 2H), 3.91 (s, 
2H), 3.73 (s, 3H), 3.60 (s, 2H), 2.43 (s, 2H), -0.04 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 
203.0, 161.2 (d, J = 245.0 Hz), 155.8, 140.8, 135.2, 129.8 (d, J = 7.6 Hz), 114.5 (d, J = 
21.4 Hz), 52.6, 46.8, 41.0, 28.5, 0.3. IR (film): 2957, 1707, 1601, 1510, 1448, 1410, 1253, 








To a solution of 2.33a (0.1 g, 0.35 mmol, 100 mol%) in CH2Cl2 (3.5 mL) and isopropyl 
alcohol (30 μL, 0.35 mmol, 100 mol%) at -20 °C was added dropwise a solution of 
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BH3•SMe2 (2M in THF 0.45 mL, 0.89 mmol, 250 mol%). The mixture was stirred at -20 
°C for 1h, at which point a solution containing both (S)-2-Methyl-CBS-oxazaborolidine 
(2M in toluene 36 μL, 35 μmol, 10 mol %) and a solution of BH3•SMe2 (2M in THF, 30 
μL) was added in one portion. The reaction mixture was allowed to stir at -20 °C for 30 
min. The temperature was increased to -15 °C over 45 min, at which point MeOH (10 
mL) was added carefully, and the reaction mixture was allowed to stir for an additional 
15 min. The reaction mixture was placed in a heating bath at 50 °C and CH2Cl2 and 
BH3•SMe2 were removed via distillation. To the remaining solution was added MeOH (5 
mL) and the resulting mixture was allowed to stir 65 °C for 1h (to break the N-B 
complex). The heating bath was removed and the reaction mixture was allowed to reach 
ambient temperature. The solvent was removed in vacuo and the resulting residue was 
purified via column chromatography (SiO2, 3:2 to 1:1 hexane/ethyl acetate) to provide 
the allylic alcohol 2.37 (36 mg, 0.13 mmol) in 35% yield as a white solid. Mp 76-77 °C. 
Chiral HPLC (Daicel Chiralpak OJ-H column, 98:2 hexanes:i-PrOH, λ = 254 nm, 1 
mL/min, t major = 43.9 min, t minor = 31.7 min ee = 70%). 1H NMR (400 MHz, CDCl3): δ 
7.48 (dd, J = 8.7, 5.5 Hz, 2H), 7.33 (m, 5H), 6.99 (t, J = 8.9 Hz, 2H), 6.09 (t, J = 3.5 Hz, 
1H), 6.02 (dd, J = 4.8, 3.4Hz, 1H), 4.37 (s, 1H), 3.65 (s, 2H), 3.35 (dd, J = 17.4, 4.4 Hz, 
1H), 3.04 (dd, J = 10.6, 2.0 Hz, 1H), 2.84 (d, J = 17.4, 1H), 2.75 (br s, 1H), 2.49 (dd, J = 
11.6, 2.0 Hz, 1H). 13C NMR (100 MHz CDCl3): δ 162.1 (d, J = 246.0 Hz), 137.6, 137.0, 
135.2 (d, J = 3.1 Hz), 129.0, 128.3, 127.3,  127.1 (d, J = 7.7 Hz), 124.5, 115.2 (d, J = 
21.5 Hz), 66.1, 62.2, 57.7, 53.0. IR (film): 3408, 3061, 3029, 2917, 2804, 1602, 1509, 
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4-(4-Fluorophenyl)-3-hydroxy-3,6-dihydro-2H-pyridine-1-carboxylic acid methyl 
ester  2.38 
 To a dry 50 mL flask, a solution of (S)-2-Methyl-CBS-oxazaborolidine catalyst 
(1M in toluene 0.4 mL, 0.04 mmol, 10 mol %) and a solution of borane dimethyl sulfide-
complex (2M in THF 2 mL, 4.00 mmol, 100 mol%) were added successively at room 
temperature. The resulting solution was cooled to -20 °C and 2.33b (1 g, 4.00 mmol, 100 
mol%) in CH2Cl2 (18 mL) was added dropwise over 1h, the reaction mixture was 
maintained at this temperature for 1h. Methanol (15 mL) was added dropwise to the 
reaction mixture and allowed to warm to room temperature. The solution was evaporated 
to dryness and purification via column chromatography (SiO2, 9:1 to 1:1 hexane/ethyl 
acetate) gives 2.38 (0.96 g, 3.85 mmol) in 95% yield as a white solid. Mp 104-105 °C;  
[α]D25  +70° (c =1.6 CH2Cl2), chiral HPLC (Daicel Chiralpak OJ-H column, 70:30 
hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min  t major = 35.2 min, t minor = 39.2 min ee = 96%)  
1H NMR (500 MHz, DMSO-d6 @ 100 °C): δ 7.52 (dd, J = 8.9, 5.5 Hz, 2H), 7.10 (t, J = 
12.0 Hz, 2H), 6.08 (t, J = 3.5 Hz, 1H), 4.79 (d, J = 6.6 Hz , 1H), 4.46 (m, 1H), 4.23 (dd, 
J = 19.0, 2.7 Hz, 1H), 3.86 (dd, J = 13.3, 3.8 Hz, 1H), 3.84 (dt, J = 17.2,  2.0 Hz, 1H), 
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3.65 (s, 3H), 3.34 (dd, J = 13.3, 3.3 Hz, 1H). 13C NMR (125 MHz DMSO-d6 @ 100 °C): 
δ 161.0 (d, J = 244.1 Hz), 155.1, 136.4, 135.2 (d, J = 3.05 Hz), 127.2 (d, J = 8.1 Hz), 
122.6, 114.2 (d, J = 20.8 Hz), 63.0, 51.5, 47.9, 42.9. IR (film): 3412, 2957, 2921, 2851, 
1693, 1601, 1511, 1470, 1448, 1411, 1231, 1130, 1062, 818, 767 cm-1. HRMS: calcd for 


















carboxylic acid methyl ester 2.39 
(Mixture of rotomers) 
 
Chlorodiphenylphosphate (0.9 ml, 4.22 mmol, 150 mol%) was added dropwise to 
a solution containing 2.38 (0.71 g, 2.81 mmol, 100 mol%), pyridine (0.45 mL, 5.62 mmol, 
200 mol%) and DMAP (0.51 g, 4.22 mmol, 150 mol%) at room temperature. After 
stirring the reaction mixture for 2h at this temperature, it was poured into a separatory 
funnel, washed with 2M aqueous CuSO4 solution (3 x 20 mL), dried over MgSO4, 
filtered and evaporated to afford an oily residue. Purification via column chromatography 
(SiO2, 9:1 to 4:1 dichloromethane/ethyl acetate) gives 2.39 (1.21 g, 2.42 mmol) in 89% 
yield as a white solid. Mp 99-100 °C. [α]D23 +36° (c = 3.33, CH2Cl2), 1H NMR (300 MHz, 
CDCl3): δ 7.34 (m, 4H), 7.18 (m, 6H), 6.94 (t, J = 8.4 Hz, 2H), 6.88 (d, J = 7.94 Hz, 2H), 
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6.22 (s, 1H), 5.62 (s, 1H), 4.55 (dd, J = 14.6, 2.8 Hz, 2H), 3.91 (d, J = 18.2 Hz, 1H), 3.76 
(s, 1H), 3.61 (s, 2H), 3.50 (d, J = 14.6 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 162.5 (d, 
J = 247.3 Hz), 155.9, 150.4, 150.0, 133.4, 129.0 (d, J = 16.0 Hz), 127.8, 127.7, 125.2, 
125.1, 119.8, 119.7, 115.4 (d, J = 21.4 Hz), 71.7, 52.7, 46.4, 43.5. IR (film): 3063, 3033, 
2962, 2840, 1706, 1590, 1512, 1488, 1446, 1410, 1283, 1232, 1190, 1130, 1009, 956, 825, 











pyridine-1-carboxylic acid methyl ester 2.40 
  To a slurry of CuCN (0.43 g, 4.81 mmol, 200 mol%) in THF (10 mL) was added 
a solution of (iPrO)Me2CH2MgCl (1M in THF 4.80 mL, 4.81 mmol, 200 mol%) at -18 °C 
(ice/NaCl). After stirring at this temperature for 40 min, the reaction mixture was further 
cooled to -50 °C and 2.39 (1.20 g, 2.40 mmol, 100 mol%) in THF (10 mL) was added 
dropwise. The reaction was allowed to warm to 0 °C over 40 min and quenched with 
10% aqueous NH4Cl (30 mL). The aqueous layer was extracted with CH2Cl2 (3 x 10mL), 
and the combined organic extracts were dried over MgSO4, filtered and evaporated to 
afford an oily residue. Purification of the residue via column chromatography (SiO2, 3:2 
hexane/ethyl acetate) gives 2.40 (0.84 g, 2.31 mmol) in 96% yield as a colorless oil. [α]D 
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23 +72 (c = 3.6, CH2Cl2). 1H NMR (300 MHz, CDCl3): δ 7.29 (m, 2H), 6.99 (t, J = 8.7 Hz, 
2H), 5.76 (s, 1H), 4.28 (m, 1H), 3.95 (m, 2H), 3.87 (d, J = 18.8 Hz, 1H), 3.71 (s, 3H), 
3.28 (dd, J = 13.2, 3.3 Hz, 1H), 2.87 (s, 1H), 1.12 (2d, J = 6.2 Hz, 6H), 0.68 (2d, J = 
10.8 Hz, 1H), 0.55 (2s, 1H), 0.09 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 162.1 (d, J = 
246.0 Hz), 156.6, 141.6, 135.9, 127.6 (d, J = 7.3 Hz), 119.5, 115.1 (d, J = 21.1 Hz), 64.9, 
52.4, 46.3, 43.8, 32.3, 25.8, 19.5, -0.78. IR (film): 3081, 2956, 2889, 1706, 1601, 1510, 
1448, 1412, 1375, 1335, 1250, 1231, 1191, 1118, 1025, 958, 880, 836, 813 cm-1. HRMS: 







methyl ester 2.41 
To a solution of 2.40 (0.82 g, 2.24 mmol, 100 mol%) in DMF (12 mL) was added  
potassium fluoride (0.52 g, 8.98 mmol, 400 mol%) and 30% aqueous hydrogen peroxide 
(3 mL, 26.94 mmol, 1200 mol%) at room. Then after stirring for 18h, it was diluted with 
water (60 mL). The aqueous layer was extracted with ether (3 x 20 mL) and combined 
ethereal extracts were washed with saturated aqueous sodium thiosulfate (20 mL), dried 
over MgSO4 and evaporated to afford colorless oil. Purification via column 
chromatography (SiO2, 4:1 to 1:1 hexane/ethyl acetate) gives 2.41 (0.41 g, 1.55 mmol) in 
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70% yield as a colorless oil. [α]D23 +84° (c = 3.06, CH2Cl2), chiral HPLC (Daicel 
Chiralpak OJ-H column, 90:10 hexanes:i-PrOH, λ = 254 nm, 0.4 mL/min, t major = 31.0 
min, t minor = 45.9 min ee = 92%), 1H NMR (500 MHz, DMSO-d6 @ 100 °C): δ 7.43 (dd, 
J = 8.8, 2.1 Hz, 2H), 7.12 (t, J = 8.9 Hz, 2H), 6.00 (t, J = 2.4 Hz, 1H), 4.27 (s, 1H), 4.18 
(m, 2H), 3.82 (dt, J  = 19.1, 2.8 Hz, 1H), 3.65 (s, 3H), 3.32 (dt, J =  10.6, 3.8, 1H), 3.18 
(m, 2H), 2.83 (dd, J = 4.2, 2.1 Hz, 1H). 13C NMR (125 MHz DMSO-d6 @ 100 °C): δ 
161.0 (d, J = 2.44.1 Hz), 155.3, 135.7 (d, J = 3.0 Hz), 135.0, 126.9 (d, J = 8.1 Hz), 121.9, 
114.4 (d, J = 21.4 Hz), 60.3, 51.5, 43.1, 41.5. IR (film): 3426, 3056, 2954, 2876, 1686, 
1601, 1510, 1448, 1412, 1375, 1228, 1131, 1091, 1039, 953, 836, 814, 768, 735 cm-1. 






4-(4-Fluorophenyl)-3-hydroxymethylpiperidine-1-carboxylic acid methyl ester 2.42 
A solution containing 2.41 (0.3 g, 1.13 mmol, 100 mol%) in CH2Cl2 (11 mL) was 
cooled to -78 °C, evacuated and filled with argon. This process was repeated two more 
times. The solution was allowed to warm to room temperature and Crabtree’s catalyst (45 
mg, 0.06 mmol, 5 mol%) was added as a solid in one portion. The mixture was purged 
with hydrogen for 5 minutes and allowed to stir under hydrogen atmosphere for 20h. The 
reaction mixture was evaporated onto silica gel and purification via column 
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chromatography (SiO2, 4:1 to 3:2 hexane/ethyl acetate) gives the saturated alcohol 2.42 
(0.21 g, 0.79 mmol ) in 69% yield. [α]D 23 -40° (c = 2.0, CH2Cl2). 1H NMR (500 MHz, 
DMSO-d6 @ 100 °C): δ 7.23 (dd, J = 7.9, 6.1 Hz, 2H), 7.06 (t, J = 8.9 Hz, 2H), 4.30 (dd, 
J = 13.3, 2.5 Hz, 1H), 4.09 (d, J = 5.6 Hz, 1H), 4.07 (d, J = 15.7 Hz, 1H), 3.64 (s, 3H), 
3.18 (m, 1H), 3.02 (m, 1H), 2.83 (t, J = 13.0 Hz, 1H), 2.66 (t, J = 11.4 Hz, 1H), 2.53 (td, 
J = 11.6, 3.2 Hz, 1H), 1.72 (m, 2H), 1.57 (qd, J = 12.6, 4.4 Hz, 1H).  13C NMR (125 
MHz DMSO-d6 @ 100 °C): δ 160.3 (d, J = 244.1 Hz), 154.7, 139.8 (d, J = 3.0 Hz), 128.5 
(d, J = 7.6 Hz), 114.3 (d, J = 21.4 Hz), 60.8, 51.5, 46.7, 43.6, 43.0, 42.8, 33.2. IR (film): 
3435, 3009, 2918, 2853, 1697, 1603, 1510, 1476, 1451, 1413, 1279, 1223, 1159, 1129, 









methyl ester  2.43 
The saturated alcohol 2.42 (0.100 g, 0.37 mmol, 100 mol%) was dissolved in THF 
(3 mL) and PPh3 (0.120 g, 0.45 mmol, 120 mol%) was added. This solution was cooled 
to 0 °C and DIAD (90 μL, 0.45 mmol, 120 mol%) was added dropwise. After stirring this 
solution at 0 °C for 10 min, sesamol (0.100 g, 0.748 mmol, 200 mol%) in THF (1mL) 
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was added dropwise, and stirring was continued at 0 °C for another 10 min then warmed 
to 50 °C for 2h. The reaction mixture was evaporated to dryness, and the resulting residue 
was dissolved in CH2Cl2 (5 mL) and washed with 2M aqueous NaOH (2 x 10mL). The 
aqueous fractions were combined and back extracted with CH2Cl2 (10 mL). The 
combined organic fractions were evaporated onto silica gel and purification via column 
chromatography (SiO2, 4:1 hexane/ethyl acetate) gives the phenolic ether 2.43 (0.11 g, 
2.84 mmol) in 76% yield as pale yellow oil. [α]D 23 -13° (c = 1.5, CH2Cl2). 1H NMR (500 
MHz, DMSO-d6 @ 100 °C): δ 7.27 (dd, J = 8.6, 5.6 Hz, 2H), 7.06 (t, J = 8.9 Hz, 2H), 6.9 
(d, J = 8.5 Hz, 1H), 6.40 (d, J = 2.4 Hz, 1H), 6.18 (dd, J = 8.3, 2.4 Hz, 1H), 5.89 (s, 2H), 
4.31 (dd, J  = 13.4, 3.0 Hz, 1H), 4.09 (dt, J = 13.3, 2.0 Hz, 1H), 3.64 (s, 3H), 3.41 (m, 
2H), 2.89 (td, J = 12.8, 2.8 Hz, 1H), 2.82 (t, J = 11.6 Hz, 1H), 2.70 (td, J = 5.8 Hz, 1H), 
2.05 (m, 1H), 1.73 (dd, J = 13.2, 3.1 Hz, 1H), 1.67 (qd, J = 12.1, 4.4 Hz, 1H). 13C NMR 
(125 MHz DMSO-d6 @ 100 °C): 160.5 (d, J = 242.6 Hz), 154.7, 153.6, 147.4, 141.0, 
139.7 (d, J = 3.0 Hz), 128.6 (d, J = 8.1 Hz), 114.5 (d, J = 21.4 Hz), 107.3, 105.9, 100.4, 
97.6, 69.0, 51.6, 46.4, 43.5, 42.9, 40.6, 32.9. IR (film): 3008, 2916, 1701, 1510, 1488, 
1450, 1412, 1276, 1223, 1185, 1132, 1037, 937, 832, 765 cm-1. HRMS: Calcd for 











To phenolic ether 2.43 (50 mg, 0.13 mmol, 100 mol%) was added KOH (94 mg, 
1.68 mmol%, 1300 mol%), ethylene glycol (1.5 mL)  and water (0.6 mL). The mixture 
was heated to 100 °C for 20h and then cooled to room temperature, diluted with water 
(10 mL) and extracted with CH2Cl2 (3 X 5 mL), the combined organic layers were 
washed with water (2 X 5 mL), dried over MgSO4, filtered, and evaporated in vacuo to 
give an oily residue.  The residue was dissolved in ether (5 mL) and the resulting solution 
was treated with 4M HCl in dioxane (5mL), to give a white solid. The white solid was 
filtered, washed with ether and dried to afford paroxetine hydrochloride (45 mg, 0.123 
mmol) 92% yield. Mp 132-134 °C,  Lit28i 136-138 °C  [α]D 23 – 85 ° (c = 1.0, CH3OH), 
Lit28i -86.5 ° 1H NMR (400 MHz, CDCl3): δ 7.20 (dd, J = 8.2, 5.5 Hz, 2H), 7.00 (t, J = 
8.5 Hz, 2H), 6.61 (d, J = 8.2 Hz, 1H), 6.32 (d, J = 2.73 Hz, 1H), 6.10 (dd, J = 8.5, 2.4 Hz, 
1H), 5.88 (s, 2H), 3.73 (dd, J = 21.5, 14.4 Hz, 2H), 3.60 (d, J = 8.2 Hz, 1H), 3.48 (dd, J = 
9.9, 4.4 Hz, 1H), 3.17 (t, J = 10.9 Hz, 1H), 2.04 (m, 1H), 2.90 (t, J = 11.3 Hz, 1H), 2.64 
(m, 1H), 2.38 (q, J = 13.3 Hz, 2H), 2.03 (d, J = 6.3 Hz, 1H). IR (film): 3401, 2925, 1605, 








4-(4-Fluorophenyl)-3-hydroxy-3,6-dihydro-2H-pyridine-1-carboxylic acid benzyl 
ester 2.44 
 To a solution containing CeCl3•7H2O (1.09 g, 2.71 mmol, 100 mol%) and 2.33c 
(0.88 g, 2.71 mmol, 100 mol%)  in methanol (20 mL) was added NaBH4 (0.102 g, 2.71 
mmol, 100 mol%) in small portions over 2 minutes at room temperature. The mixture 
was allowed to stir for 5 minutes, after which water (30 mL) was added the reaction 
mixture was extracted with dichloromethane (3 X 20 mL), the organic extracts were then 
combined, dried over MgSO4, filtered and concentrated in vacuo to afford an oily residue. 
Purification via column chromatography (SiO2, 3:1 hexane/ethyl acetate) gives 2.44 (0.68 
g, 2.08 mmol) in 76% yield as a white solid. Mp 106-108 °C,  1H NMR (500 MHz, 
DMSO-d6 @ 100 °C): δ 7.53 (dd, J = 8.8, 5.5 Hz, 2H), 7.36 (m, 5H), 7.11 (t, J = 8.9 Hz, 
2H), 6.09 (t, J = 3.5 Hz, 1H), 5.15 (s, 2H),  4.86 (t, J = 5.4 Hz , 1H), 4.49 (m, 1H), 4.29 
(dd, J = 19.1, 3.7 Hz, 1H), 3.92 (dd, J = 13.2, 3.7 Hz, 1H), 3.89 (d, J = 16.5 Hz, 1H), 
3.39 (dd, J = 13.2, 3.1 Hz, 1H). 13C NMR (125 MHz DMSO-d6 @ 100 °C): δ 161.0 (d, J 
= 244.1 Hz), 154.5, 136.6, 136.4, 135.2 (d, J = 3.05 Hz), 127.8, 127.2 (d, J = 7.6 Hz), 
127.1, 126.9, 122.6, 114.2 (d, J = 21.4 Hz), 71.6, 63.0, 47.9, 43.0. IR (filml): 3414, 3033, 
2915, 1691, 1510, 1432, 1360, 1229, 1125, 1070, 819, 698 cm-1. HRMS: Calculated for 



















carboxylic acid benzyl ester 2.45 
 Chlorodiphenylphosphate (0.5 ml, 2.31 mmol, 150 mol%), 2.44 (0.5 g, 1.54 
mmol, 100 mol%), pyridine (0.25 mL, 3.08 mmol, 200 mol%) and DMAP (0.28 g, 2.31 
mmol, 150 mol%) were reacted according to the procedure described for 2.39. The crude 
product was purified via column chromatography (SiO2, 9:1 to 4:1 dichloromethane/ethyl 
acetate) to give 2.45 (0.74 g, 1.32 mmol) in 86% yield as a white solid. Mp 59-61 °C. 1H 
NMR (300 MHz, CDCl3): δ 7.24 (m, 17H), 6.91 (t, J = 8.4 Hz, 2H), 6.88 (d, J = 7.94 Hz, 
2H), 6.20 (s, 1H), 5.62 (s, 1H), 5.2 (s, 1H), 4.60 (dd, J = 14.4, 3.0 Hz, 2H), 3.92 (d, J = 
19.5 Hz, 1H), 3.76 (s, 1H), 3.52 (dd, J = 14.1, 2.4 Hz, 1H). 13C NMR (75 MHz, CDCl3): 
δ 162.5 (d, J = 247.3 Hz), 155.3, 150.4, 150.0, 136.3, 133.4, 129.0 (d, J = 16.0 Hz), 
128.4, 127.8, 127.7, 125.2, 125.0, 119.8, 115.4 (d, J = 21.4 Hz), 71.7, 67.4, 46.4, 43.6. IR 
(film): 3065, 2951, 1706, 1590, 1511, 1489, 1429, 1283, 1230, 1190, 1010, 957, 825, 766, 












carboxylic acid benzyl ester 2.46.  
To a stirred solution of Ar-OCH2SnBu3 (240 mg, 0.54 mmol, 300 mol%) in THF 
(3 mL) at -78 °C was added n-BuLi (2.5 M in hexanes, 0.18 mL, 0.45 mmol, 250 mol%) 
dropwise. The reaction mixture was stirred at -78 °C for 1h at which point CuBr•SMe2 
(110 mg, 0.54 mmol, 300 mol%) in Me2S (0.5 mL) was added dropwise. The reaction 
mixture was stirred an additional 30 minutes at -78 °C, at which 2.45 (100 mg, 0.18 
mmol, 100 mol%) in THF (1 mL) was added. The reaction mixture continued to stir at -
78 °C for an additional 1h period, at which point the reaction mixture was allowed to 
warm to -10 °C and 10% NH4Cl aq (10 mL) was added. The aqueous layer was extracted 
with dichloromethane (3 x 5 mL), and the combined organic extracts were dried over 
MgSO4, filtered and evaporated to afford an oily residue. Purification of the residue via 
column chromatography (SiO2, 3:2 hexane:ethyl acetate) gives the title compound 2.46 
(22 mg, 0.05 mmol) in 27% yield. 1H NMR (500 MHz, DMSO-d6 @ 100 °C): δ 7.45 (dd, 
J = 8.8, 5.5 Hz, 2H), 7.29 (s, 5H), 7.13 (t, J = 8.8 Hz, 2H), 6.68 (d, J = 8.4 Hz, 1H), 6.41 
(d, J = 2.4 Hz, 1H), 6.22 (dd, J = 8.5, 2.3 Hz, 1H), 6.10 (t, J = 3.4 Hz, 1H), 5.89 (s, 2H), 
5.08 (AB pattern J = 12.6 Hz, 2H),  4.33 (d, J  = 13.3 Hz, 2H),  3.90 (d, J = 19.2, Hz, 1H), 
3.72 (d, J = 5.1 Hz, 2H), 3.29 (d, J = 3.4 Hz, 2H), 3.20 (s, 1H). 13C NMR (125 MHz 
DMSO-d6 @ 100 °C): 161.2 (d, J = 244.6 Hz), 154.5, 153.5, 147.4, 141.0, 136.5, 135.4, 
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134.1, 127.7, 127.1, 127.1 (d, J = 8.1 Hz), 126.8, 123.2, 114.6 (d, J = 21.4 Hz), 107.3, 
106.0, 100.4, 97.7, 68.1, 65.8, 43.1, 41.8, 36.9. IR (NaCl): 3033, 2962, 2877, 1701, 1602, 
1508, 1465, 1431, 1260, 1224, 1184, 1129, 1037, 814 cm-1. HRMS: Calcd for 


























2-(4-Fluorophenyl)cyclohex-2-enone 2.17c. 1H NMR (400 MHz, CDCl3) δ 7.28 
(m, 2H), 7.02 (m, 3H), 2.58 (t, J = 6.5 Hz, 2H), 2.53 (q, J = 5.5 Hz, 2H), 2.10 (quint, J = 
6.5 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 197.9, 162.3 (d, J = 246.0 Hz), 147.9, 139.3, 
132.4, 130.2 (d, 7.7 Hz), 114.8 (d, J = 21.5 Hz), 38.9, 26.5, 22.8. FTIR (NaCl): 3038, 























2-(4-Chlorophenyl)cyclohex-2-enone 2.17d. 1H NMR (300 MHz, CDCl3): δ 
7.31(A part of AB pattern, J = 8.7 Hz, 2H), 7.24 (B part of AB pattern, J = 8.7 Hz, 2H), 
7.03 (t, J = 8.7 Hz, 1H), 2.56 (m, 4H), 2.10 (q, J = 6.2 Hz, 2H). 13C NMR (75.5 MHz, 
CDCl3): δ 197.6, 148.2, 139.3, 134.9, 133.5, 129.9, 128.1, 38.9, 26.5, 22.8. FTIR (NaCl): 
2940, 2858, 1673, 1482, 1345, 1099, 826, cm-1. HRMS: calcd for C12H12OCl [M+1] 
































 2-(4-Chlorophenyl)cyclohex-2-enone 2.17e. 1H NMR (400 MHz, CDCl3) δ 7.46 
(A part of AB pattern, J = 8.5 Hz, 2H), 7.18 (B part of AB pattern J = 8.5 Hz, 2H), 7.03 
(t, J = 4.4 Hz, 1H) , 2.58 (t, J = 6.5 Hz, 2H), 2.53 (q, J = 5.8 Hz, 2H), 2.10 (quint, J = 
6.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 197.6, 148.3, 139.3, 135.3, 131.1, 130.3, 
121.7, 38.9, 26.5, 22.9. FTIR (NaCl): 2945, 2869, 1667, 1481, 913, 732, 645 cm-1. 




















































2-(3-Fluorophenyl)cyclohex-2-enone 2.17f. 1H NMR (400 MHz, CDCl3): δ 7.30 
(m, 1H), 7.06 (m, 3H), 6.98 (td, J = 10.3, 1.0 Hz, 1H), 2.56 (m, 4H), 2.10 (quint, J = 6.16 
Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 197.5, 162.4 (d, J = 245.23 Hz), 148.7, 139.2, 
138.5 (d, J = 7.69 Hz), 129.4 (d, 8.45 Hz), 124.2, 115.5 (d, J = 21.50 Hz), 114.2 (d, J = 
21.53 Hz), 38.9, 26.5, 22.7. FTIR (NaCl): 3055, 2940, 2863, 1667, 1585, 1471, 1422, 




































2-(3-Methoxyphenyl)cyclohex-2-enone 2.17g. 1H NMR (300 MHz, CDCl3):  
7.24 (t, J = 8.2 Hz, 1H), 7.02 (t, J = 8.5 Hz, 1H), 6.86 (m, 3H), 3.79 (s, 3H), 2.57 (t, J = 
6.5 Hz, 2H), 2.52 (q, J = 5.8 Hz, 2H), 2.09 (quint, J = 6.2 Hz, 2H). 13C NMR (75.5 MHz, 
CDCl3): δ 197.8, 159.1, 148.1, 140.1, 137.8, 128.9, 121.0, 114.1, 113.1, 55.1, 39.0, 26.5, 
22.8. FTIR (NaCl): 3011, 2836, 1667, 1579, 1481, 1356, 1290, 1050, 782, 689 cm-1.  




























2-(4-Fluoro-3-methylphenyl)cyclohex-2-enone 2.17i. 1H NMR (400 MHz, 
CDCl3): δ 7.12 (d, J = 7.5 Hz, 1H), 7.08 (m, 1H), 6.96 (m, 2H), 2.57 (t, J = 6.5 Hz, 2H), 
2.52 (q, J = 6.2 Hz, 2H), 2.26 (s, 3H), 2.09 (quint, J = 6.2 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ 197.9, 160.9 (d, J = 245.23 Hz), 147.7, 139.5, 132.2, 131.7 (d, J = 4.61 Hz), 
127.5 (d, J = 8.46 Hz), 124.2 (d, J = 17.68 Hz), 114.5 (d, J = 22.29 Hz), 38.9, 26.5, 22.8, 
14.5. FTIR (NaCl): 3049, 2929, 2864, 1673, 1498, 1345, 1236, 1121, 809 cm-1. HRMS: 
































2-(4-Bromophenyl)cyclopent-2-enone 2.18e. 1H NMR (400 MHz, CDCl3) δ 7.75 (t, J = 
6.2 Hz, 1H), 7.51 (A part of AB pattern, J = 8.9 Hz, 2H), 7.42 (B part of AB pattern J = 
8.9 Hz, 2H), 2.60 (m, 2H), 2.51 (m, 2H). 13C NMR (100 MHz, CDCl3): δ  207.2, 159.2, 
142.2, 131.5, 130.4, 128.5, 122.4, 35.6, 26.2. FTIR (NaCl): 3054, 2918, 1699, 1486, 907, 



















2-(3-Fluorophenyl)cyclopent-2-enone 2.18f. 1H NMR (400 MHz, CDCl3): δ 
7.86 (t, J = 3.1 Hz, 1H), 7.46 (m, 2H), 7.33 (t, J = 7.9 Hz, 1H), 7.02 (t, J = 8.2 Hz, 1H), 
2.72 (m, 2H), 2.61 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 207.1, 162.7, (d, J = 245.2 
Hz), 159.8, 142.2, 133.6 (d, J = 8.45 Hz), 129.9 (d, J = 8.46 Hz), 122.6, 115.1 (d, J = 
21.5 Hz) 114.0 (d, J = 22.3 Hz), 35.7, 26.2. FTIR (NaCl): 3046, 2918, 1700, 1585, 1487, 


















2-(3-Methoxyphenyl)cyclopent-2-enone 2.18g. 1H NMR (400 MHz, CDCl3): δ 
7.82 (t, J = 2.9 Hz, 1H), 7.22 (m, 3H), 6.87 (m, 1H), 3.83 (s, 3H), 2.70 (m, 2H), 2.59 (m, 
2H). 13C NMR (100 MHz, CDCl3): δ.207.4, 159.5, 143.1, 132.9, 129.3, 119.4, 114.0, 
112.4, 55.2, 35.8, 26.1. FTIR (NaCl): 3065, 2929, 2830, 1694, 1579, 1481, 1333, 1235, 



















2-(3-Trifluoromethylphenyl)cyclopent-2-enone 2.18h. 1H NMR (400 MHz, 
CDCl3): δ 7.92 (m, 2H), 7.52 (m, 3H), 2.74 (m, 2H), 2.62 (m, 2H). 13C NMR (100 MHz, 
CDCl3): δ 206.9, 160.1, 142.2, 132.6, 131.2, 130.9, 130.5, 128.9, 125.0 (q, J = 3.8 Hz), 
123.8 (q, J = 3.8 Hz), 35.6, 26.3. FTIR (NaCl): 3071, 2923, 2852, 1694, 1437, 1322, 
1109, 1077 cm-1 . HRMS: calcd for C12H10OF3 [M+1] 227.0683 found 227.0683. 
 
 







13C NMR of 2.18h 
 





2-(4-Fluoro-3-methylphenyl)cyclopent-2-enone 2.18i. 1H NMR (400 MHz, 
CDCl3) δ 7.76 (m, 1H), 7.53 (d, J = 1.7 Hz, 1H), 7.48 (m, 1H) 7.00 (t, J = 9.2 Hz, 1H), 
2.69 (m, 2H), 2.59 (m, 2H), 2.29 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 207.6, 161.3, (d, 
J = 246.7 Hz), 158.4, 142.5, 130.2, 127.4, 126.3, 124.7 (d, J = 17.68 Hz), 115.0 (d, J = 
22.3 Hz), 35.7, 26.0, 14.6. FTIR (NaCl): 3076, 2912, 1683, 1503, 1312, 1229, 1109, 831, 
781 cm-1. HRMS: calcd for C12H12OF [M+1] 191.0872 found 191.0875. M.P 66-68 °C. 
 
 

















2-(4-Fluorophenyl)but-2-enal 2.19c. 1H NMR (400 MHz, CDCl3) δ 9.59 (s, 1H), 
7.11 (m, 4H), 6.86 (q, J = 6.8 Hz, 1H), 2.01 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ  193.4, 162.4 (d, J = 247.5 Hz), 151.6, 144.1, 131.3 (d, J = 8.4 Hz), 128.0, 
115.4 (d, J = 21.5 Hz), 15.9. FTIR (NaCl): 3059, 2830, 2704, 1694, 1508, 1224, 841, 732 





















2-(4-Fluorophenyl)but-2-enal 2.19d. 1H NMR (400 MHz, CDCl3) δ 9.59 (s, 1H), 7.37 
(q, J = 7.9 Hz, 1H), 7.05 (t, J = 8.5 Hz, 1H), 6.95 (d, J = 7.9 Hz, 1H), 6.87 (t, J = 7.5 Hz, 
1H), 2.01 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 192.9, 162.5, (d, J = 246.8 
Hz), 151.9, 143.9, 134.3 (d, J = 8.5 Hz), 129.9 (d, J = 8.5 Hz), 125.2, 116.5 (d, J = 21.5 
Hz), 114.8 (d, J = 20.7 Hz), 15.9. FTIR (NaCl): 2825, 2716, 1694, 1574, 1432, 1246, 908, 






















1-Fluoro-4-(1-nitro-2-phenylvinyl)benzene 2.20c. 1H NMR (400 MHz, CDCl3): 
δ 8.25 (s, 1H), 7.33 (m, 3H), 7.27 (t, J = 6.0 Hz, 2H), 7.20 (t, J = 8.6 Hz, 2H), 7.10 (d, J 
= 7.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 163.8 (d, J = 251.3 Hz), 148.8, 135.5, 
133.0 (d, J = 8.2 Hz), 131.3, 131.2, 131.1, 129.0, 126.7, 116.9 (d, J = 21.7 Hz). FTIR 
(NaCl): 3054, 1651, 1601, 1510, 1448, 1327, 1226, 1158, 971, 843, 765, 690 cm-1. 





















1-Methoxy-3-(1-nitro-2-phenylvinyl)benzene 2.20d. 1H NMR (400 MHz 
CDCl3): δ 8.21 (s, 1H), 7.40 (t, J = 8.0 Hz,  1H), 7.25 (d, J = 7.4 Hz, 1H), 7.23 (t, J = 7.8 
Hz, 2H), 7.10 (d, J = 7.4 Hz, 2H), 7.05 (ddd, J = 1.0, 2.5, 5.9 Hz, 1H), 6.91 (d, J = 7.6 
Hz, 1H), 7.86 (s, 1H), 3.80 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 160.3, 149.6, 135.0, 
131.9, 131.4, 131.3, 131.1, 130.6, 129.0, 123.0, 116.2, 116.0, 55.6. FTIR (NaCl): 3055, 
2911, 1646, 1514, 1448, 1316, 1244, 1113, 897, 753, 681 cm-1. HRMS: calcd for 




















1-Fluoro-2-methyl-4-(1-nitro-2-phenylvinyl)benzene 2.20e. 1H NMR (400 
MHz CDCl3): δ 8.21 (s, 1H), 7.34 (d, J = 7.4 Hz, 1H), 7.26 (t, J = 6.6 Hz, 2H), 7.17 (d, J 
= 6.6 Hz, 1H), 7.10 (m, 4H), 2.31 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 162.2 (d, J = 
250.0 Hz), 148.9, 134.9, 133.8, 133.7, 131.1, 130.9, 129.9 (d, J = 8.2 Hz), 128.8, 126.4, 
126.2, 116.1 (d, J = 22.4 Hz), 14.6. FTIR (NaCl): 3048, 2931, 1652, 1593, 1521, 1449, 
1372, 1324, 1243, 1200, 1118, 980, 905, 767, 690, 767, 690 cm-1. HRMS: calcd [M+1] 
for C15H13NO2F 258.0930 found 258.0929. MP 85–86 °C pale yellow solid. 
 
 
















1-Bromo-4-[1-nitro-2 -(4-methoxyphenyl)vinyl]benzene 2.21b.1H NMR (400 
MHz CDCl3): δ 8.24 (s, 1H), 7.62 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 7.06 (d, J 
= 8.6 Hz, 2H), 6.79 (d, J = 8.6 Hz, 2H), 3.80 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 
162.2, 146.4, 135.8, 133.5, 132.9, 132.6, 130.2, 124.6, 123.4, 114.7, 55.6. FTIR (NaCl): 
3048, 2967, 1644, 1601, 1517, 1484, 1379, 1303, 1258, 1174, 1069, 971, 832, 801 cm-1. 

























1-Fluoro-4-[1-nitro-2-(4-methoxyphenyl)vinyl]benzene 2.21c. 1H NMR (400 
MHz, CDCl3): δ 8.24 (s, 1H), 7.32 (m, 2H), 7.20 (t, J = 8.6 Hz, 2H), 7.06 (d, J = 8.8 Hz, 
2H), 6.76 (d, J = 8.8 Hz, 2H), 3.79 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 163.7 (d, J = 
250.6 Hz), 162.1, 146.5, 135.7, 133.4, 133.0 (d, J = 8.2 Hz), 127.3, 123.6, 116.8 (d, J = 
21.7 Hz), 114.6, 55.6. FTIR (NaCl): 3072, 2935, 2839, 1645, 1601, 1517, 1461, 1304, 
1259, 1223, 1176, 1207, 974, 833, 794 cm-1. HRMS: calcd for C15H13NO3F [M+1] 



















1-Fluoro-4-[1-nitro-2-(4-methoxyphenyl)vinyl]benzene 2.21d. 1H NMR (400 
MHz CDCl3): δ 8.20 (s, 1H), 7.38 (t, J = 7.6 Hz, 1H), 7.31 (d, J = 7.4 Hz, 1H), 7.13 (m, 
2H), 7.04 (d, J = 8.8 Hz, 2H), 6.74 (d, J = 7.0Hz, 2H), 3.80 (s, 3H), 2.39 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 162.0, 147.8, 139.4, 135.0, 133.5, 131.2, 131.1, 130.9, 129.4, 
127.8, 123.9, 114.5, 55.6, 21.7. FTIR (NaCl): 3013, 2932, 2825, 1644, 1599, 1511, 1460, 
1273, 1298, 1254, 1175, 1026, 880, 829, 784 cm-1. HRMS: calcd for C16H16NO3 [M+1] 


















1-Bromo-2-(2-nitro-2-phenylvinyl)benzene 2.22b. 1H NMR (400 MHz, CDCl3): 
δ 8.39 (s, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.42 (m, 3H), 7.27 (dd, J = 1.4, 8.0 Hz, 2H), 
7.13 (td, J = 1.7, 7.8 Hz, 1H), 7.01 (t, J = 7.8 Hz, 1H), 6.76 (dd, J = 1.4, 8.0 Hz, 1H). 13C 
NMR (100 MHz, CDCl3): δ 151.8, 137.8, 133.7, 133.4, 132.5, 131.4, 131.3, 130.9, 130.7, 
130.3, 129.8, 129.1, 127.4, 126.2. FTIR (NaCl): 3059, 1651, 1585, 1523, 1464, 1327, 
1281, 1211, 1166, 1027, 971, 912, 863, 757, 699 cm-1. HRMS: Calcd for C14H11NO2Br 





















1-Methyl-2-(2-nitro-2-phenylvinyl)-1H-pyrrole 2.23b. 1H NMR (400 MHz, 
CDCl3): δ 8.33 (s, 1H), 7.51 (m, 3H), 7.33 (d, J = 4.1 Hz, 2H), 6.85 (s, 1H), 5.99 (t, J = 
2.5Hz, 1H), 5.51 (d, J = 4.1Hz, 1H), 3.78 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 143.7, 
131.8, 130.5, 130.0, 129.7, 125.8, 123.9, 117.6, 110.9, 34.6. FTIR (NaCl): 3031, 1634, 
1526, 1485, 1413, 1412, 1267, 1169, 1064, 978, 917, 740, 712, 654 cm-1. HRMS: calcd 





















2-[2-(4-Bromophenyl)-2-nitrovinyl]-1-methyl-1H-pyrrole 2.23c. 1H NMR (400 
MHz, CDCl3): δ 8.33 (s, 1H), 7.67 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 6.85 (s, 
1H), 6.89 (s, 1H), 6.04 (t, J = 2.0 Hz, 1H), 5.61 (dd, J = 1.0, 4.3 Hz, 1H), 3.80 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 142.0, 132.8, 132.1, 130.4, 129.9, 125.2, 124.1, 124.0 
117.5, 110.9, 34.4. FTIR (NaCl): 3048, 1629, 1586, 1505, 1443, 1290, 1243, 1180, 1060, 
979, 924, 828, 772, 750 cm-1. HRMS: calcd for C13H12N2O2Br [M+1] 307.0082 found 
























1-Methyl-2-(2-nitro-2-m-tolylvinyl)-1H-pyrrole 2.23d. 1H NMR (400 MHz, 
CDCl3): δ 8.31 (s, 1H), 7.41 (t, J = 7.6 Hz, 1H), 7.31 (d, J = 7.6 Hz, 1H), 7.12 (d, J = 8.4 
Hz, 3H), 6.85 (d, J = 2.1 Hz, 1H), 6.00 (dd, J = 2.4, 4.1 Hz, 1H), 5.54 (dd, J = 1.2, 4.1 
Hz, 1H), 3.79 (s, 3H), 2.40 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 143.9, 139.5, 131.7, 
130.9, 130.8, 129.7, 129.6, 127.4, 125.9, 123.7, 117.6, 110.9, 34.6, 21.7. FTIR (NaCl): 
3042, 1630, 1526, 1483, 1411, 1275, 1064, 1010, 747 cm-1. HRMS: calcd for C14H15N2O2 






















3-[2-(4-Fluorophenyl)-2-nitrovinyl]furan 2.24b. 1H NMR (400 MHz, CDCl3): δ 
8.17 (s, 1H), 7.60 (s, 1H), 7.35 (d, J = 5.3 Hz, 1H), 7.33 (d, J = 5.3 Hz, 1H), 7.24 (td, J = 
2.0, 0.6 Hz, 1H), 7.22 (t, J = 8.4Hz, 2H), 5.59 (d, J = 2Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ 163.8 (d, J = 251.3 Hz), 147.9, 147.4, 144.7, 133.0 (d, J = 8.2 Hz), 126.8 (d, J 
= 12.7Hz), 126.7, 119.1 116.6 (d, J = 21.7 Hz), 109.2. FTIR (NaCl): 3142, 3060, 2919, 
1645, 1601, 1497, 1318, 1279, 1222, 1159, 1094, 1015, 977, 845, 750, 600, 563 cm-1. 

























1H NMR (400 MHz, CDCl3): δ 8.43 (s, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.59 (d, J = 8.4 Hz, 
3H), 7.35 (m, 4H), 7.25 (m, 4H), 6.8 (s, 1H), 3.37 (s, 3H). 13C NMR (100 MHz, CDCl3): 
δ 164.0 (d, J = 252.0, Hz), 147.9, 146.1, 134.7 (d, J = 3.0 Hz), 132.6 (d, J = 8.2 Hz), 
130.4, 129.6, 128.3, 127.2, 126.2, 126.1, 124.4, 119.4, 117.1 (d, J = 21.7Hz), 113.9, 21.9. 
FTIR (NaCl): 3148, 2926, 1644, 1599, 1507, 1447, 1376, 1316, 1225, 1175, 1140, 1093, 
 123
970, 812, 759, 669, 576 cm-1. HRMS: calcd for C23H18N2O4FS [M+1] 437.0971 found 





















2.25c. 1H NMR (400 MHz, CDCl3): δ 8.41 (s, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.62 (d, J = 
7.4 Hz, 1H), 7.59 (d, J = 8.4 Hz, 2H), 7.39 (td, J = 1.2, 7.4 Hz, 1H), 7.32 (td, J = 1.2, 8.0 
Hz, 1H),  7.21 (m, 4H), 3.37 (s, 3H), 2.36 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 162.5 
(d, J = 250.6, Hz), 148.1, 146.1, 134.7 (d, J = 8.9 Hz), 133.6, 133.5, 130.3, 129.7, 129.6, 
128.3, 127.2, 126.9, 126.1, 125.9, 124.4, 119.3, 116.7 (d, J = 22.4 Hz), 113.9, 21.9, 14.9. 
FTIR (NaCl): 3142, 2925, 1644, 1599, 1500, 1447, 1378, 1318, 1242, 1175, 1139, 1093, 
970, 906, 812, 747, 670 cm-1. HRMS: calcd for C24H20N2O4FS [M+1] 451.1128 found 
































































4-(4-Fluorophenyl)-3-oxo-3,6-dihydro-2H-pyridine-1-carboxylic acid benzyl ester  
2.33c.
 









































4-(4-Fluorophenyl)-3-oxo-piperidine-1-carboxylic acid methyl ester 2.34b  
 
 














1-Benzyl-4-(4-fluorophenyl)-3-methoxymethylene piperidine 2.35 
 
1H NMR of 2.35 
 












































































4-(4-Fluorophenyl)-3-hydroxy-3,6-dihydro-2H-pyridine-1-carboxylic acid methyl 




































carboxylic acid methyl ester 2.39 




























pyridine-1-carboxylic acid methyl ester 2.40 



















































































































































carboxylic acid benzyl ester 2.45 









































                                                 
1 For selected reviews on the aldol reaction, see: (a) Palomo, C.; Oiaride, M.; Garcia, J. 
M.; Chem. Eur. J. 2002, 8, 37. (b) Machajewski, T. D.; Wong, C.-H. Angew. Chem. Int. 
Ed. 2002, 39, 1353. (c) Denmark, S. E.; Stavenger, R. A. Acc. Chem. Res. 2000, 33, 432. 
(d) Nelson, S. G. Tetrahedron Asymmetry 1998, 9, 357. 
  
2 For selected reviews on the Michael reaction, see: (a) Krause, N.; Hoffman-Roder, A. 
Synthesis 2001, 2, 271. (b) Gorobets, E. V.; Miftakhov, M. S.; Valeev, F. A. Russ. Chem. 
Rev. 2000, 69, 1001. (c) Johnson, J. S.; Evans, D. A.Acc. Chem. Res. 2000, 33, 325. (d) 
Shibasaki, M.; Sasai, H. Top. Stereochem. 1999, 22, 201. (e) Christoffers, J. Eur. J. Org. 
Chem. 1998, 7, 1259. (f) Krause, N. Angew. Chem. Int. Ed. 1998, 37, 283. 
 
3 Stork, G.; Rosen, P.; Godman, N. L. J. Am. Chem. Soc. 1961, 83, 2965. (b) Stork, G.; 
Rosen, P.; Goldman, N.; Coombs, R. V.; Tsuji, J. J. Am. Chem. Soc.1965, 87, 275.  
 
4 For selected reviews on nucleophilic catalysis see: (a) Dalko, P. I.; Moisan, L. Angew. 
Chem. Int. Ed. 2001, 40, 3726. (b) Enders, D.; Grondal, C.; Huttl, M. R. M. Angew. 
Chem. Int. Ed. 2007, 46, early view, DOI: 10.1002/anie.200603129 
 
5 For Krische’s reaction in nucleophilic catalysis area, see: (a) Cho, C.-W.; Kong, J. R.; 
Krische, M. J. Org. Lett. 2004, 6, 1337. (b) Cho, C.-W.; Krische, M. J. Angew. Chem. Int. 
Ed. 2004, 43, 6689. (c) Park, H.; Cho, C. -W.; Krische, M. J. J. Org. Chem. 2006, 71, 
7892. (d) Wang, J. C.; Ng, S. S.; Krische, M. J. J. Am. Chem. Soc. 2003, 125, 3682. (e) 
Wang, J.-C.; Krische, M. J. Angew. Chem. Int. Ed. 2003, 42, 5855. (f) Jellerichs, B. G.; 
Kong, J. R.; Krische, M. J. J. Am. Chem. Soc. 2003, 125, 7758. (g) Wang L.–C.; Luis, A. 
L.; Agapiou, K.; Jang, H.–Y.; Krische, M. J. J. Am. Chem. Soc. 2002, 124, 2402. (h) 
Agapiou, K.;  Krische, M. J. Org. Lett. 2003, 5, 1737-1740.  
 
6  For selected reviews on nickel-catalyzed of preformed enolate arylation, see: (a) 
Semmelhack, M. F.; Stauffer, R. D.; Rogerson, T. D. Tetrahedron Lett. 1973, 45, 4519. 
(b) Millard, A. A.; Rathke, M. W.; J. Am. Chem. Soc. 1977, 99, 4833. (c) Fauvarque, F.; 
Jutand, A. J. Organomet. Chem. 1979, 177, 273. 
 
7 For selected reviews on palladium-catalyzed arylation of preformed enolates, see: (a) 
Kosugi, M.; Hagiwara, I.; Sumiya, T.; Migita, T. Bull. Chem. Soc. Jpn. 1984, 57, 242. (b) 
Kosugi, M.; Negishi, Y.; Kameyama, M. Migita, T. Bull. Chem. Soc. Jpn. 1985, 58, 
3383. (c) Kawajima, I.; Nakamura, E. Acc. Chem. Res. 1985, 18, 181. (d) Galarini, R.; 
Musco, A.; Pontellini, R.; Santi, R. J. Mol. Catal. 1992, 72, L11. 
 
8  For selected reviews on palladium-catalyzed direct arylation of ketones, see: (a) 
Palucki, M.; Buckwald, S. L.; J. Am. Chem. Soc. 1997, 119, 11108. (b) Hamann, B. C.; 
Hartwig, J. F. J. Am. Chem. Soc. 1997, 119, 12382. (c) Satoh, T.; Kawamura, Y.; Miura, 
 152
                                                                                                                                                 
M.; Nomura, M. Angew. Chem. Int. Ed. 1997, 36, 1740. (d) Kawatsura, M.; Hartwig, J. F. 
J. Am. Chem. Soc. 1999, 121, 1473. (e) Fox, J. M.; Huang, X.; Chieffi, A.; Buchwald, S. 
L. J. Am. Chem. Soc. 2000, 122, 1360.  
 
9  For selected reviews on asymmetric nickel/ palladium-catalyzed direct arylation of 
ketones, see: (a) Ahman, J.; Wolfe, J, P.; Troutman, M. V.; Palucki, M.; Buchwald, S. L. 
J. Am. Chem. Soc. 1998, 120, 1918. (b) Hamada, T.; Chieffi, A.;  Ahman, J.; Buchwald, 
S. L. J. Am. Chem. Soc. 2002, 124, 1261. (c) Lee, S.; Hartwig, J. F. J. Org. Chem. 2001, 
66, 3402. (d) Spielvogel, D.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 3500. 
 
10  For selected reviews encompassing the use of arylbismuth(V) reagents, see: (a) 
Freedman, L. D.; Doak, G. O. Chem. Rev. 1982, 82, 15. (b) Barton, D. H. R.; Finet, J.-P. 
Pure Appl. Chem. 1987, 59, 937. (c) Abramovitch, R. A.; Barton, D. H. R.; Finet, J.-P.; 
Tetrahedron 1988, 44, 3039. (d) Finet, J.-P. Chem. Rev. 1989, 89, 1487. 
 
11 Barton D. H. R.; Lester, D. J.; Motherwell, W. B.; Papoula, T. B. J. Chem. Soc. Chem. 
Commun. 1980, 246. 
 
12 For arylation of β-dicarbonyl compounds using bismuth(V) reagents, see: (a) Barton, 
D. H. R.; Blazejewski, J.-C.; Charpiot, B.; Finet, J.-P.; Motherwell, W. B.; Papoula, M. 
T. B.; Stanforth, S. P. J. Chem. Soc., Perkin Trans. 1 1985, 2667. (b) Barton, D. H. R.; 
Charpiot, B.; Motherwell, W. B. Tetrahedron Lett. 1982, 23, 3365. (c) Barton, D. H. R.; 
Blazejewski, J. C.; Charpiot, B.; Lester, D. J.; Motherwell, W. B.; Barros Paoula, M. T. J. 
Chem. Soc. Chem. Commun. 1980, 827. 
 
13 For selected reviews on c-arylation of phenols using bismuth(V) reagents, see: (a) 
Barton, D. H. R.; Bhatnagar, N. Y.; Blazejewski, J.-C.; Charpiot, B.; Finet, J.-P.; Lester, 
D. J.; Motherwell, W. B.; Papoula, M. T. B.; Stanforth, S. P. J. Chem. Soc., Perkin Trans. 
1 1985, 2657. (b) Barton, D. H. R.; Bhatnagar, N. Y.; Finet, J.-P.; Khamsi, J.; 
Motherwell, W. B.; Stanforth, S. P. Tetrahedron 1987, 43, 323.  
 
14 For arylation of preformed enolates using bismuth(V) reagents, see: Arnauld, T.; 
Barton, D. H. R.; Normant, J.-F.; Doris, E. J. Org. Chem. 1999, 64, 6915 and references 
therein (b) Ooi, T.; Goto, R.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 10494. 
 
15 Barton, D. H. R.; Bhatnagar, N. Y.; Finet, J. –P.; Motherwell, W. B. Tetrahedron 1986, 
42, 3111.  
 
16 (a) Beletskaya, I. P.; Cheprakov, A. V. Chem. Rev. 2000, 100, 3009. (b) Koelsch, C. F.; 
Boekelheide, V. J. Am. Chem. Soc.1944, 66, 412. 
 
17 Koech, P. K.; Krische, M. J. J. Am. Chem. Soc. 2004, 126, 5350. 
 
 153
                                                                                                                                                 
18 Finet, J. P.; Combes, S. Synth. Commun. 1996, 26, 4569. 
 
19   For selected reviews on nitroalkenes in organic synthesis, see: (a) Corey, E. J.; 
Estreicher, H. J. Am. Chem. Soc. 1978, 100, 6294. (b) Seebach, D.; Colvin, E. W.; Lehr, 
F.; Weller, T. Chimia 1979, 33, 1. (c) Barrett, A. G. M.; Graboski, G.; Chem. Rev. 1986, 
86, 751. (d) Rosini, G.; Ballini, R. Synthesis 1988, 833. (e) Barrett, A. Chem Soc. Rev. 
1991, 20, 95. 
 
20 For nitroalkenes as dienophiles in Diels-Alder reactions, see: (a) Ranganathan, D.; Rao, 
C. B.; Ranganathan, S.; Mehrotra, A. K.; Iyengar, R. J. Org. Chem. 1980, 45, 1185. (b) 
Corey, E. J.; Estreicher, H. Tetrahedron Lett. 1981, 22, 603. (c) Ono, N.; Miyake, H.; 
Kaji, A. J. Chem. Soc., Chem. Commun. 1982, 33. (d) Kurth, M. J.; O’Brien, M. J.; Hope, 
H.; Yanuck, M. J. J. Org. Chem. 1985, 50, 2626. (e) Baruah, P. D.; Mukherjee. S.; 
Mahajan, M. P. Tetrahedron 1990, 46, 1951. (f) Enders, D.; Meyer, O.; Raabe, G. 
Synthesis, 1992, 1242. 
 
21  For selected reviews on conjugate addition to nitroalkenes, see: (a) Pecunioso, A.; 
Menicagli, R. J. Org. Chem. 1989, 54, 2391. (b) Schafer, H.; Seebach, D. Tetrahedron 
1995, 51, 2305. (c) Versleijen, J. P. G.; Leusen, A. M. V.; Feringa, B. L. Tetrahedron 
Lett. 1999, 40, 5803. (d) Ji, J.; Barnes, D. M.; Zhang, J.; King, S. A.; Wittenberger, S. J.; 
Morton, H. E. J. Am. Chem. Soc. 1999, 121, 10215. (e) Hayashi, T.; Senda, T.; 
Ogasawara, M. J. Am. Chem. Soc. 2000, 122, 10716. (f) Luchaco-Cullis, C. A.; Hoveyda, 
A. H. J. Am. Chem. Soc. 2002, 124, 8192.   
 
22 (a) Kabalka, G. W.; Varma, R. S. Org. Prep. Proc. Int. 1987, 19, 283. 
 
23  For nitroalkenes as insecticides, see : (a) Bousquet, E. W.; Kirby, J. E.; Searle, N. E. 
U.S. Patent 2,335,384, 1943; Chem. Abstr. 1944, 38, 2834.  
  
24  For antifungal activity of nitroalkenes, See: (a) Brian, P. W.; Grove, J. F.; McGowan, 
J. C. Nature 1946, 158, 876. (b) McGowan, J. C.; Brian, P. W.; Hemming, H. G. Ann. 
Appl. Biol. 1948, 35, 25.  
 
25 For antibacterial activity of nitroalkenes, see: (a) Schales, O.; Graefe, H. A. J. Am. 
Chem. Soc. 1952, 74, 4486. (b) Milhazes, N.; Calheiros, R.; Marques, M. P. M.; Garrido, 
J.; Cordeiro, M. N. D.S.; Rodrigues, C.; Quinteira, S.; Novais, C.; Peixe, L.; Borges, F. 
Bioorg. Med. Chem. 2006, 14, 4078.  
 
26 For nitroalkenes as antitumor agents, see: (a) Zee-Cheng, K.-Y.; Cheng, C. C. J. Med. 
Chem. 1969, 12, 157. (b) Kim, J. H.; Kim, J. H.; Lee, G. E.; Lee, J. E.; Chung, I. K. Mol. 
Pharmacol. 2003, 63, 1117. 
 154
                                                                                                                                                 
 
27 For a review, see: Gunasekara, N. G.; Noble, S.; Benfield, P. Drugs, 1998, 55, 85.  
 
28 Physical resolution of racemates: (a) Christensen, J. A.; Squires, R. F. German Patent 
2,404,113, 1974; Chem. Abstr. 1974, 81, 152011q. (b) Stemp, J. A.; Miller, D.; Martin, 
R. T. Eur. Patent 0190496, 1985; Chem. Abstr. 1987, 106, 18361. (c) Faruk, E. A.; 
Martin, R. T. EP Patent 223,334,1986; Chem. Abstr. 1987, 107, 96594. (d) Willcocks, K.; 
Barnes, R. D.; Rustidge, D. C.; Tidy, D. J. D. J. Labelled Compd. Radiopharm. 1993, 33, 
783. (e) Engelstoft, M.; Hansen, J. B. Acta Chem. Scand. 1996, 50, 164. (f) Istvan, B.; 
Laszlo, C.; Laszlo, D.; Kalman, H.; Istvan, H.; Janos, K.; Andras, N.; Eva, W. P.; 
Juhaszida, D.; Judit, N. B. U. S. Patent 6657062, 1997; Chem. Abstr. 1998, 128, 127941. 
(g) Sugi, K.; Itaya, N.; Katsura, T.; Igi, M.; Yamakazi, S.; Ishibashi, T.; Yamaoka, T.; 
Kawada, Y.; Tagami, Y. Eur. Patent 0812827, 1997; Chem. Abstr. 1998, 128, 75308. (h) 
Kreidl, J.; Czibula, L.; Nemes, A.; Deutschne, J. I.; Werkne Papp E.; Nagyne Bagdy J.; 
Dobay, L.; Hegedus, I.; Harsanyi, K.; Borza, I. WO Patent 9801424, 1998; Chem. Abstr. 
1998, 128, 127941. (i) Czibula, L.; Nemes, A.; Sebök, F.; Szántay, C. Jr.; Mák, M. Eur. 
J. Org. Chem. 2004, 3336.  
 
29 Enzyme catalyzed asymmetric transformations: (a) Zepp, C. M.; Gao, Y.; Heefner, D. 
L. U. S. Patent 5,258,517, 1993; Chem. Abstr. 1993, 120, 217289. (b) Curzons, A. D.; 
Powell L. W.; Keay, A. M. WO Patent 9322284, 1993; Chem. Abstr. 1993, 120, 163991. 
(c) Yu, M. S.; Jacewicz, V. W.; Shapiro, E. WO Patent, 9853824, 1998; Chem. Abstr. 
1998, 128, 151093. (d) Gledhill, L.; Kell, C. M. WO Patent 9802556, 1998; Chem. Abstr. 
1998, 128, 151093. (e) Yu, M. S.; Lantos, I.; Yu, P. Z.-Q. J.; Cacchio, T. Tetrahedron 
Lett. 2000, 41, 5647. (f) Gonzalo, G. D.; Brieva, R.; Sánchez, V. M.; Bayod, M.; Gotor, 
V. J. Org. Chem. 2001, 66, 8947.  
 
30 Chiral auxiliary based approaches: (a) Amat, M.; Hildago, J.; Bosch, J. Tetrahedron 
Asymmetry, 1996, 7, 1591. (b) Adger, B. M.; Potter, G. A.; Fox, M. E. WO Patent 
9724323, 1997. Chem. Abstr. 1997, 127, 149075. (c) Murthy, K. S. K.; Rey, A. W. U. S. 
Patent 5962689, 1999. WO Patent 9907680, 1999; Chem. Abstr. 1999, 130, 182361. (d) 
Amat, M.; Bosch, J.; Hildago, J.; Canto, M.; Perez, M.; Llor, N.; Molins, E.; Miravitlles, 
C.; Orozco, M.; Luque, J. J. Org. Chem. 2000, 65, 3074. (e) Cossy, J.; Mirguet, O.; 
Pardo, D. G.; Desmurs, J.-R., Tetrahedron Lett. 2001, 42, 7805. (f) Cossy, J.; Mirguet, 
O.; Pardo, D. G.; Desmurs, J.-R. New J. Chem. 2003, 27, 475. (g) Yamada, S.; Jahan, I. 
Tetrahedron Lett. 2005, 46, 8673. 
 
31 Asymmetric deprotonation using chiral bases: (a) Johnson, T. A.; Curtis, M. D.; Beak, 
P. J. Am. Chem. Soc. 2001, 123, 1004. (b) Greenhalgh, D. A.; Simpkins, N. S. Synlett 




                                                                                                                                                 
32 Catalytic enantioselective transformations: (a) Taylor, M. S.; Jacobsen, E. N. J. Am. 
Chem. Soc. 2003, 125, 11204. (b) Hughes, G.; Kimura, M.; Buchwald, S. L. J. Am. 
Chem. Soc. 2003, 125, 11253.  
 
33 Naturally occurring chiral starting materials: (a) Cossy, J.; Mirguet, O.; Pardo, D. G.; 
Desmurs, J.-R., Tetrahedron Lett. 2001, 42, 5705. (b) Cossy, J.; Mirguet, O.; Pardo, D. 
G.; Desmurs, J.-R., Eur. J. Org. Chem. 2002, 35, 3543.  
 
34 Chen, L. C.; Wang, E.–C.;  Lin, J.-H.;  Wu, S.–S.; Heterocycles, 1984 , 22, 2769. 
 
35 Fortunato, J. M.; Ganem, B. J. Org. Chem. 1976, 41, 2194. 
 
36 For enantioselective protonation of enol silanes related to reactions see: (a) Ishihara, K.; 
Kaneeda, M.; Yamamoto, H. J. Am. Chem. Soc. 1994, 116, 11179. (b) Ishihara, K.; 
Nakamura, S.; Kaneeda, M.; Yamamoto, H. J. Am. Chem. Soc. 1996, 118, 12854. (c) 
Ishihara, K.; Nakashima, D.; Hiraiwa, Y.; Yamamoto, H. J. Am. Chem. Soc. 2003, 125, 
24. (d) Yanagisawa, A.; Touge, T.; Arai, T. Angew. Chem. Int. Ed. 2005, 44, 1546.  
 
37 For selected reviews encompassing enantioselective protonation of enol silanes, see: (a) 
Fehr, C. Angew. Chem., Int. Ed. Engl. 1996, 35, 2567. (b) Yanagisawa, A.; Ishihara, K.; 
Yamamoto, H. Synlett 1997, 411. (c) Duhamel, Lucette; Duhamel, Pierre; Plaquevent, J.-
C. Tetrahedron: Asymmetry 2004, 15, 3653. 
 
38 For a review, see: Corey, E. J.; Helal, C. J. Angew. Chem. Int. Ed. 1998, 37, 1986. 
 
39 For anti-selective copper-mediated SN2’ allylic substitution of allylic phosphates, see: 
(a) Chong, J. M.; Belelie, J. L. J. Org. Chem. 2001, 66, 5552. (b) Chong, J. M.; Belelie, J. 
L. J. Org. Chem. 2002, 67, 3000. (c) Calaza, M. I.; Hupe, E.; Knochel, P. Org. Lett. 2003, 
5, 1059. (d) Dieter, R. K.; Gore, V. K.; Chen. N. Org. Lett. 2004, 6, 763.  
 
40 (a) Tamao, K.; Ishida, N. Tetrahedron Lett. 1984, 25, 4245. (b) Tamao, K.; Ishida, N.; 
Kumada, M. Org. Synth. 1990, 69, 96. (c) Matsuumi, M.; Ito, M.; Kobayashi, Y. Synlett 
2002, 1508.  
 
41 Crabtree, R. H.; Davis, M. W. J. O,rg. Chem. 1986, 51, 2655.  
 
42 For reviews encompassing substrate-directed hydrogenation, see: (a) Brown, J. M. 
Angew. Chem. Int. Ed. Engl. 1987, 26, 190. (b) Hoveyda, A. H.; Evans, D. A.; Fu, G. C. 
Chem. Rev. 1993, 93, 1307.  
 
43 (a) Mitsunobu, O. Synthesis 1981, 1. (b) Shi, Y.-N.; Hughes, D. L.; McNamara, J. M. 
Tetrahedron Lett. 2003, 44, 3609. 
 
 156
                                                                                                                                                 
44 Gilligan, P.J.; Cain, G. A.; Christos, T. E.; Cook, L.; Drummond, S.; Johnson, A. L.; 
Kergaye, A. A.; McElroy, J. F.; Rohrbach, K. W.; Schmidt, K. W.; Tam, S. M. J. Med. 
Chem. 1992, 35, 4344.  
 
43 Mikami, T.; Harada, M.; Naraka, K. Chem. Lett. 1999, 425. 
 
46 Majetich, G.; Liu, S.; Fang, J.; Siesel, D.; Zhang, Y. J. Org. Chem. 1997, 62, 6928. 
 
47 Kojima, M; Sakuragi, H.; Tokumaru, K. Bull. Chem. Soc. Jpn. 1987, 60, 3331. 
 
48 Prasad, B. S. A.; Knochel, P. Tetrahedron, 1997, 53, 1671. 
 
49 Syper, L. Tetrahedron  1987, 43, 2853. 
 
50 Anand, R. C., Ranjan, H. Indian J. Chem. 1984, 23B, 1054. 
 
51 Desai, R. C.; Meurer, L. C.; Finke, P. E. Tetrahedron Lett. 2002, 43, 4569. 
 
52 Nakamura, E.; Shimada, J.; Kuwajima , I. J. Chem,Soc. Commun. 1983, 498. 
 
53 Clinch, K.; Marquez, C. J.;  Parrott, M. J.; Ramage, R. Tetrahedron 1989, 45, 239. 
 
54 Dana, P. G.; Thuan, M. S. L. T. Bull. Soc. Chim. Fr. 1974, 2089. 
 
55 Mampreian, D. M.; Hoveyda, A. H. Org. Lett. 2004, 6, 2829. 
 
56 McNulty, J.; Steere, J. A.; Wolf, S. Tetrahedron Lett. 1998, 39, 8013. 
 
57 Haginoya, N.; Kobayashi, S.; Komoriya, S.; Yoshino, T.; Suzuki, M.; Shimada, T.; 
Watanabe, K.; Hirokawa, Y.; Furugori, T.; Nagahara, T. J. Med. Chem. 2004, 47, 5167. 
 
58 Buchi, G.; Mak, C.-P. J. Org. Chem. 1977, 42, 1784. 
 
59 (a) Yamamura, K.; Watarai, S.; Kinugas, T. Tetrahedron Lett. 1972, 28, 2829. (b) 
Hata, E.; Yomada, T.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 1995, 68, 3629. 
 
60 Still, W. C.; Kahn, M;  Mitra, A. J. Org. Chem. 1978, 43, 2. 
 





Chapter 3: Copper-Catalyzed Enantioselective Tandem Conjugate 
Addition-Arylation Using Bismuth(V) Reagents 
 
3.1 Introduction 
 Tandem C-C bond forming transformations are attractive synthetic methods, as 
they enable a rapid increase in molecular complexity from readily available starting 
materials.1,2 The advantage of these transformations is the ability to form several bonds 
and multiple contiguous stereogenic centers in a single manipulation utilizing a single 
catalyst without isolation and purification of the intermediates. The development of 
tandem transformations relies on latent functionality, meaning reaction on one site of a 
molecule induces a reaction at a different site. Potential functional groups for tandem 
reactions are enones, enals and enoates which can undergo conjugate addition (CA) 
followed by subsequent electrophilic trapping of the resulting nucleophilic enolate.3 This 
type of tandem conjugate addition-electrophilic trapping strategy was first employed by 















3.3 Lycopodine3.1 3.2  
Scheme 3.1 Stork’s application of tandem conjugate addition-alkylation in total synthesis 
of lycopodine 
Subsequent to Stork’s seminal report, application of conjugate addition-
electrophilic trapping reaction has increased dramatically in the chemical literature.5 Such 
methods include the copper-catalyzed conjugate addition of Grignard reagents to α,β-
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unsaturated carbonyl compounds and trapping of the incipient enolates with classical 
electrophiles such as alkyl halides,6 carbonyls,7 acylating agents,8 Michael acceptors,9 
and iminium ions. 10  These catalytic tandem conjugate addition-electrophilic trapping 
transformations are useful, however greater versatility and higher yields are obtained 
when stoichiometric organocuprate reagents are employed. Additionally, these reactions 
are not enantioselective. In the last decade catalytic asymmetric conjugate addition 
methods have received considerable interest and the Krische group has made 
contributions to this field. 
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3.2 Asymmetric Copper-Catalyzed Tandem Conjugate Addition-
Electrophilic Trapping Reactions 
3.2.1 Mechanistic Features 
Catalytic conjugate addition of Grignard reagents to α,β-usaturated carbonyl 
compounds is one of the oldest and well developed transformations. However, 
asymmetric variants of these transformations are under developed. Conversely, in the last 
decade, highly enantioselective Cu-catalyzed conjugate addition reaction of organozinc 
reagents to α,β-unsaturated carbonyl compounds have been studied extensively. 11 
Effective methods for asymmetric conjugate addition of alkylzinc reagents to cyclic 
enones,12 including the more challenging cyclopentenones,13 lactones,14 nitroalkenes,15 
and acyclic enones16  have been developed. A simplified mechanism for asymmetric 
conjugate addition starts with a chiral copper(I) complex A, alkyl transfer from R2Zn to 
this copper complex A results in alkylcopper complex B (Scheme 3.2). Simultaneous 
complexation of the enone carbonyl by the alkylzinc fragment and the coordination of the 
alkylcopper complex to the π-bond give the bimetallic complex C. This bimetallic 
complex provides a rigid transition state which translates to high levels of stereocontrol. 
Subsequent alkyl transfer to the β-terminus of the enone generates a zinc enolate, which 
can be trapped by a variety of electrophiles such as aldehydes, ketones, carboxylates and 




















Scheme 3.2 Catalytic cycle for copper-catalyzed conjugate addition of organozinc 
reagents to enones 
3.2.2 Copper-Catalyzed Asymmetric Tandem Conjugate Addition-Electophilic 
Trapping Reactions Involving Organozinc Reagents 
In 1997 Feringa and co-workers reported the first catalytic asymmetric tandem 
conjugate addition of organozinc reagents to α,β−usaturated carbonyl compounds with 
subsequent trapping of the resulting enolate with aldehydes (Scheme 3.3). 17  This 
asymmetric tandem conjugate addition-aldol reaction involving dimethylzinc and 2-
cyclohexenone 3.4 provides trans-2,3-disubstituted cyclohexanone 3.6 in the presence of 
a copper(I) salt and phosphoramidite ligand 3.8. In this transformation complete control 
of both relative and absolute stereochemistry is achieved in vicinal functionalization of 
both cyclohexenone and cyclopentenone. The synthetic utility of the asymmetric tandem 
conjugate addition/aldol was demonstrated in total synthesis of PGE1 (prostaglandin E1) 
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3.13 PGE1 methyl ester







Scheme 3.4 Application of asymmetric tandem conjugate addition-aldol reaction in total 
synthesis of PGE1 methyl ester 
 In 2004 Krische and co-workers reported a copper-catalyzed conjugate 
addition/intramolecular electrophilic trapping transformation that utilize ketones, esters 
and nitriles as terminal electrophiles (Scheme 3.5).18  Enone substrates containing an 
appendant ketone, ester or nitrile functionality undergo conjugate addition in the presence 
of organozinc reagents and catalytic Cu(OTf)2/P(OEt)3 followed by electrophilic trapping 
 162
to provide bicyclic products in excellent yields and modest diastereoselectivity. When the 
phosphoramidite lingand 3.8 is used in place of P(OEt)3, asymmetric tandem conjugate 
addition-aldol is achieved in high yields and excellent enantioselectivity. This 
transformation represents the first use of ketones, esters and nitriles as electrophiles in 




















Scheme 3.5 Copper-catalyzed asymmetric intramolecular conjugate addition-aldol 
reaction 
The zinc enolates generated via asymmetric conjugate addition of organozinc 
reagents to enones can be trapped by π-allyls obtained through palladium ionization of 
allylic acetate to provide 2,3-disubstituted enones 3.17 in good yields and excellent 
enantioselectivity (Scheme 3.6).19 Feringa and co-worker subjected the product of this 
reaction to Wacker oxidation to obtain a ketone which was then subjected to base 
promoted annulation to afford bicyclic product 3.18. 
O
















    THF, RT
3.18
13:1 dr,
96% ee  
Scheme 3.6 Copper-catalyzed asymmetric conjugate addition-allylation reaction 
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Hoveyda and co-workers have developed peptide derived chiral ligand 3.22 for an 
asymmetric copper-catalyzed conjugate addition of dialkylzinc reagents to α,β-
unsaturated carbonyl compounds in excellent yields and excellent enantioselectivity.16 
This asymmetric conjugate addition results in the generation of a zinc enolate, which can 
be trapped by alkyl halides and tosylates to provide products with contiguous 
stereocenters (Scheme 3.7). The use of the peptide-based chiral phosphine ligand has 
enabled functionalization of six, seven and the more challenging five membered cyclic 
enones in excellent enantioselectivity. This methodology has been applied in a concise 
total synthesis of anti-cancer clavularin B 3.21 in only four steps with 42% overall 
yield.13b 
O (CuOTf)2·C6H6 (1 mol%)3.22 (2.4 mol%)























Scheme 3.7 Hoveyda’s asymmetric Copper-catalyzed conjugate addition-alkylation 
reaction 
3.2.3 Copper-Catalyzed Asymmetric Tandem Conjugate Addition-Electophilic 
Trapping Reactions Involving Grignard Reagents 
Enantioselective conjugate addition of Grignard reagents to α,β-unsaturated 
carbonyl compounds was the first asymmetric transformation to be studied.20 This work 
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focused mainly on the chiral auxiliary approach, using readily available chiral alcohols, 
amines and thiols. In 1988, Lippard and co-workers reported the first enantioselective 
catalytic conjugate addition of Grignard reagents to enones using chiral amide ligands.21 
Subsequent to this seminal report several methods involving chiral thiolates22 and chiral 
monophosphine23 ligands were reported. However, enantioselectivities for these reactions 
rarely surpassed 90% ee. Tomioka’s asymmetric conjugate addition of BuMgCl to 
cyclohexenone 3.4 using chiral amidophosphine (Scheme 3.8) 23c and Sammakia’s  
















Scheme 3.8 Asymmetric conjugate addition of Grignard reagents to enones using 
amidophosphine 3.24 
The major problem limiting the development of highly enantioselective copper-
catalyzed conjugate addition of Grignard reagents to α,β-unsaturated carbonyl 
compounds is the competing uncatalyzed background reaction. Another challenge is 
stopping the competing 1,2-addition of the Grignard reagent to the carbonyl group. The 
advantage of using Grignard reagents over dialkylzinc reagents is that they are 
inexpensive, readily available and all the alkyl groups in the reagent can be transferred. In 
an effort to address these problems, Feringa and co-workers have developed a highly 
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enantioselective copper-catalyzed conjugate addition of Grignard reagents to enones and 
enoates with selectivity up to 98% ee using ferrocenyl diphosphine ligands (Scheme 
3.9). 24  Trapping of the magnesium enolates generated via enantioselective copper-
catalyzed conjugate addition to enones with reagents other than water is unknown. Herein 
we report the first enantioselective conjugate addition of Grignard reagents to 
cyclohexenone with subsequent electrophilic trapping of the resulting enolate with aryl 
















Scheme 3.9 Copper-catalyzed asymmetric conjugate addition on Grignard reagents to 




3.3 Copper-Catalyzed Enantioselective Tandem Conjugate Addition of 




Our studies began with examination of 2-cyclohexenone 3.4. Exposure of 3.4 to 
EtMgBr (120 mol) in the presence of CuCl (5 mol%) and Taniaphos 3.26 (6 mol%) at 
0 °C in Et2O solvent (0.1 M), for 10 min, followed by addition of commercially available 
Ph3BiCl2 (150 mol%) in THF gave the product 3.27 in 10% isolated yield and 91% ee as 
a single stereoisomer as determined by 1H NMR analysis (Table 3.1, entry 1). It was 
speculated that the magnesium enolate might aggregate in solution and thus addition of 
hexamethylphosphoramide (HMPA) would help break these aggregates increasing 
enolate reactivity. Gratifyingly, addition of HMPA (120 mol%) gave an increase in yield 
of 3.27 to 34% (Table 3.1, entry 2). Under identical conditions, but increasing the loading 
of Ph3BiCl2 from 150 mol% to 200 mol% the yield of 3.27 improved to 50% (Table 3.1, 
entry 3). A potential problem in this reaction is the competing 1,2-addition of the 
Grignard reagent to the enone. We speculated that decreasing the reaction temperature to 
-78 °C would slow down this competing pathway. Indeed, a decrease in temperature to -
78 °C led to a 63% isolated yield of 3.27 (Table 3.1, entry 4). Performing the reaction in 
MeOtBu as a solvent gave 3.27 in 60% isolated yield and 96% ee (Table 3.1, entry 5). 
Finally by using CuBr•SMe2 in place of CuCl we could obtain 3.27 in 62% yield and 
96% ee. These reaction conditions represent our standard conditions for conjugate 
addition-arylation (Table 3.1, entry 6). 
 
 167
Table 3.1 Optimization for Copper-catalyzed enantioselective tandem conjugate addition-
arylation of 3.4 
Et
Ph
OO 1) CuX (5 mol%)
    TaniaPhos (6 mol%)
    EtMgBr (120 mol%)
    Solvent (0.1M), Temp °C
2) Additive (120 mol%)
    Ph3BiCl2, THF
3.4


















MeOtBu HMPA -78 °C 62 962006














3.3.2 Substrate Scope 
 
Under these standard conditions, the substrate scope of the tandem conjugate 
addition-arylation of enones reaction was explored. Enone 3.4 undergoes tandem 
conjugate addition of CH3MgBr, EtMgBr, n-PrMgBr and n-BuMgBr with subsequent 
enolate arylation using Ph3BiCl2 to give products 3.27-3.30 in modest to good yields and 
excellent enantiomeric excess (Table 3.2). In each case, the products were obtained as 
single stereoisomer, as determined by 1H NMR analysis. To further probe the scope of 
this transformation, triarylbismuth(V) dichlorides were prepared by first treating ArMgBr 
with BiCl3 followed by oxidation of the resulting triarylbismuth(III) compound with 
sulfuryl chloride (SO2Cl2).25 Tandem conjugate addition-arylation using para and meta 
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substituted triarylbismuth(V) dichlorides gave products 3.31-3.34 in modest yields and 
excellent enantiomeric excess (Table 3.2).  










































1) CuBr·SMe2 (5 mol%)
    TaniaPhos (6 mol%)
    RMgBr (120 mol%)
    MeOtBu  (0.1M), 0 °C
2) HMPA (120 mol%)
    Ar3BiCl2 (200 mol%), THF >95:5 d.r
3.4 3.27-3.34
 
aCited yields are of isolated material. In all cases, > 95:5 diasterioselectivity is observed 
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3.4 Summary and concluding remarks 
In summary, we have developed a highly diastereo- and enantioselective method 
for vicinal difunctionalization of enones via tandem enantioselective conjugate addition-
arylation using bismuth(V) reagents. To the best of our knowledge, this is the first 
example of tandem conjugate addition-arylation of enones using bismuth(V) reagents. 
The chemical yields for this reaction are modest due to competing polymerization and 
1,2-addition to the carbonyl of the ketone, though we are able to perform a one pot 
difunctionalization which has been traditionally been restrained to two separate steps. 
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3.5 Experimental Section 
General  
All reactions were performed under an atmosphere of argon, unless otherwise 
indicated. Anhydrous solvents were transferred by an oven-dried syringe. Flasks were 
flame-dried and cooled under argon. diethylether (Et2O) was distilled from 
sodium/benzophenone ketyl. Dichloromethane (DCM) was distilled from calcium 
hydride. Hexamethylphosphoramide (HMPA) was distilled under reduced pressure from 
calcium hydride. Other solvents and chemical reagents obtained from commercial 
sources were used without further purification, unless otherwise noted. The known 
products 3.27, 3.28,26 3.30,27 and 3.32,28 exhibited spectral data identical in all aspects as 
those reported in literature.  
Analytical thin-layer chromatography (TLC) was carried out by using 0.2-mm 
commercial silica gel plates (DC-Fertigplatten Krieselgel 60 F254, EMD Chemicals). 
Solvents for chromatography are listed as volume/volume ratios. Infrared spectra were 
recorded on a Perkin-Elmer 1420 spectrometer. Samples were prepared as films through 
evaporation from dichloromethane or chloroform solution on sodium chloride plates. 
High-resolution mass spectra (HRMS) were obtained on a Karatos MS9 by using 
chemical ionization in the positive ionization mode. Accurate masses are reported for the 
molecular ion (M + 1) or a suitable fragment ion. Melting points were determined on a 
Thomas Hoover Uni-melt apparatus in open capillaries and are uncorrected.  
Proton NMR (1H NMR) spectra were recorded with a Varian Gemini (300 MHz) 
spectrometer, and Varian Gemini (400 MHz) spectrometer. Chemical shifts (δ) are 
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expressed as ppm relative to trimethylsilane (δ = 0.00 ppm), referenced to the residual 
protic solvent. Coupling constants are reported in Hertz. Carbon-13 NMR (13C NMR) 
spectra were recorded on a Varian Gemini 300 (75 MHz) spectrometer, Varian Gemini 
400 (100 MHz) spectrometer and Inova 500 (125 MHz) spectrometer. Chemical shifts (δ) 
are expressed as ppm relative to trimethylsilane (δ = 0.0 ppm), referenced to the center of 
the triplet at δ = 77.0 ppm for deuteriochloroform. 13C NMR analyses were run routinely 
with broadband decoupling.  
Representative procedure for the copper-catalyzed tandem enantioselective 
conjugate addition-arylation of enone 3.4  
To a 10 mL round bottom flask charged with CuCl (0.01 mmol, 5 mol%) and 
Taniaphos (0.02 mmol, 6 mol%) was added Et2O (2.5 mL, 0.1M). The suspension was 
stirred at 25 °C for 30 min. 2-Cyclohexenone 3.4 (0.31 mmol, 100 mol%) was added to 
the resulting homogenous solution and allowed to stir for an additional 10 min, after 
which the reaction vessel was cooled to -78 °C , EtMgBr (3M in Et2O, 0.37 mmol, 120 
mol%) was then added dropwise over 5 min. The reaction mixture was stirred for 1h at -
78 °C, at which point HMPA (0.37 mmol, 120 mol%) and  a solution of Ph3BiCl2 (0.62 
mmol, 200 mol%) in THF (3 mL) were added. The stirring reaction mixture was removed 
from the cooling bath and allowed to warm to room temperature over a period of 3 h. A 
solution of 50 % aqueous Na2CO3 (3 mL) was added and allowed to stir for 10 min to 
convert excess Ph3BiCl2 to the more polar and insoluble Ph3BiCO3 for easy purification. 
The resulting mixture was filtered through celite, rinsing three times with Et2O (5 mL). 
The filtrate was then extracted with Et2O (3 X 5 mL), the combined organic extracts were 
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dried over MgSO4, filtered and evaporated onto silica gel. Purification via column 
chromatography (SiO2, 17:1 to 9:1 hexane/ethyl acetate) gives compound 3.27.  
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3-Ethyl-2-phenylcyclohexanone 3.2726 1H NMR (400 MHz, CDCl3): δ 7.33 (t, J 
= 6.8 Hz, 2H), 7.25 (t, J = 6.8 Hz, 2H), 7.06 (d, J = 7.2 Hz, 1H), 3.30 (d, J = 11.6 Hz, 
1H), 2.52 (m, 1H), 2.45 (td, J = 5.1, 13.1 Hz, 1H), 2.14 (m, 2H), 1.98 (m, 1H), 1.78 (qt, J 
= 3.8, 13.3 Hz, 1H), 1.52 (qd, J = 3.4, 13.0 Hz, 1H), 1.25 (m, 1H), 1.07 (hept, J = 7.2 
Hz, 1H), 0.80 (t, J = 7.5 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 210.3, 137.4, 129.3, 
128.2, 126.7, 63.3, 46.3, 41.9, 30.0, 27.1, 25.8, 10.5.  Chiral HPLC: Daicel Chiralpak 
OD-H column, 95:5 hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  t major = 14.48 min, t minor 
= 15.79 min ee = 97%. [α]D23 +80.4 ° (c =1 CH2Cl2) 
 
 















3-Metyl-2-phenylcyclohexanone 3.2826 1H NMR (300 MHz, CDCl3): δ 7.30 (m, 
3H), 7.06 (d, J = 6.9 Hz, 2H), 3.18 (d, J = 11.5 Hz, 1H), 2.52 (m, 1H), 2.43 (qd, J = 6.9, 
13.6 Hz, 1H), 2.14 (m, 2H), 2.01 (d, J = 14.9 Hz, 1H), 1.82 (qt, J = 4.6, 11.8 Hz, 1H), 
1.59 (td, J = 3.6, 13.1 Hz, 1H), 0.80 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 
209.9, 137.4, 129.2, 128.1, 126.7, 65.1, 41.7, 40.6, 34.2, 25.9, 21.2. Chiral HPLC: Daicel 
Chiralpak OD-H column, 95:5 hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  t major = 14.48 























2-Phenyl-3-propylcyclohexanone 3.29 1H NMR (400 MHz, CDCl3): δ 7.33 (t, J 
= 6.8 Hz, 2H), 7.25 (t, J = 5.8 Hz, 1H), 7.05 (d, J = 6.8 Hz, 2H) 3.27 (d, J = 11.3 Hz, 
1H), 2.52 (m, 1H), 2.44 (qdd, J = 1.0, 5.8, 13.7 Hz, 1H), 2.14 (m, 2H), 2.04 (m, 1H), 1.78 
(qt, J = 4.4, 14.0 Hz, 1H), 1.50 (qd, J = 3.4, 13.0 Hz, 1H),  1.35 (m, 1H), 1.11(m, 3H), 
0.74 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 210.3, 137.4, 129.3, 128.2, 
126.7, 63.7, 44.7, 41.9, 36.8, 30.6, 25.9, 19.4, 14.0. FTIR (NaCl): 3019, 2948, 2857, 
1712, 1496, 1452, 1313, 1176, 745, 698, 556 cm-1. HRMS: calcd for C15H21O [M+1] 
217.1592 found 217.1591. Chiral HPLC: Daicel Chiralpak OD-H column, 95:5 
hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  t major = 13.04 min, t minor = 14.73 min ee = 























3-Butyl-2-phenylcyclohexanone 3.3027 1H NMR (400 MHz, CDCl3): δ 7.31 (t, J 
= 7.1 Hz, 2H), 7.24 (d, J = 7.0 Hz, 1H), 7.05 (d, J = 6.6 Hz, 2H) 3.28 (d, J = 11.3 Hz, 
1H), 2.51 (m, 1H), 2.46 (qd, J = 5.8, 13.4 Hz, 1H), 2.08 (m, 2H), 1.78 (m, 1H), 1.53 (m, 
1H),  1.24 (m, 6H), 1.08 (t, J = 6.7 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 210.3, 
137.4, 129.3, 128.1, 126.7, 63.6, 44.8, 41.9, 34.1, 30.6, 28.4, 25.8, 22.5, 13.9. Chiral 
HPLC: Daicel Chiralpak OD-H column, 95:5 hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  
t major = 12.57 min, t minor = 14.00 min ee = 91%. [α]D21 +93.7 ° (c = 0.8 CH2Cl2). 
 
 














3-Ethyl-2-(4-fluorophenyl)cyclohexanone 3.31 1H NMR (300 MHz, CDCl3): δ 
7.02 (d, J = 7.2 Hz, 4H), 3.30 (d, J = 12.0 Hz, 1H), 2.51 (m, 1H), 2.41 (td, J = 6.4, 13.8 
Hz, 1H), 2.14 (m, 2H), 1.92 (m, 1H), 1.76 (dt, J = 3.3, 13.0 Hz, 1H), 1.54 (q, J = 13.5 
Hz, 1H),  1.25 (m, 1H), 1.06 (quint, J = 7.2 Hz, 1H), 0.80 (t, J = 7.2 Hz, 3H). 13C NMR 
(75 MHz, CDCl3): δ 210.1, 161.7 (d, J = 144 Hz) 133.0, 130.6 (d, J = 7.7 Hz), 115.1 (d, 
J = 21.4 Hz), 62.5, 46.6, 41.9, 30.1, 27.0, 25.9, 10.4. FTIR (NaCl): 2962, 2934, 2864, 
1712, 1602, 1509, 1456, 1221, 1178, 1158, 822 cm-1. HRMS: calcd for C14H18OF [M+1] 
221.1342 found 221.1344. Chiral HPLC: Daicel Chiralpak OD-H column, 99:1 
hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  t major = 16.17 min, t minor = 16.58 min ee = 




























3.Methyl-2-p-tolylcyclohexanone 3.3228 1H NMR (400 MHz, CDCl3): δ 7.16 (t, 
J = 8.2 Hz, 2H), 6.98 (d, J = 8.2 Hz, 2H), 3.18 (d, J = 11.5 Hz, 1H), 2.52 (m, 1H), 2.46 
(qd, J = 5.9, 13.7 Hz, 1H), 2.36 (s, 3H), 2.10 (m, 3H), 1.85 (qt, J = 3.6, 13.3 Hz, 1H),  
1.62 (qd, J = 3.3, 12.5 Hz, 1H), 0.85 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 
210.2, 136.3, 134.3, 129.1, 129.0, 64.7, 41.8, 40.5, 34.3, 25.9, 21.2, 21.1. Chiral HPLC: 
Daicel Chiralpak OD-H column, 95:5 hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  t major = 
12.89 min, t minor = 13.86 min ee = 91%. [α]D21 +27 ° (c = 0.73 CH2Cl2) 
 














2-(4-Bromophenyl)-3-propylcyclohexanone 3.33 1H NMR (400 MHz, CDCl3): 
δ 7.47 (d, J = 8.5 Hz, 2H), 6.94 (d, J = 8.5 Hz, 2H), 3.26 (d, J = 11.6 Hz, 1H), 2.52 (m, 
1H), 2.43 (tdd, J = 1.0, 6.2, 13.7 Hz, 1H), 2.14 (m, 2H), 1.96 (m, 1H), 1.78 (qt, J = 4.1, 
13.0 Hz, 1H), 1.49 (q, J = 11.3 Hz, 1H),  1.34 (m, 1H), 1.10 (m, 3H), 0.75 (t, J = 7.2 Hz, 
3H). 13C NMR (100 MHz, CDCl3): δ 209.8, 136.4, 131.3, 131.0, 120.7, 63.2, 44.9, 41.9, 
36.7, 30.7, 25.9, 19.3, 14.0. FTIR (NaCl): 2954, 2931, 2848, 1713, 1478, 1454, 1407, 
1172, 1067, 1002, 802 cm-1. HRMS: calcd for C15H20O [M+1] 295.0698 found 295.0702. 
Chiral HPLC: Daicel Chiralpak OD-H column, 95:5 hexanes:i-PrOH, λ = 254 nm, 0.5 

























3-Butyl-2-(3-methoxyphenyl)cylohexanone 3.34. 1H NMR (300 MHz, CDCl3): 
δ 7.24 (t,  J = 7.8 Hz, 1H), 6.81 (dd, J = 1.8, 7.6 Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 6.61 
(s, 1H),  3.79 (s, 3H), 3.25 (d, J = 8.1 Hz, 1H), 2.51 (m, 1H), 2.42 (td, J = 5.8, 13.3 Hz, 
1H), 2.10 (m, 3H), 1.78 (m, 1H), 1.53 (q, J = 10.7 Hz, 1H),  1.20 (m, 6H), 0.78 (t, J = 6.9 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 210.2, 159.4, 139.0, 129.1, 121.7, 115.3, 111.9, 
63.7, 55.1, 44.7, 41.9, 34.1, 30.6, 28.5, 25.8, 22.6, 13.9. FTIR (NaCl): 2931, 2849, 1713, 
1596, 1578, 1484, 1454, 1290, 1255, 1161, 1043, 767, 691 cm-1. HRMS: calculated 
[M+1] for C17H25O2 261.1855 found 261.1856. Chiral HPLC: Daicel Chiralpak OD-H 
column, 95:5 hexanes:i-PrOH, λ = 254 nm, 0.5 mL/min,  t major = 16.64 min, t minor = 
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Chapter 4 Hydrogen Mediated Catalytic Addition of Metallo-Aldehyde 




Hydrogenation is the most cost effective and atom economical process, however it 
is limited to simple reduction of unsaturated π-systems.1 Few hydrogenation reactions 
have been utilized in the context of C-C bond formation: they include hydroformylation,2 
Fischer-Tropsch-type reactions3 and other C-C bond forming reactions.4 Many reductive 
C-C bond forming reactions involve stoichiometric reductants such as silane, borane, 
alane and stannane. These reactions often generate stoichiometric byproducts of which 
some are toxic. Conversely hydrogenative C-C bond formations are environmentally 
benign, atom economical, and cost efficient because stoichoimetric byproducts are not 
generated. Inspired by the profound impact of these reactions the Krische group became 
interested in developing general methods for hydrogenative C-C bond forming reactions. 
4.1.1 Mechanistic Features 
In the conventional hydrogenation the mechanism involves a dihydrido metal 
complex that hydrometallates the alkyne or alkene to give a organomonohydrido metal 
complex intermediate (Scheme 4.1, eq 1). For C-C bond formation to occur capture of 
this organomonohydrido metal intermediate is necessary, however this is not possible due 
to rapid C-H reductive elimination. Based on Schrock and Osborn studies on 
hydrogenation using cationic rhodium complexes the dihydrido (RhIIIH2LnX) and the 
monohydrido rhodium (RhIHLn) complexes exist in equilibrium in the presence of an 
exogenous base.5 The use of a mild base generates monohydrido metal complex, this 
 190
could extend the lifetime of the hydrometallated intermediates since it lacks an appendant 
hydride, thus C-C bond formation is possible (Scheme 4.1, eq 2). An alternative pathway 
involves oxidative coupling to furnish a metallocyle which is known in other rhodium 
catalyzed couplings (Scheme 4.1, eq 3).6 In this pathway C-C bond formation precedes 
hydrogen activation to form the metallocycle, subsequent σ-bond metathesis with 
hydrogen provides the C-C bond formation product. On the basis of these mechanistic 
hypotheses the Krische group has developed a family of catalytic hydrogen mediated C-C 
bond forming reactions. The focus of this chapter is to give an overview of the reductive 



































































4.1.2 Reductive Aldol Under Hydrogenation Conditions 
4.1.2.1 Rh-Catalyzed Hydrogenative Aldol Using Aldehyde Acceptors 
Predicated on the mechanistic hypothesis described in section 4.1.1 the Krische 
group has developed a rhodium catalyzed hydrogen mediated aldol reaction.7 To assess 
the feasibility of this hydrogen mediated reductive aldol reaction, an intramolecular 
system was designed that contains a phenyl-substituted monoenone monoaldehyde. 
Exposure of this substrate to Rh(COD)2OTf (10 mol%) and PPh3 (24 mol%), under 
atmosphere of hydrogen, provided the aldol cyclization product in 21% with concomitant 
formation of simple alkene reduction products (Table 4.1, entry 1). On the basis of 
Schrock and Osborn’s5 observation that addition of base facilitates the deprotonation of 
LnRhIII(H2)X to form RhIHLn which would circumvent competing simple reduction, 
KOAc was added. Gratifyingly the yield of the desired products was improved 
dramatically (Table 4.1, entry 2). Additionally, electron-deficient phosphine ligands like 
(p-CF3Ph)3P improved the partitioning between aldol products and conjugate reduction 
products (Table 4.1, entry 4). This was rationalized by invoking and intramolecular co-
ordination of the metal complex to the aldehyde, thus increasing its electrophilicity. 
Notably, neutral rhodium complexes such as Wilkinson’s catalyst provided low yields of 
the aldol product with substantial quantities of conjugate reduction product (Table 4.1, 
entry 5). Control experiments were performed to rule out the possibility of a tandem 
conjugate reduction-base aided aldol reaction. The product of conjugate reduction was 
subjected to the reaction conditions and no product was obtained. Also this 
transformation does not proceed via Morita-Baylis-Hilman reaction since no cyclization 
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product was obtained in the absence of hydrogen. The syn-diastereoselectivity can be 
accounted for by a Zimmerman-Traxler type transition state assuming the formation of a 
Z-enolate. Aromatic, heteroaromatic, and aliphatic monoenone monoaldehyde substrates 
participate in this transformation. 





















































 An intermolecular variant of this transformation has been developed through 
adjustment of the reaction conditions (Table 4.2). Here two equivalent of the enone, 
Rh(COD)2OTf (5 mol%), PPh3 (12 mol%), and KOAc (50 mol%) in an atmosphere of 
hydrogen provide reductive aldol products in good yield with modest diastereoselectivity. 
By using tri-2-furylphophosphine modified rhodium catalysts the diastereoselectivity of 
the reductive aldol reaction was improved tremendously (Table 4.3). 8  The 
diastereoselectivities observed in this reaction at ambient temperature and pressure are 
comparable to those achieved in related aldol reaction at low-temperature using alkali 
enolates. 9  This remarkable diastereoselectivity is attributed to π-acidic ligand tri-2-
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furphosphine which renders the rhodium center Lewis acidic resulting in a tighter 
Zimmerman-Traxler type transition state. 
Table 4.2 Intermolecular reductive aldol reaction under hydrogenation conditions 
Rh(COD)2OTf (5 mol%)
PPh3 (12 mol%)
H2 (1 atm), KOAc (50 mol%)


































Table 4.3 Highly syn-selective reductive aldol through tri-2-furylphosphine effect 
Rh(COD)2OTf (5 mol%)
(2-Fur)3P (12 mol%)































90%, 25 :1 dr
4.7
90%, 17 :1 dr
4.8
95%, 50 :1 dr
4.9





4.1.2.2 Rh-Catalyzed Hydrogenative Aldol Using Ketone Acceptors 
 Having developed the Rh-catalyzed hydrogenative aldol reaction involving 
aldehyde acceptors, the methodology was then extended to other electrophilic partners 
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such as ketones. Whereas similar aldol reactions using ketone acceptors are known,10 it 
was anticipated that conjugate reduction would predominate over reductive aldol due to 
the reduced electrophilicity of the ketones compared to the aldehydes. Rh-catalyzed 
reductive aldol of monoenone mono ketone substrates performed at elevated temperature 
(80 °C) provided the desired aldol products in good yields and excellent 
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Scheme 4.2 Rh-catalyzed hydrogenative aldol using ketone acceptors 
It was possible to attenuate formation of the undesired conjugate reduction 
product by using a more electrophilic dione acceptors. The dione acceptors are more 
reactive due to the inductive effect and also the relief of dipole-dipole interaction after 
reaction. Monoenone with appendant dione substrates undergo hydrogenative reductive 
aldol at ambient temperature to provide bicyclic products as single diastereomers 
(Scheme 4.4). Here five and six membered ring formation is achieved setting 3 
contiguous stereocenters, of which two are quaternary, in a single manipulation.The 
conjugate addition products were not observed, with exception of the strained cis-
decalone 4.13. 
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Based on deuterium labeling experiments, ESI-MS data and control experiments a 
plausible catalytic cycle was proposed (Scheme 4.3).12 Starting with oxidative addition of 
molecular hydrogen to cationic rhodium complex LnRhIX generates 
dihydridorhodium(III) complex LnRhIII(H2)X. Due to its enhanced acidity,13 it can be 
deprotonated by an exogenous base to afford a monohydride complex LnRhIH. These 
complexes are in equilibrium5 leading  to two possible catalytic cycles: the monohydride 
catalytic cycle starts with hydrometallation of the enone A by LnRhIH to give the 
rhodhium (I) enolate B, which can undergo electrophilic trapping by the appendant 
ketone or aldehyde to yield the aldolate C (Scheme 4.3). The rhodium(I) aldolate C 
undergoes hydrogen oxidative addition to give the dihydrido rhodium(III) aldolate D 
which reductively eliminates to afford the aldol product E. The dihydride cycle involves 
LnRhIII(H2)X  which hydrometallates the enone A to yield LnRh(III)(alkyl)(hydrido) 
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enolate intermediate F. which can undergo either alkyl-hydrogen reductive elimination to 
give the undesired conjugate reduction product G or in the presence of exogenous base 
the LnRh(III)(alkyl)(hydrido) enolate F can be deprotonated to yield the rhodhium(I) 


















































Scheme 4.3 A plausible catalytic mechanism for hydrogenative aldol reaction 
4.1.2.3 Rh-Catalyzed Hydrogenative Generation of Metallo-Aldehyde Enolates via 
Enal Hydrogenation.  
The utility of metallo-aldehyde enolates in the context of an aldol reaction is 
complicated by the formation of products that derive from polyaldolization, dehydration, 
and Tischenko-type reaction.14 Catalytic aldolizations using aldehyde enolates have been 
achieved indirectly through preformed enol silane, or via imminium ion-enamine 
catalysis. 15  Given the mild conditions of the Rh-catalyzed reductive aldol reaction, 
Krische and co-workers have shown that this method can be used to generate metallo-
 197
aldehyde enolates which are subsequently trapped by glyoxals (Table 4.5).16 The aldol 
products (β-hydroxy aldehydes) were not stable and therefore derivatization in situ to the 
corresponding pyridazine by adding methanolic hydrazine was performed. Coupling of 
acrolein and crotonaldehyde to a variety of aromatic and heroaromatic glyoxals is 
achieved under Rh-catalyzed hydrogenative reductive aldol conditions. Although the 
chemical yields are modest, this transformation represents a novel method for synthesis 
of pyridazine rings. 












































4.2 Catalytic Addition of Metallo-Aldehyde Enolates to Ketones 
Catalytic direct addition of metallo-aldehyde enolates to ketones is, to the best of 
our knowledge, unprecedented. Although a stoichiometric method to accomplish these 
aldolizations was reported by Oshima. 17  The primary issues limiting the utility of 
metallo-aldehyde enolates in cross-aldolizations with ketone partners are polyaldolization 
at the stage of enolate formation and the diminished thermodynamic driving force. 
According to the Ab initio calculations by Oshima, the formation of 3-hydroxyaldehyde 
((CH3)2CH(OH)CH2CHO from acetone and acetaldehyde has a formation energy of 
21.155 kcal/mol, whereas the formation of 3-hydroxyketone (CH3CH(OH)CH2COCH3) is 
exothermic with a formation energy of -10.455 kcal/mol. When generating alkali enolates 
from aldehydes polyaldolization is a big problem. For example if an aldehyde is treated 
with a base to form an enolate, as soon as this enolate is formed it will react with another 
molecule of the aldehyde to give an aldolate (Scheme 4.4). This aldolate contains a 
reactive aldehyde moiety which can react with another enolate, this process repeats to 



















Enolate AldolateAldehyde  
Scheme 4.4 Polyaldolization during enolate generation 
Inspired by the mild conditions for the intra- and intermolecular aldolization of 
enone pronucleophiles with glyoxals, aldehyde, and ketone acceptors7-8, 11,16 we directed 
our efforts to a more challenging variant: the cross-aldol reaction between aldehydes 
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enolates and ketones under hydrogenation conditions. Herein, we report an 
intramolecular catalytic cross-aldol cyclization of keto-enals under hydrogenation 
conditions.18 
4.2.1 Optimization 
To explore the viability of the catalytic addition of metallo-aldehyde enolates to 
ketones, keto-enal substrate 4.18a (Table 4.6) was synthesized via allylation of 2-methyl-
1,3-cyclohexanedione, followed by cross metathesis of the allylated product with acrolein 
using Grubbs second generation catalyst. Exposure of 4.18a to RhI(COD)2OTf (10 
mol%), PPh3 (24 mol%), and KOAc, (100 mol%) in dichloroethane (DCE) at 40 oC  
under an atmosphere of hydrogen (1 atm) gave the aldol product 4.18b in 23% yield, 
accompanied by a 50% yield of the simple conjugate reduction product 4.18c (Table 4.6, 
entry 1). Based on the mechanism, we speculated that the use of a stronger base could 
generate a Rh(I) enolate from Rh(III)(hydrido)-enolate thus shifting the mechanism to the 
monohydride catalytic cycle resulting in an increase in the desired aldol product. 
Accordingly, upon substituting potassium carbonate for potassium acetate the yield of 
4.18b increased to 40% (Table 4.6 entry 2). It was speculated that under dilute conditions 
polyaldolization associated with aldehyde enolates would be minimized. Indeed under 
more dilute conditions, 4.18b is obtained in 59% yield (Table 4.6, entry 3). Under 
identical conditions, but changing the solvent to THF the yield of 4.18b is increased to 
65% (Table 4.6, entry 4). Finally, using a more electron deficient phosphine ligands, 
4.18b is obtained in greater than 70% yield (Table 4.6, entries 5 and 6). All reactions 
were run at 40 °C, attempts to perform the reactions at room temperature caused 
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increased reaction time and diminished yields. These conditions were applied to other 
substrates to afford both 5- and 6- membered aldol cyclization products (Table 4.7). 































4.18b           4.18c
23%           (50%)
40%           (28%)
59%          (29%)
65%         (32%)
72%         (22%)






















4.2.2 Substrate Scope 
Under our standard conditions aldol cycloreduction proceeds well to provide 5-
membered bicyclic aldol products 4.18b and 4.19b in 72% and 73% yield, accompanied 
by 16% and 21% of 1,4 reduction products respectively. As illustrated by substrates 
4.20a and 4.21a, cyclization to form 6-membered rings occurs in slightly diminished 
yields due to increased levels of conjugate reduction products. Here, aldol reaction 
provides products 4.20b and 4.21b in 63% and 59% yields with 1,4 reduction products in 
30% and 29% respectively. The structural assignment of 4.18b and 4.21b were 
corroborated by single crystal x-ray diffraction analysis (Figure 4,1 and 4.2). The major 
diastereomer in both cases is the syn-aldol product.  
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4.18a, n = 2, m = 1
4.19a, n = 1, m = 1
4.20a, n = 1, m = 2



































4.18b-4.21b, Yield %, syn:anti, 






Figure 1 Relative stereochemistry as determined by single X-ray diffraction analysis for 









To expand the substrate scope of this new variant of catalytic aldol reaction, we 
explored other substrates (Scheme 4.5). Substrates 4.22a and 4.23a undergo 
cycloreduction to furnish aldol products 4.22b and 4.23b in moderate yields, these 
examples demonstrate that aromatic ketones are viable electrophilic partners in this 
transformation. The relative stereochemistry of the syn-aldol major product in 4.22b was 
confirmed by NOE experiments. Keto-enals 4.24a and 4.25a highlight the 
chemoselectivity of this aldolization reaction when non symmetrical ketones acceptors 
are used. For 4.24a the geminal dimethyl substitution makes one of the ketones sterically 
encumbered and thus the less sterically hindered ketone undergoes aldol cyclization. In 
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substrate 4.25a cyclization occurs onto the ketone and not the N-benzyl amide. Notably 
hydrogenolytic cleavage of N-benzyl amide is not observed. Monoenal monoketone 
substrate 4.26a undergoes reductive aldol cyclization efficiently, relative to the 1,3-dione 








4.22a, n = 1











4.22b, 63%, 1:3, syn:anti
4.22c, (21% 1,4 Reduction)
4.23b,  61%, 2:1, syn:anti











4.24b, 63%, 2:1, syn:anti














4.25b, 67%, 2:1, syn:anti













4.26b, 61%, 5:1, syn:anti




Scheme 4.5 Catalytic aldol cycloredution of keto-enals 4.22a-4.26a 
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 The observed syn-aldol stereochemistry of the product in this reaction can be 
rationalized by invoking a Zimmerman-Traxler transition state and the intermediacy of a 
(Z)-enolate (Scheme 10). The anti-aldol products observed could be attributed to 
isomerization of the enolates from (Z)-enolate to (E)-enolates. The modest syn:anti ratios 
are consistent with lack of selectivity inherent to aldol additions employing aldehyde 
enolates. 19  This methodology is the first example of catalytic addition of metallo-





















Scheme 4.6 Transition state model consistent with observed stereochemistry 
4.3 Summary and Concluding Remarks 
We have developed the first example of catalytic direct cross-aldolization of 
metallo-aldehyde enolates with ketones under hydrogenation conditions. These results 
and those previously studied in our group, involving catalytic hydrogen-mediated 
reductive coupling of enones to carbonyl acceptors support the feasibility of developing a 
broad class of catalytic C-C bond forming reactions using our enone-electrophile 
template. This catalytic cross-aldolization of aldehyde enolates with ketones still require 
some improvement, since the aldol products are formed in modest diastereoselectivity 
and are accompanied by simple reduction products. Future work will be devoted to the 
design of a catalyst system that would address these problems. 
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4.4 Experimental Section 
General 
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Anhydrous solvents were transferred by an oven-dried syringe. Flasks were flame-dried 
and cooled under a stream of argon. Dichloroethane was distilled from calcium hydride. 
Tetrahydrofuran was distilled from sodium and benzophenone. Acrolein was dried over 
magnesiun sulfate and then distilled under argon atmosphere. The acid derived from 
4.18b was prepared via Jones oxidation of 4.18b.20 
Analytical thin-layer chromatography (TLC) was carried out using 0.2-mm 
commercial silica gel plates (DC-Fertigplatten Krieselgel 60 F254). Preparative column 
chromatography employing silica gel was performed according to the method of Still.21 
Solvents for chromatography are listed as volume/volume ratios. Melting points were 
determined on a Thomas-Hoover melting point apparatus in a sealed tube. Infrared 
spectra were recorded on a Perkin-Elmer 1420 spectrometer. High-resolution mass 
spectra (HRMS) were obtained on a Karatos MS9 and are reported as m/e (relative 
intensity). Accurate masses are reported for the molecular ion (M+1) or a suitable 
fragment ion. 
Proton nuclear magnetic resonance (1H NMR) spectra were recorded with a 
Varian Gemini (300 MHz) spectrometer, a Mercury (400 MHz) spectrometer and an 
Inova (500 MHz) spectrometer. Chemical Shifts are reported in delta (δ) units, parts per 
million (ppm) downfield from trimethylsilane. Coupling constants are reported in Hertz 
(Hz). Carbon-13 nuclear magnetic resonance (13C NMR) spectra were recorded with a 
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Varian Gemini 300 (75 MHz) spectrometer, a Mercury 400 (100 MHz) spectrometer and 
an Inova 500 (125 MHz) spectrometer. Chemical shifts are reported in delta (δ ) units, 
parts per million (ppm) relative to the center of the triplet at 77.00 ppm for 
deuteriochloroform. 13C NMR spectra were routinely run with broadbrand decoupling. 
Representative Procedure for the Synthesis of Substrates 4.18a, 4.19a, 4.22a, 4.24a, 
4.24a, and 4.26a  
To a solution of Grubbs second-generation metathesis catalyst (0.142 g, 0.17 
mmol, 1 mol%) in anhydrous dichloromethane (100 mL) was added a solution containing 
2-allyl-2-methylcyclohexane-1,3-dione11 (2.77 g, 16.7 mmol, 100 mol%) in 
dichloromethane (70 mL) and acrolein (2.2 mL, 33.4 mmol, 200 mol%). The solution 
was refluxed overnight under an argon atmosphere. After removal of the solvent in vacuo 
the dark brown residue was purified via column chromatography (SiO2: hexane/ethyl 
acetate, 4:1) to yield 4.18a (1.77 g, 64%). 
Representative Procedure for the Synthesis of Substrates 4.20a, and 4.21a 
To a solution of 2-methyl-2-propionaldehyde-1,3-cyclopentanedione5 (1.53 g, 
9.08 mmol, 100 mol%) in 50 mL chloroform was added wittig reagent 
(formylmethylene)triphenylphosphorane (5.54 g 18.16 mmol, 200 mol%). The mixture 
was stirred overnight at 50 °C and then concentrated in vacuo to give a wet brown solid. 
This material was purified via column chromatography (SiO2: hexane/ ethyl acetate, 9:1 
to 7:3) to yield 4.20a (0.632 g, 35%). 
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Procedure for the Synthesis of Substrates 4.23a 
To a vigorously stirred mixture of 2-methyl-1, 3-indanedione22 (1 g, 6.25 mmol, 
100 mol%) and H2O (15 mL) was added acrolein (0.6 mL, 9.37 mmol, 150 mol%). The 
mixture was stirred at room temperature for 15h and then extracted with dichloromethane 
(3 x 20 mL), dried over MgSO4 and concentrated in vacuo to give a yellow oil (1.27 g 
94% yield) of sufficient purity for the next step. This material (1 g, 4.63 mmol 100 
mol%) was refluxed in chloroform with the wittig reagent 
(formylmethylene)triphenylphosphorane (2.82 g, 9.26 mmol, 200 mol%) for 18h. Product 
purification was done via column chromatography (SiO2: hexane/ ethyl acetate, 8:2) to 
give a yellow oil (0.56 g, 40%). 
(Benzylpropionylamino)-acetic acid ethyl ester 
To a solution containing benzylamino-acetic acid ethyl ester23 (13.5 g, 69.7 mmol, 
100 mol%) in chloroform (100 mL) and triethylamine (20 mL, 139.8 mmol, 200 mol%) 
at 0 ºC, was added propionyl chloride (7.2 mL, 76.8 mmol, 110 mol%) dropwise over 1h. 
The mixture was stirred for an additional hour at room temperature and then diluted with 
chloroform 200 mL and washed with 5% aqueous acetic acid (1 X 100 mL), water (1 X 
200 mL), brine (1 X 100 mL), and dried over MgSO4. The organic layer was evaporated 
in vacuo to afford a yellow liquid (17.24g, 99%) of sufficient purity for the next step.  
3- Allyl-1-benzyl-3-methylpyrrolidine-2,4-dione 
To a refluxing suspension of NaH (60% dispersion in mineral oil) (1.0 g, 22.07 
mmol, 110 mol%) in THF (50 mL), was added dropwise a solution of 
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(benzylpropionylamino)-acetic acid ethyl ester (5.0 g, 20.07 mmol, 100 mol%), in THF 
(50 mL). After addition was complete the reaction was refluxed for 12h during which a 
pale yellow solid formed. The mixture was cooled and the solid was filtered and dried in 
vacuo to yield a pale yellow solid (5.04g, 99%), of sufficient purity for the next step. To 
this material (3.0 g, 11.06 mmol, 100 mol%) in water (11 mL) allylbromide (2.68 g, 
22.12 mmol, 200 mol%) was added, this mixture was stirred at 50 °C for 15h. The 
reaction mixture was extracted with dichloromethane (3 X 10 mL), dried over MgSO4 
and concentrated in vacuo to give a yellow oil. This material was purified via column 
chromatography (SiO2: hexane/ethyl acetate, 8:2 to 6:4) to yield 1.72g, 64% of the title 
compound 
Benzoic acid 2-oxo-hex-5-enyl ester 
Benzoyl chloride (1.45 mL, 12.5 mmol, 110 mol%), was added dropwise to a 
stirred solution of 1-hydroxy-hex-5-en-2-one 24  (1.30 g, 11.3 mmol, 100 mol%) in 
pyridine (20 mL) and di-isopropylethylamine (1 mL) at 0 °C. The solution was stirred at 
this temperature for 1h and then at room temperature for 2h. The reaction mixture was 
evaporated at reduced pressure, the residue was treated with 20 mL of ice cold saturated 
with NaHCO3 and extracted with ethyl acetate (2 X 100 mL). The organic phase was 
washed with 6M HCl (1 X 10 mL), aqueous NaHCO3 (1 X 10 mL), and water (1 X 5 mL). 
The solution was dried over MgSO4 and the solvent removed in vacuo to afford a pale 
yellow liquid. This product was purified via column chromatography (SiO2: hexane/ethyl 
acetate, 4:1) to yield (2.43g, 99%) of a colorless liquid. 
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Representative Procedure for Catalytic Aldol Cycloreduction of Keto-enals 4.18a-
4.26a 
To a clean dry 25 mL round bottom flask charged with Rh(COD)2OTf (24 mg, 
0.0515 mmol, 10 mol%) and triphenylphosphine (32 mg, 0.123 mmol, 24 mol%) was 
added 10 mL of dry THF. The mixture was stirred for 10 minutes under argon 
atmosphere, at which point 4.18a (100 mg, 0.515 mmol, 100 mol%) and potassium 
carbonate (72 mg, 0.515 mmol, 100 mol%) was added. The system was purged with 
hydrogen gas and the reaction was allowed to stir at 40 ºC under 1 atm of hydrogen until 
complete consumption of substrate, at which point the solvent was evaporated and the 
product was purified via column chromatography 
7a-Hydroxy-3a-methyl-4-oxo-octahydroindene-1-carboxylic acid 4.18b-acid 
derivative. 
A chromic acid solution was added dropwise to a stirred solution of 4.18b (0.050 
g, 0.25 mmol, 100 mol%) in 2 mL ether at 0 °C. The addition continued until a persistent 
orange color was observed. The mixture was stirred for 30 minutes, at which point 
methanol was added until excess chromic acid had been destroyed. The mixture was 
filtered and the filtrate extracted with dichloromethane (3x10 mL). The extracts were 
combined, dried over MgSO4, concentrated in vacuo and purified via silica gel column 
chromatography dichloromethane/ethyl acetate 4:1 to yield 4.18b-acid derivative (0.036g, 
74%) as a white solid. 
.
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4-(1-Methyl-2,6-dioxocyclohexyl)but-2-enal 4.18a. 1H NMR (300 MHz, 
CDCl3): δ 9.43 (d, J = 7.9 Hz, 1H), 6.67 (dt, J = 15.6, 7.4 Hz, 1H), 6.09 (ddt, J = 15.6, 
7.2, 1.3, Hz, 1H), 2.74 (m, 4H), 2.60 (m, 2H), 2.09 (m, 1H), 1.87 (m, 1H), 1.39 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ 208.8, 193.6, 152.5, 135.6, 64.5, 37.6, 36.4, 23.2, 17.3. 
FTIR (NaCl): 2970, 2888, 2822, 1695, 1454, 1419, 1116, 917, 717, 640 cm-1. HRMS 
calcd for C11H15O3 [M+1] 195.1021 found 195.1016. 
 
 













 7a-Hydroxy-3a-methyl-4-oxo-octahydro-indene-1-carbaldehyde 4.18b 
Colorless oil, 1H NMR (300 MHz, CDCl3): δ 9.74 (d, J = 1.7 Hz, 1H), 2.58 (m, 4H), 2.54 
(m, 1H), 2.19 (m, 1H), 2.01 (m, 3H), 1.86 (m, 1H), 3.26 (m, 2H), 1.19 (s, 3H). 13C NMR 
(75 MHz, CDCl3): δ 212.3, 204.1, 85.4, 62.3, 54.9, 36.7, 31.2, 29.9, 20.5, 20.3, 17.9. 
FTIR (NaCl): 3447, 2965, 2883, 1695, 1460, 1419, 1352, 1306, 1202, 1152, 1081, 989 

















7a-Hydroxy-3a-methyl-4-oxo-octahydroindene-1-carboxylic acid 4.18b-acid 
derivative. 1H NMR (400 MHz, dmso-d6): δ 11.90 (br s, 1H), 5.74 (s, 1H), 2.58 (m, 1H), 
2.23 (m, 3H), 2.07-1.92 (m, 2H), 1.83 (m, 2H), 1.49 (m, 2H), 1.36 (m, 1H), 1.04 (s, 3H). 
13C NMR (75 MHz, dmso-d6): δ 212.8, 173.1, 83.8, 61.8, 48.4, 36.4, 29.4, 28.8, 21.6, 
19.8, 18.5. FTIR (NaCl): 3462, 2950, 2683, 1705, 1460, 1430, 1210, 1080, 930 cm-1. 
















4-(1-Methyl-2,6-dioxocyclohexyl)butyraldehyde 4.18c. Yellow oil, 1H NMR 
(300 MHz, CDCl3): δ 9.73 (t, J = 1.3 Hz, 1H), 268 (m, 4H), 2.43 (td, J = 5.8, 1.3 Hz, 2H), 
2.00 (m, 2H), 1.80 (m, 2H), 1.45 (m, 2H), 1.26 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 
210.1, 201.6, 65.4, 43.7, 37.9, 35.6, 20.4, 17.6, 17.4. FTIR (NaCl): 2964, 2871, 1727, 
1688, 1454, 1427, 1334, 1131, 933, 839 cm-1. HRMS: calcd for C11H17O3 [M+1] 





















4-(1-Methyl-2,5-dioxocyclopentyl)but-2-enal 4.19a. 1H NMR (300 MHz, 
CDCl3): δ 9.48 (d, J = 7.7 Hz, 1H), 6.71 (dt, J = 15.6, 7.4 Hz, 1H), 6.09 (ddt, J = 15.6, 
7.9, 1.3 Hz, 1H), 2.91 (m, 2H), 2.73 (m, 2H), 2.61 (dd, J = 8.7, 1.3 Hz, 2H), 1.21 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ 214.5, 193.1, 150.1, 136.2, 55.9, 36.2, 34.9, 20.0. FTIR 
(NaCl): 2965, 2842, 2755, 1736, 1680, 1342, 1413, 1127, 978, 814 cm-1.HRMS: calcd for 






















6a-Hydroxy-3a-methyl-4-oxo-octahydropentalene-1-carbaldehyde 4.19b. This 
product was obtained as an inseparable mixture of syn/anti (2:1) diastereomers. Colorless 
oil, 1H NMR (300 MHz, CDCl3): δ 9.76 (d, J =1.2 Hz, 0.5H (anti)), 9.80 (d, J = 1.5 Hz, 
1H (syn), 3.00 (td, J = 9.6, 1.4 Hz, 1H), 2.92 (s, 1H), 2.70 (td, J = 8.5, 1.4, Hz, 1H), 2.58 
(m, 1H). 13C NMR (75 MHz, CDCl3): δ 220.4, 203.6, 88.6, 59.7, 59.0, 35.5, 33.5, 32.3, 
23.8, 16.9. FTIR (NaCl): 3428, 2965, 2875, 1719, 1641, 1556, 1458, 1256, 1073, 754 cm-


















 4-(1-Methyl-2,5-dioxocyclopentyl)butyraldehyde 4.19c.Yellow oil, 1H NMR 
(400 MHz, CDCl3): δ 9.70 (t, J = 1.4 Hz, 1H), 2.81 (m, 4H), 2.41 (td, J = 7.2, 1.4 Hz, 
2H), 1.65 (m, 2H), 1.53 (m, 2H), 1.13 (s, 3H). 13C NMR (75.5 MHz, CDCl3): δ 216, 
201.2, 56.6, 43.7, 35.1, 34.2, 19.6, 17.1. FTIR (NaCl): 2936, 2869, 1724, 1452, 1378, 


















5-(1-Methyl-2,5-dioxocyclopentenyl)pent-2-enal 4.20a. 1H NMR (300 MHz, 
CDCl3): δ 9.47 (d, J = 8.6 Hz, 1H), 6.69 (dt, J = 15.6, 6.7 Hz, 1H), 6.05 (dd, J = 15.6, 7.9 
Hz, 1H), 2.79 (m, 4H), 2.23 (m, 2H), 1.86 (t, J = 7.9 Hz, 2H), 1.17 (s, 3H).13C NMR (100 
MHz, CDCl3): δ 215.7, 193.6, 156.2, 133.3, 56.0, 35.0, 32.0, 27.8, 20.3. FTIR (NaCl): 
2930, 2847, 1721, 1680, 1634, 1450, 1413, 1291, 1127, 1081, 994 cm-1. HRMS: calcd for 


















Colorless oil, 1H NMR (400 MHz, CDCl3): δ 9.79 (d, J = 0.7 Hz, 1H), 3.50 (s, 1H), 2.55 
(m, 1H), 2.33 (m, 1H), 2.24 (m, 2H), 2.06 (m, 1H), 1.78 (m, 3H), 1.57 (m, 1H), 1.34 (m, 
2H), 1.04 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 218.5, 205.3, 78.5, 53.9, 53.8, 33.9, 
31.1, 29.8, 22.4, 20.8, 17.4. FTIR (NaCl): 3416, 2939, 2848, 1711, 1716, 1454, 1378, 





















 3a-Hydroxy-7a-methyl-1-oxo-octahydroindene-4-carbaldehyde 4.20b-anti. 
Colorless oil, 1H NMR (400 MHz, CDCl3): 9.84 (d, J = 0.7 Hz, 1H), 2.72 (s, 1H), 2.55 
(m, 2H), 2.47 (m, 2H), 2.22 (m, 1H), 1.80 (m, 1H), 1.55 (m, 2H), 1.35 (m, 3H), 1.10 (s, 
3H). 13C NMR (75 MHz, CDCl3): δ 219.4, 205.7, 78.0, 53.9, 53.6, 32.7, 31.9, 27.3, 24.1, 
20.2, 12.6. FTIR (NaCl): 3421, 2934, 2840, 1710, 1644, 1449, 1306, 1219, 1178, 1086, 

















 5-(1-Methyl-2,5-dioxo-cyclopentyl)pentanal 4.20c. Yellow oil, 1H NMR (300 
MHz, CDCl3): δ 9.73 (t, J = 1.5 Hz 1H), 2.76 (m, 4H), 2.41 (td, J = 7.2, 1.5 Hz, 2H), 1.64 
(m, 2H), 1.55 (q, J = 7.5 Hz, 2H), 1.15 (m, 2H), 1.11 (s, 3H). 13C NMR (75.5 MHz, 
CDCl3): δ 216.5, 201.9, 56.5, 43.3, 35.2, 35.0, 24.1, 22.1, 19.4. FTIR (NaCl): 2929, 2719, 
1762, 1716, 1460, 1419, 1373, 1291, 1096, 1045, 989 cm-1. HRMS: calcd for C11H17O3 
































5-(1-Methyl-2,6-dioxocyclohexyl)pent-2-enal 4.21a. Yellow solid 1H NMR (300 
MHz, CDCl3): δ 9.48 (d, J = 7.9 Hz, 1H), 6.77 (dt, J = 15.6, 6.7 Hz, 1H), 6.08 (dd, 15.6, 
7.9 Hz, 1H), 2.71 (m, 4H), 2.04 (m, 2H), 1.99 (m, 4H), 1.32 (s, 3H).13C NMR (75 MHz, 
CDCl3): δ 209.9, 193.9, 157.1, 133.0, 64.6, 38.0, 32.9, 28.2, 22.7, 17.4. FTIR (NaCl): 
2990, 2951, 2834, 1724, 1693, 1642, 1456, 1219, 1130, 1025, 916 cm-1. HRMS: calcd for 
C12H17O3 [M+1] 209.1178 found 209.1175. MP 51-53 °C. 
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White solid, 1H NMR (300 MHz, CDCl3): δ 9.76 (d, J = 2.7 Hz, 1H), 2.67 (s, 1H), 2.58 
(m, 1H), 2.41 (m, 1H), 2.28 (m, 1H), 2.17 (m, 1H), 2.02 (m, 1H), 1.91 (m, 2H), 1.71 (m, 
4H), 1.49 (m, 2H), 1.19 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 212.9, 205.2, 75.2, 54.4, 
53.2, 36.3, 31.6, 29.4, 22.3, 21.9, 21.3, 18.9. FTIR (NaCl): 3417, 2945, 2845, 1712, 1629, 
1459, 1178, 1166, 962 cm-1 HRMS: calcd for C12H19O3 211.1334; [M+1] found 211.1330. 














5-(1-Methyl-2,6-dioxocyclohexyl)pentanal 4.21c.Yellow oil, 1H NMR (400 
MHz, CDCl3); δ 9.70 (t, J = 1.7 Hz, 1H), 2.62 (m, 4H), 2.38 (td, J = 5.8, 1.7 Hz, 2H), 
1.91 (m, 2H), 1.76 (m, 2H), 1.54 (qt, J = 7.4 Hz, 2H), 1.19 (s, 3H), 1.10 (m, 2H). 13C 
NMR (100 MHz, CDCl3): δ 210.2, 202.1, 65.3, 43.4, 37.9, 36.4, 24.2, 22.1, 20.0, 17.5. 
FTIR (NaCl): 2940, 1721, 1685, 1454, 1419, 1367, 1342, 1224, 1183, 1132, 1106, 1019, 




















4-(2-Methyl-1,3-dioxoindan-2-yl)but-2-enal 4.22a. White solid 1H NMR (400 
MHz, CDCl3): δ 9.37 (d, J = 7.9 Hz, 1H), 8.00 (m, 2H), 7.91 (m, 2H), 6.66 (dt, J = 15.3, 
7.7, Hz, 1H), 6.10 (ddt, J = 14.3, 7.9, 1.0 Hz, 1H), 2.77 (dd, J =7.9, 1.4 Hz, 2H), 1.35 (s, 
3H). 13C NMR (100 MHz, CDCl3): δ 202.6, 193.2, 150.5, 140.6, 136.3, 136.1, 123.7, 
53.2, 37.1, 19.5. FTIR (NaCl): 3083, 2974, 2924, 2858, 1739, 1700, 1677, 1603, 1266, 
974 cm-1 HRMS: calcd for C14H13O3 [M+1] 229.0865 found 229.0854. MP 92-94 °C. 
 
 

















carbaldehyde 4.22b-syn. Colorless oil, 1H NMR (400 MHz, CDCl3): δ 9.91 (d, J = 1.0 
Hz, 1H), 7.75 (m, 3H), 7.55 (m, 1H), 3.83 (s, 1H), 3.14 (dd, J = 5.1, 2.4, Hz, 1H), 2.16 
(m, 1H), 2.00 (m, 1H), 1.76 (m, 1H), 1.42 (m, 1H), 1.26 (s, 3H). 13C NMR (125 MHz 
DMSO-d6): δ 208.3, 202.8, 156.6, 136.1, 134.0, 129.5, 125.3, 122.6, 87.5, 60.4, 59.4, 
35.9, 24.1, 18.5. FTIR (NaCl) 3421, 3064, 2940, 2862, 1704, 1603, 1460, 1382, 1297, 













































carbaldehyde 4.22b-anti. Colorless oil, 1H NMR (300 MHz, CDCl3): δ 9.71 (d, J = 2.4 
Hz, 1H), 7.75 (dt, J = 8.9, 1.0 Hz, 1H), 7.67 (td, J = 6.5, 1.4 Hz, 1H), 7.58 (d, J = 7.5 Hz, 
1H), 7.51 (td, J = 6.8, 1.0 Hz, 1H), 3.14 (m, 1H), 2.68 (s, 1H), 2.32 (dd, J = 6.5, 5.7 Hz, 
1H), 1.71 (m, 2H,) 1.18 (m, 4H). 13C NMR (100 MHz, CDCl3): δ 208.5, 203.8, 155.1, 
136.2, 135.2, 129.8, 124.8, 123.4, 87.9, 60.2, 59.2, 36.0, 23.8, 18.3. FTIR (NaCl): 3440, 
2974, 2877, 1704, 1603, 1464, 1258, 1052, 1006, 699 cm-1. HRMS: calcd for C14H15O3 



































































4-(2-Methyl-1,3-dioxo-indan-2-yl)butyraldehyde 4.22c. White solid, 1H NMR 
(300 MHz, CDCl3): δ 9.65 (t, J = 1.4 Hz, 1H), 7.99 (m, 2H), 7.89 (m, 2H), 2.36 (td, J = 
6.2, 1.4 Hz, 2H), 1.84 (m, 2H), 1.42 (m, 2H), 1.29 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 
204.5, 201.6, 141.4, 136.2, 123.7, 54.0, 44.8, 34.8, 20.1, 17.8. FTIR (NaCl): 3433, 2943, 
2839, 2741, 1739, 1700, 1604, 1460, 1374, 1289, 1239, 990, 792, 730 cm-1. HRMS: calcd 





















5-(2-Methyl-1,3-dioxoindan-2-yl)pent-2-enal 4.23a. Yellow oil, 1H NMR (400 
MHz, CDCl3); δ 9.36 (d, J = 7.9 Hz, 1H), 7.94 (m, 2H), 7.85 (m, 2H), 6.62 (dt, J = 15.7, 
6.5 Hz, 1H), 5.84 (ddt, J = 15.7, 7.5, 1.7 Hz, 1H), 2.15 (m, 2H), 1.98 (m, 2H) 1.27 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 203.7, 193.5, 156.2, 140.9, 136.0, 133.1, 123.4, 53.2, 
32.7, 28.1, 20.0. FTIR (NaCl): 3083, 2966, 2920, 2815, 1743, 1701, 1592, 1444, 1266, 























carbaldehyde 4.23b. Colorless oil, 1H NMR (300 MHz, CDCl3): δ 9.81 (d, J = 0.2 Hz, 
1H), 7.76 (d, 7.5 Hz, 1H), 7.63 (m, 2H), 7.46 (m, 1H), 4.16 (s, 1H), 2.25 (m, 2H), 1.80 (m, 
2H), 1.67 (m, 1H), 1.55 (m, 1H), 1.27 (m, 1H), 1.08 (s, 3H). 13C NMR (75 MHz, CDCl3): 
δ 205.7, 204.5, 156.0, 134.5, 133.4, 128.9, 124.1, 78.7, 59.4, 56.9, 29.6, 23.0, 22.1, 21.5. 
FTIR (NaCl): 3417, 2944, 2870, 1709, 1611, 1468, 1297, 1204, 1048, 761 cm-1. HRMS: 
















4-(2-Methyl-1,3-dioxo-indan-2-yl)pentanal 4.23c.Yellow oil, 1H NMR (300 
MHz, CDCl3): δ 9.63 (t, J = 1.7 Hz, 1H), 7.95 (m, 2H), 7.84 (m, 2H), 2.29 (td, J =7.5, 1.5 
Hz, 2H), 1.80 (m, 2H), 1.49 (qt, J = 7.2 Hz, 2H), 1.24 (s, 3H), 1.10 (m, 2H). 13C NMR 
(75 MHz, CDCl3): δ 204.5, 202.1, 141.2, 135.9, 123.4, 53.8, 43.3, 35.1, 24.5, 22.2, 19.8. 
FTIR (NaCl):  2927, 2850, 1740, 1701, 1598, 1462, 1260, 971, 716 cm-1. HRMS: calcd 

























4-(1,3,3-Trimethyl-2,5-dioxo-cyclopentyl)but-2-enal 4.24a. Yellow oil,.1H NMR (400 
MHz, CDCl3): δ 9.48 (d, J = 7.9 Hz, 1H), 6.67 (dt, J = 15.7, 7.5 Hz, 1H), 6.10 (ddt, J = 
15.7, 7.9, 1.4 Hz, 1H), 2.75 (A part of AB system, J = 18.3 Hz, 1H), 2.58 (dd, J = 7.5, 
1.0, Hz, 2H), 2.55 ( B part of AB system, J = 18.3 Hz, 1H) 1.30 (s, 3H), 1.23 (s, 3H), 
1.18 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 219.2, 214.5, 193.1, 150.4, 136.2, 55.5, 
50.5, 46.5, 37.0, 26.0, 25.1, 21.1. FTIR (NaCl): 2971, 2928, 2873, 1720, 1689, 1452, 

























4.24b-syn. Colorless oil, 1H NMR (300 MHz, CDCl3): δ 9.75 (d, J = 1.4 Hz, 1H), 3.27 (s, 
1H), 2.89 (m, 1H), 2.15 (m, 1H), 2.00 (m, 3H), 1.78 (m, 1H), 1.59 (m, 1H), 1.19 (s, 3H), 
1.16 (s, 3H), 1.11 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 225.3, 204.3, 86.8, 60.4, 59.2, 
50.2, 46.0, 35.3, 27.4, 26.0, 23.0, 18.5. FTIR (NaCl): 3479, 2967, 2862, 1716, 1460, 1375, 























4.24b-anti. Colorless oil, 1H NMR (300 MHz, CDCl3): δ 9.93 (d, J = 1.4 Hz, 1H), 2.94 (t, 
J = 8.5 Hz, 1H), 2.10 (s, 1H), 1.93 (m, 5H), 1.66 (m, 1H), 1.19 (s, 3H), 1.18 (s, 3H) 1.14 
(s, 3H). 13C NMR (75 MHz, CDCl3): δ 223.8, 203.4, 87.0, 61.5, 59.4, 45.6, 45.5, 34.6, 
26.8, 26.4, 20.9, 17.8. FTIR (NaCl): 3409, 2966, 2862, 1716, 1448, 1456, 1262, 1176 






















4-(1,3,3-Trimethyl-2,5-dioxo-cyclopentyl)butyraldehyde 4.24c. Yellow oil, 1H 
NMR (400 MHz, CDCl3): δ 9.70 (t, J = 1.4 Hz, 1H), 2.69 (A part of AB system, J = 18.5 
Hz, 1H), 2.59 (B part of AB system, J = 18.5 Hz, 1H), 2.39 (td, J = 7.2, 1.4 Hz, 2H), 
1.63 (m, 2H), 1.40 (m, 2H), 1.26 (s, 3H), 1.24 (s, 3H), 1.17 (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ 220.9, 216.1, 201.2, 56.2, 50.9, 46.3, 43.7, 34.4, 26.5, 24.9, 21.0, 17.4. FTIR 
NaCl: 2971, 2927, 1723, 1636, 1456, 1130, 1010 cm-1. HRMS calculated [M+1] for 






























(Benzylpropionylamino)-acetic acid ethyl ester.This compound was isolated as 
a mixture of rotomers in the ratio (1.2:1). 1H NMR (400 MHz, DMSO-d6): δ 7.29 (m, 
5H), 4.62, 4.49 (2s, 2H), 4.12, 3.99 (2s, 2H), 4.06 (m, 2H), 2.31 (2q, J = 8.5 Hz, 2H), 
1.14 (2t, J = 5.5 Hz, 3H), 0.96 (2t, J = 7.5 Hz, 3H). 13C NMR (100 MHz, DMSO-d6): δ 
173.7, 173.5, 169.6, 169.2, 137.6, 137.4, 128.6, 128.3, 127.8, 127.3, 127.1, 126.8, 60.8, 
60.3, 51.6, 49.2, 48.7, 48.0, 25.3, 25.2, 14.0, 13.9, 14.0,13.9, 9.2. FTIR (NaCl):  3064, 
3033, 2994, 2947, 1743, 1650, 1471, 1386, 1188, 1033, 904 cm-1. HRMS: calcd for 





















3-Allyl-1-benzyl-3-methylpyrrolidine-2,4-dione.Yellow oil. 1H NMR (300 MHz, 
CDCl3): δ 7.29 (m, 5H), 5.64 (m, 1H), 5.06 (d, J = 17.1 Hz, 2H), 4.75 (A part of AB 
system, J = 14.6 Hz, 1H), 4.54 (B part of AB system, J = 14.5 Hz, 1H), 3.65 (A part of 
AB system, d, J = 17.8 Hz, 1H), 3.52 (B part of AB system, d, J = 17.8 Hz, 1H), 2.44 (m, 
2H), 1.25 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 210.2, 174.4, 135.1, 131.5, 128.9, 128.3, 
128.0, 119.8, 54.6, 51.8, 45.8, 40.0, 19.4. FTIR (NaCl): 3064, 3033, 2967, 2920, 1775, 


























4-(1-Benzyl-3-methyl-2,4-dioxopyrrolidin-3-yl)but-enal 4.25a. Yellow oil, 1H NMR 
(400 MHz, CDCl3): δ 9.35 (d, J = 7.9 Hz, 1H), 7.35 (m, 3H), 7.24 (m, 2H), 6.63 (td, J = 
15.4, 7.5  Hz, 1H), 6.11 (ddt, J = 15.7, 7.9, 1.4, Hz, 1H), 4.81 (A part of AB system,  J =  
14.7 Hz, 1H), 4.47 (B part of AB system,  J = 14.7 Hz, 1H) 3.76 (A  part of AB system, J 
= 18.1, 1H), 3.58 (B part of AB system  J = 18.1 Hz, 1H) 2.68 (m, 2H), 1.32 (s, 3H). 13C 
NMR (100MHz, CDCl3): δ 208.8, 193.1, 173.4, 149.9, 136.3, 134.8, 129.1, 128.3, 65.8, 
54.2, 50.9, 46.0, 37.4, 19.8, 15.2. FTIR (NaCl): 3033, 2928, 2847, 2746, 1775, 1678, 

























carbaldehyde 4.25b. Colorless oil, 1H NMR (400 MHz, CDCl3): δ 9.71 (d, J = 1.0 Hz, 
1H), 7.31 (m, 3H), 7.17 (m, 2H), 4.45 (AB system, 2H), 3.45 (s, 1H), 3.26 (s, 2H), 2.77 (t, 
J = 7.3 Hz, 1H), 2.27 (m, 1H), 2.04 (m, 1H), 1.80 (m, 1H), 1.67 (m, 1H), 1.22 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 203.8, 177.5, 135.9, 128.8, 128.7, 128.1, 127.8, 127.8, 
83.1, 60.4, 56.8, 54.9, 46.4, 34.7, 23.7, 17.1. FTIR (NaCl): 3390, 2824, 2858, 2365, 2334, 

























4-(1-Benzyl-3-methyl-2,4-dioxo-pyrrolidin-3-yl)butyraldehyde 4.25c. Yellow 
oil, 1H NMR (400 MHz, CDCl3): δ 9.71 (d, J = 1.4 Hz, 1H), 7.31 (m, 5H), 4.66 (s, 2H), 
3.72 (A part of AB system, J = 18.1 Hz, 1H), 3.63 ( B part of AB system d, J = 18.7 Hz, 
1H), 2.41 (t, J = 6.5 Hz, 2H), 1.75 (m, 2H), 1.57 (m, 1H), 1.45 (m, 1H) 1.25 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 210.5, 201.2, 174.7, 135.1, 129.0, 128.4, 128.2, 54.4, 51.4, 
45.9, 43.7, 34.8, 20.2, 17.4. FTIR (NaCl): 2967, 2916, 2843, 1777, 1689, 1441, 1262 cm-1. 






















Benzoic acid 2-oxohex-5-enyl ester. Colorless liquid 1H NMR (300 MHz, 
CDCl3): δ 8.10 (m, 2H), 7.53 (m, 3H), 5.79 (m, 1H), 5.03 (m, 2H), 4.87 (s, 2H), 2.58 (t, J 
= 7.0 Hz, 2H), 2.37 (q, J = 6.7 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 203.2, 165.8, 
136.4, 133.4, 133.4, 129.8, 129.1, 128.8, 115.7, 68.4, 38.0, 27.1. FTIR (NaCl): 3080, 
2982, 2912, 1798, 1716, 1608, 1448, 1413, 1278, 1215, 1118, 1076, 982 cm-1. HRMS: 























Benzoic acid 2,7-dioxo-hept-5-enyl ester 4.26a. White solid 1H NMR (400 MHz, 
CDCl3): δ 9.45 (d, J = 7.7 Hz, 1H), 8.05 (d, J = 5.6 Hz, 2H) 7.56 (m, 1H), 7.43 (t, J = 
12.0 Hz, 2H), 6.82 (dt, J = 6.7, 15.6 Hz, 1H), 6.08 (ddt, J =15.9, 7.9, 1.3, Hz, 1H), 4.86 
(s, 2H), 2.71 (m, 2H), 2.63 (t,  J = 5.1 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 202.3, 
193.6, 165.8, 155.7, 133.5, 133.4, 129.7, 128.8, 128.5, 68.2, 36.5, 25.6. FTIR (NaCl): 
3068, 2932, 2815, 2741, 1736, 1681, 1452, 1266, 1130, 1087, 1029, 974 cm-1. HRMS: 






















Benzoic acid 2-formyl-1-hydroxycyclopentylmethyl ester 4.26b. Colorless oil, 
1H NMR (400 MHz, CDCl3): δ 9.88 (d, J = 2.0 Hz, 1H), 8.03 (dd, J = 6.5, 1.4  Hz, 2H), 
7.58 (tt, J = 7.5 Hz, 1.0 1H), 7.46 (t, J = 8.2 Hz, 2H), 4.49 (A part of AB system, J = 
11.4 Hz, 1H), 4.42 (B part of AB system, J = 11.4 Hz, 1H), 3.08 (s, 1H), 2.80 (t,d, J = 
8.9, 2.0 Hz, 1H), 2.20 (m, 1H), 2.01 (m, 2H), 1.87 (t, J = 6.5, 2H), 1.76 (m, 1H). 13C 
NMR (100 MHz, CDCl3): δ 204.1, 166.6, 133.3, 129.7, 129.5, 128.5, 82.6, 70.3, 57.3, 
38.1, 25.7, 22.4. FTIR (NaCl): 3452, 3056, 2963, 1720, 1445, 1270, 1102, 1017 cm-1. 

























































Benzoic acid 2.7-dioxo-heptyl ester 4.26c. Colorless oil, 1H NMR (400 MHz, 
CDCl3): δ 9.76 (t, J = 1.7 Hz, 1H), 8.09 (d, J = 7.2 Hz, 2H), 7.59 (t, J = 7.2 Hz, 1H), 
7.46 (t, J = 7.9, 2H), 4.87 (s, 2H), 2.54 (t, J = 7.2, 2H), 2.46 (m, 2H), 1.68 (m, 2H). 13C 
NMR (100 MHz, CDCl3): δ 203.6, 202.0, 165.8, 133.4, 129.8, 129.1, 128.5, 68.4, 43.5, 
38.4, 22.5, 21.4. FTIR (NaCl): 2935, 2881, 2722, 1720, 1596, 1448, 1274, 1177, 1099, 
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